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ABSTRACT 
 
Colorectal cancer is the third most common cancer worldwide, and nutrition has been 
reported to play an important role on its incidence, development and prevention. Moreover, 
a high fat diet has been related to the risk of obesity, inflammation and cancer. This thesis 
tests the possible preventive effects of fatty acids, and phytochemicals on the prevention of 
colorectal cancer in two separate experiments. The animal model used in this work was the 
ApcMin/+ mouse, which has been described as an excellent model for chemopreventive 
studies of colorectal cancer, because it mimics the rapid development of adenomatous 
polyposis in humans. In both studies a high fat diet was used and the endpoints of interest 
were body and organs weight, mitosis and apoptosis in the small intestine and colon tissue, 
local and systemic cytokines levels, and tumour number and size. In the fatty acids 
experiment mice were treated for ten weeks with diets rich in corn, palm or fish oil. While 
in the phytochemical experiment mice were treated with a mix of coffee, cocoa, walnuts, 
turmeric, thyme and berries. The results of the present study is not consistent with those 
showing a beneficial effect of fish oil or phytochemical on cancer prevention. Although 
fish oil reduced tumour size, it was unable to reduce tumour number, cell proliferation and 
levels of pro-inflammatory cytokines. The phytochemical diet also failed to show any 
protective effect against colorectal cancer development, but instead increased tumour size 
and number, as well as the levels of pro-inflammatory cytokines. In the present study fish 
oil and phytochemicals did not have a positive effect on prevention of colorectal cancer in 
ApcMin/+ mouse. 
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1. GENERAL INTRODUCTION 
 
1.1. COLORECTAL CANCER 
 
1.1.1. Basic concepts and epidemiology 
 
Cancer is a group of more than 100 diseases characterized by uncontrolled cellular growth 
as a result of changes in the genetic information of cells. Cells and tissues are complex 
systems with critical stages and checkpoints to ensure normal growth, development, and 
function. Normally the division, differentiation, and death of cells are carefully regulated. 
All cancers start as a single cell that has lost control of its normal growth and replication 
process. 
 
Cancer of prostate, female breast, colon and lung are the most common cancers and 
comprise almost half of the total cancer burden. In men, prostate cancer continues to be the 
most frequent cancer, followed by lung and colorectal cancer, while breast cancer remains 
the most frequent neoplasm in women, followed by colorectal cancer. In Norway, in 2008, 
26,121 people were diagnosed with cancer, for which 14,000 occurred among men and 
12,121 among women. The most common cancers in Norway are the same as the ones 
observed in the United Kingdom (Norway 2009; UK 2010).  
 16
73 %
20 %
7 %
Sporadic CRC Familial CRC Hereditary CRC syndromes
 
Figure 1.1 Classification of colorectal cancer (Rodriguez-Bigas, Cutait et al. 2010). 
 
Colorectal cancer (CRC) is a cancer that forms either in the tissues of the colon or of the 
rectum, and the main types are: i) adenocarcinomas; ii) squamous cell carcinomas; iii) 
carcinoid tumours; iv) sarcomas; and v) lymphomas. More than 95% of colorectal cancers 
are adenocarcinomas with the cancer starting in the gland cells in the lining of the 
intestinal wall.  Colorectal cancer can be classified into three forms according to the way 
that it has developed, which are hereditary, familial and sporadic (Figure 1.1). The 
proportion of each form may be different in different populations, but generally the 
majority of colorectal cancer cases are considered sporadic. The most common hereditary 
syndrome is Hereditary Non-Polyposis Colorectal Cancer (HNPCC), and the second most 
common is the Familial Adenomatous Polyposis Coli (FAP), in which disease occurs due 
to germline mutation of the Adenomatous Polyposis Coli (APC) gene (Jankowski 2008). 
 
Colorectal cancer is more prevalent in North America, Argentina, Australia, New Zealand 
and parts of Europe, Japan, and Israel, and for this reason, is commonly regarded as a 
Western lifestyle disease. Colorectal cancer is one of the most frequent cancers worldwide. 
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In 2007, 298,000 new cases of cancer were recorded in the United Kingdom according to 
the report from Cancer Research UK (UK 2011). 
 
1.1.2. Types of colorectal cancer 
 
1.1.2.1. Hereditary non-polyposis colorectal cancer (HNPCC) 
 
Hereditary non-polyposis colorectal cancer is also known as Lynch syndrome and cancer 
family syndrome. In hereditary non-polyposis colorectal cancer, colon malignancies 
usually occur from a single or a few adenomas. HNPCC is an autosomal dominant 
condition caused by mutation of one of the mismatch repair (MMR) genes. These genes 
are responsible for maintaining the fidelity of DNA by correcting base-pair mismatches 
that occur during cell replication. MutL homolog 1 (MLH1), MutS homolog 2 (MSH2), 
MutS homolog 3 (MSH3), MutS homolog 6 (MSH6) and postmeiotic segregation 
increased 2 (PMS2) are the main proteins involved in this system. When a mismatch is 
detected, a number of steps take place: MSH2 associates with either MSH6 or MSH3, and 
MLH1 couples with PMS2, PMS1, or MLH3. The recognition of mismatches and 
insertion-deletion loops is carried out by the complex formed by a MutS and a MutL, 
which interacts with replication factor C. Excision of the mismatch is performed by 
proteins such as exonuclease 1 and proliferating cell-nuclear antigen. Finally, resynthesis 
and re-ligation of the DNA strand is carried out by DNA polymerase $ and DNA ligase 
(Figure 1.2) (Vilar and Gruber 2010). 
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Figure 1.2  Model of the proposed mechanism of mismatch repair proteins (Vilar and Gruber 
2010). 
 
If the repair process is damaged the microsatellite sequences can lose or gain nucleotides 
and this phenomenon is termed microsatellite instability (MSI). Ultimately, loss of 
function of DNA repair proteins results in genomic instability that promotes mutations in 
other genes and facilitates malignant transformations. HNPCC accounts for about 1% to 
3% of all colorectal cancer. The lifetime risk of colorectal cancer in persons with a MMR 
gene mutation approaches 80%, and the mean age at diagnosis of colorectal cancer in this 
syndrome is 44 years old (Gearhart and Ahuja 2010). 
 
HNPCC is caused by mutation in one of four DNA MMR genes: MSH2, MLH1, PMS2, 
and MSH6. The germline mutations of MSH2 and MLH1 account for more than 90% of 
the mutations found in HNPCC families. It seems that the genetic pathway leading to 
tumorigenesis in HNPCC considerably overlaps with the sporadic and FAP cancer, but 
there are differences in the involvement of the different genes. Tumours of the HNPCC 
pathway also show mutations of APC, p53 and K-ras genes, but the incidence of p53 and 
K-ras mutation is less frequent than in chromosomal instability (Gearhart and Ahuja 2010). 
.  
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In addition, there are certain genes involved with important roles in the regulation of cell 
growth that have coding microsatellite sequences, such as transforming growth factor #1 
receptor II (TGF-#1RII), retinoblastoma-protein-interacting zinc fingers (RIZ), T-cell 
factor 4 (TF4), bcl-2-associated X protein (BAX), and insulin-like growth factor II receptor 
(IGFRIIR). Among these, the tumorigenic role of TGF-#1RII and BAX mutations is the 
best characterized. Mutation of TGF-#1RII is the most common among the above-
mentioned genes, occurring in about 90% of MSI-associated cancers. Change of function 
of this receptor leads to dysregulation of the SMAD protein pathway that has an important 
role in transcription regulation. The BAX gene is affected in about 33% of MSI-associated 
cancers, and the mutation of this gene leads to disruption of the function of B-cell 
CLL/lymphoma 2 (bcl-2) mediated apoptosis pathway (Jankowski 2008). 
 
Histologically, HNPCC is more likely to be poorly differentiated, abundant in extra-
cellular mucin, and distinguished by a lymphoid host response to the tumour. HNPCC 
patients and family members can develop a wide range of extracolonic malignancies. The 
highest risk for other tumours is that for endometrial cancer (40-70% lifetime risk). Also, 
these patients can have adenocarcinomas of the stomach, small bowel, biliary tract or 
ovary and transitional cell carcinoma of the ureter. The lifetime risk for these cancers range 
between 2% and 13% (Rozen 2001). 
 
1.1.2.2. Familial Adenomatous polyposis (FAP) 
 
Familial adenomatous polyposis is a rare autosomal dominant disease with almost 100% 
penetrance. The disease is maintained in the population at a frequency of about 1 in 8000, 
and is characterized by a large number of colorectal adenomas, more than 100, and 
accounts for approximately 1% to 2% of all colorectal cancer.  FAP is inherited as an 
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autosomal dominant disease caused by a germline mutation of the tumour suppressor gene 
APC. In this condition, one mutated APC allele is inherited as a germline mutation from 
the affected parent, and adenomas develop when the second allelle (from the unaffected 
parent) becomes mutated or lost. The identification of an interstitial deletion on 
chromosome 5q21 in a patient with Garder’s syndrome, followed by linkage analysis, led 
to the positional cloning of the adenomatous polyposis coli gene in 1991. APC is a large 
gene, encompassing 15 exons with an open reading frame of 8538 base pair. It encodes a 
protein of 2843 amino acids with a molecular weight of 310kDa. More than 800 different 
germline mutations in the APC gene have been published and the most (>90%) are 
nonsense mutations and frameshift mutations that lead to premature stop codons. The 
resulting protein is truncated and presumably non-functional (Spigelman, Phillips et al. 
1994).  
 
The APC protein (Figure 1.3) is a multifaceted regulator of colonic epithelial cell 
homeostasis and participates in the process of cell proliferation, migration, differentiation, 
apoptosis, and chromosomal segregation (Sieber, Tomlinson et al. 2000) . The proximal 
portion of the APC protein contains regions that enable oligomerization as well as binding 
to proteins that regulate the actin cytoskeleton, thereby affecting cell morphology, polarity, 
and migration. In its central portion, the APC protein binds to #-catenin, a protein that 
normally maintains cell-cell junctions by anchoring a cell surface adhesion molecule, E-
cadherin. The carboxy-terminal portion of APC contains a domain that contributes to 
proper chromosomal segregation and cytoskeleton regulation. Because the vast majority of 
APC mutations truncate the protein, this has the dual effect of disrupting the constitutive 
breakdown of #-catenin, leading to activation of cancer-associated genes, and creating 
abnormal chromosomal segregation, leading to chromosomal instability (Fodde, Smits et 
al. 2001) 
 21
 
 
It is not the mutation itself that is of relevance, but its localization within the gene, since it 
defines the length of the mutant APC protein. The FAP phenotype (age of onset, type and 
number of intestinal polyps and extracolonic tumours) correlates somewhat with the type 
and location of APC mutations. Generally, mutations in the central region of the gene give 
a profuse polyposis phenotype with thousands of intestinal polyps. A deletion of 5 base 
pairs at codon 1309 is the most frequent mutation (18% of all FAP patients). Another 
frequent mutation is a deletion of 5 base pairs at codon 1061 (12% of all FAP patients). 
Despite the above genotype-phenotype correlations, various reports suggest that the 
location of the mutation along the APC gene is not the sole determinant of phenotype, and 
that other genetic and environmental factors may play a role (Jankowski 2008). 
 
The majority of patients with FAP develop hundreds to thousands of colorectal polyps. 
Polyp development starts in the distal colorectum at an average age of 15 years, and most 
patients become symptomatic by the age of 25-30 years. The number and size of these 
polyps increases with time, ultimately reaching 100 to 5000 in number. Usually there is a 
positive family history. However, up to 25% of FAP patients do not have a family history, 
suggesting spontaneous germline mutations in these patients (Spigelman, Phillips et al. 
1994). 
Figure 1.3 The adenomatous polyposis coli (APC) protein. (Fodde, Smits et al. 2001). 
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APC mutations occur in up to 80% of adenomas and adenocarcinomas and 4.3% of the 
preneoplastic lesion called an aberrant crypt foci or ACF (Powell, Zilz et al. 1992). An 
important function of the APC gene is the prevention of accumulation of #-catenins. APC 
protein translated from the APC gene is a major factor in the WNT signalling pathway 
(Figure 1.4) and APC regulates cell proliferation by binding and degrading #-catenin 
protein that promotes cell proliferation (Aoki and Taketo 2007).  In the absence of a WNT 
signal, the level of free intracellular -catenin is minimized by sending it for degradation 
in the proteasome. Free cytoplasmic -catenin, which is in equilibrium with -catenin at 
adherens junctions, is recruited to a 'destruction complex' containing APC, axin/conductin 
and glycogen synthase kinase 3  (GSK3 ). GSK3  phosphorylates -catenin, allowing it 
to be recognized by an SCF (Skp1-Cul1-Fbox) complex containing the F-box protein -
TrCP. Other proteins in the SCF complex catalyse the addition of a polyubiquitin chain to 
-catenin, allowing -catenin to be recognized and degraded by the proteasome. 
Consequently, -catenin cannot reach the nucleus, and cannot co-activate TCF-responsive 
genes. Groucho, a corepressor, also prevents the activation of TCF-responsive genes in the 
absence of -catenin (Fodde, Smits et al. 2001).  
 
However, In the presence of WNT, its receptor, Frizzled, in complex with LRP6, is 
activated. This leads to a poorly understood signalling cascade in which Dishevelled 
activates GBP — an inhibitor of GSK3 . Consequently, -catenin cannot be targeted for 
destruction and is free to diffuse into the nucleus, where it acts as a co-activator for TCF-
responsive genes, which targets c-myc, cyclin D1 and c-jun genes and promotes cell 
proliferation (Fodde, Smits et al. 2001; Watson 2006; Tanaka 2009).   
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Figure 1.4 WNT signalling pathway. (a) In the absence of a WNT signal. (b) In the presence of 
WNT. (Fodde, Smits et al. 2001). 
 
 
1.1.2.3. Sporadic Colorectal Cancer 
 
Colorectal cancer not associated with hereditary cancer syndromes are defined as sporadic. 
The lifetime risk of developing sporadic colorectal cancer after age 50 is approximately 
5%. In addition to genetic predisposition, environmental factors including a diet low in 
fibre, vegetables and folate but high in fat, red meat and alcohol, sedentary occupation, and 
cigarette smoking are believed to be associated with an increased colorectal cancer risk 
(Jankowski 2008). 
 
Genomic destabilization is an early step in sporadic tumour development. Inactivation of 
the APC gene is the first molecular event in sporadic colorectal cancer. Somatic APC 
mutation is identified in approximately 60-80% of sporadic colorectal cancers and 
adenomas. About 50% of sporadic tumours with intact APC are reported to show 
mutations of #-catenin. P53 mutations have been identified in 40-50% of sporadic 
colorectal cancers. P53 mutation occurs at the time of transition from adenoma to 
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carcinoma. Patients with cancers involving a p53 mutation have a worse outcome and 
shorter survival time than patients without p53 mutation. K-ras mutation has been found in 
15-68% of sporadic colorectal adenomas and in 40-65% of cancers. Mutated k-ras protein 
activates a variety of effectors pathways that leads to constitutive growth promotion. Point 
mutations of the DCC (Deleted in Colorectal Carcinoma) gene have been identified in 
approximately 6% of sporadic colorectal cancers. Mutations on SMAD, a tumour 
suppressor gene has been associated with progression of cancers (Gearhart and Ahuja 
2010). 
 
1.1.2.4. Sporadic MSI-Colorectal Cancer 
 
Most sporadic colorectal cancer follows the chromosomal instability (CIN) pathway, but 
about 15% of them show a different pathway and these are associated with deficient 
mismatch repair. In contrast to HNPCC, these sporadic microsatellite instability high 
(MIS-H) associated colorectal cancer carry no germline mutation of DNA repair genes, the 
underlying mechanism is usually epigenetic silencing of the genes. Epigenetic changes 
affect the gene function by methylation of cytosine residues of cytosine- and guanine-rich 
0.5-2-kb regions, so called CpG islands in promoter sequences. As a consequence, there is 
no transcription of the gene, hence the gene is silenced. Methylation in MSI-H-associated 
colorectal cancer most commonly occurs at the promoter regions of hMLH1 (Jankowski 
2008). 
 
Methylation of the genome on one hand is considered as a normal aging process, in as 
much it shows an increased frequency with progressive age. It is also more commonly 
found in females. As a consequence, MSI-H-associated sporadic colorectal cancer is more 
frequent in elderly females. On the other hand it is possible that in some instances there is a 
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predisposition to increased genomic methylation. Colorectal tumour development against a 
background of increased genomic methylation is designated CpG island methylation 
phenotype (CIMP). CIMP is characterized by promoter methylation of multiple genes that 
are methylated in cancer but not in normal tissue. This type of methylation is termed Type 
C in contrast to age-related Type A methylation (Malkhosyan, Yamamoto et al. 2000). 
 
Sporadic MSI-H-associated colorectal cancer differs from HNPCC not just in their genetic 
background but also in clinical and pathologic features. Sporadic MSI-H-associated 
colorectal cancer, as mentioned, tends to be more common in females and is seen in older 
individuals, usually 65 years of age. They also have a greater tendency to develop in the 
proximal colon than it is seen in HNPCC. There is also increasing evidence that while 
HNPCC develops from traditional colorectal adenomas, most if not all sporadic MSI-H 
colorectal cancers arise from serrated polyps. The sporadic MSI-H tumours show high 
frequency of b-raf mutation and microsatellite instability, while k-ras mutation rate was 
found to be very low. B-raf is part of the mitogen activating protein kinase activating 
cascade, which regulates various cellular activities, such as gene expression, mitosis, 
differentiation, and cell survival/apoptosis (Moran, Ortega et al. 2010).  
 
1.1.3. Adenocarcinoma Sequence 
 
Accumulation of alterations during carcinogenesis leads to impairment of normal growth 
inhibition by increased cell growth and by inhibition of apoptosis, resulting in clonal 
expansion of tumour cells. Normally the balance between cell proliferation and apoptosis 
in the colonic mucosa is tightly regulated in order to maintain a constant cell number. The 
disturbance of the balance results in an escape from the normal homeostasis of cell number 
and favours the survival of mutated and undifferentiated cells. Inhibition of proliferation 
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and increase in apoptosis of these aberrant cells are important mechanisms of prevention of 
colon cancer (Leslie, Carey et al. 2002).  
 
Figure 1.5 shows a schematic representation of the adenocarcinoma sequence in colorectal 
cancer first described by Vogelstein (Vogelstein, Fearon et al. 1988). The process of cancer 
development can be divided into different steps. It starts with DNA damage and mutations 
in the initiation phase, followed by growth of transformed cells in the promotion stage, 
leading to malignant growth and invasion in the progression stage (Li and Lai 2009). 
During development of colon cancer normal colonic epithelium transforms into 
hyperproliferative epithelium and then further on into adenoma, carcinoma and eventually 
metastasis, through accumulation of genetic alterations. Crucial genes involved in this 
process include APC, K-ras, SMAD, DCC, p53, c-myc, and COX-2 (Li and Lai 2009). The 
animal model of colorectal cancer that was used in this thesis was the ApcMin/+ mouse, 
which has a mutation on the APC gene. Moreover, genetic studies using mutant mice have 
demonstrated that mutations in the APC gene are responsible for intestinal tumorigenesis 
(Nandan and Yang 2010). This is discussed in detail in section 1.3.2. 
 
Figure 1.5 A schematic representation of the adenocarcinoma sequence in colorectal cancer 
(Moran, Ortega et al. 2010). 
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Cell proliferation and cell death can also be affected by some mediators of inflammation 
that have a pro-tumorigenic or anti-tumorigenic inflammatory response. Inflammation can 
also be a result of activation of oncogenes. For example, the activation of the oncogene 
RAS (rat sarcoma oncogene) turns it into a dominant oncogene capable of inducing cell 
proliferation. RAS activation results in a pro-tumorigenic microenvironment surrounding 
tumour cells and induces the expression of various inflammatory cytokines and 
chemokines (Borrello, Degl'Innocenti et al. 2008). Moreover, NF-kB  is a transcription 
factor and key mediator of inflammation-induced carcinogenesis which also affects  cell 
proliferation (Shen and Tergaonkar 2009). NF-kB, under normal cellular conditions, binds 
to and is negatively regulated by inhibitor of kappa B in the cytoplasm. Following an 
inflammatory stimulus, inhibitor of kappa B is phosphorylated and undergoes proteosomal 
degradation. This allows  activated NF-kB to translocate to the nucleus where it activates 
the transcription of target genes, including inflammation-related genes (cytokines, 
chemokines, NOS, COX-2, and TNF-"). By increasing the expression of several cell cycle 
genes, activated NF-kB leads to increased cell proliferation (Pikarsky, Porat et al. 2004). 
 
Another mechanism that can also affect cell proliferation is the prostaglandin pathway s. 
Cyclooxygenases (COX) are enzymes required for the production of prostaglandins from 
fatty acids. Prostaglandins, especially PGE2, are produced by COX and are key mediators 
in inflammation and inflammation-associated cancers (Schetter, Heegaard et al. 2010). 
There are two cycloxygenase isoforms, COX-1 and COX-2. COX-1 is constitutively 
expressed at relatively low levels, whereas COX-2 is the inducible from of the enzyme and 
is primarily responsible for the increased COX activity due to chronic inflammation. 
Initially found to be highly expressed in colon adenocarcinomas, COX-2 has now been 
found to be highly expressed in nearly every tumour type examined. Expression of COX-2 
activity is necessary and sufficient to cause a malignant transformation in multiple in vitro 
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and animal models. COX-2 activity and the subsequent increase of PGE2 can affect cell 
proliferation, DNA mutation, angiogenesis, apoptosis and metastasis (Harris 2009).  
 
Apoptosis, may be considered one of the important targets in a preventive approach against 
cancer and this programmed-cell death is a complex process that involves the active 
participation of affected cells in a self-destruction cascade (Ramos 2008). Apoptosis seems 
to be an essential defense against the appearance of somatic mutations that constitute the 
earliest steps in tumorigenesis. At later stages in the adenoma-carcinoma sequence, 
mutations or gene-silencing events that cause an inhibition of apoptosis are thought to be 
critical for the survival and growth of tumours (Johnson 2002).  
 
 
1.1.4. Risk Factors for Colorectal Cancer 
 
1.1.4.1. Obesity 
 
The World Health Organization defines obesity as an abnormal or excess fat accumulation 
in adipose tissue, to the extent that health is impaired (Donohoe, Pidgeon et al. 2010). 
Obesity is a result of positive energy balance and prevails in conditions of energy excess. 
As a consequence of major economic, social and technological changes, many populations 
find themselves in environments characterized by abundant calorie-rich food and low 
physical activity requirements. As a result, obesity is rapidly approaching epidemic 
proportions in many parts of the world and has become a major public health concern 
(Gunter and Leitzmann 2006).  
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Epidemiological studies have provided evidence for the association of obesity with cancer 
(Calle, Rodriguez et al. 2003; Calle and Kaaks 2004). In parallel to the geographic 
variation seen in obesity rates worldwide, colorectal cancer incidence is highest in affluent 
industrialized countries such as the United States, Australia, and Western Europe (Gunter 
and Leitzmann 2006). The World Cancer Research Fund (WCRF) used a standardized 
approach to analysis of the evidence and concluded that there is convincing evidence of an 
association between obesity and oesophageal adenocarcinomas, pancreas, colorectal, 
breast, endometrial and kidney cancer (WCRF 2007). 
 
The largest meta-analysis to date includes 282,000 patients from prospective observational 
studies with over 133 million person-years of follow up (Renehan, Tyson et al. 2008). This 
analysis showed that high BMI is associated with an increased incidence of many types of 
cancer, which is in agreement with others results (Lin, Zhang et al. 2004; Moore, Bradlee 
et al. 2004; Tamakoshi, Wakai et al. 2004). There is a modest but consistently reported 
relationship between in the incidence of colonic cancer and obesity, with a relative risk of 
1.24-1.59 in obese men and 1.09-1.22 in obese women, as previously reported in published 
meta-analyses (Donohoe, Pidgeon et al. 2010).  The risk is greater for cancer of the colon 
than of the rectum. Colonic adenomas, precursor lesions for colorectal cancer, have also 
been associated with increased BMI (Bird, Frankl et al. 1998; Kono, Handa et al. 1999; 
Wang, Lin et al. 2005). Most studies demonstrate a stronger association between obesity 
and colorectal cancer in men than in women. 
 
In accordance to the epidemiological results, data from animal studies have also shown that 
a high fat diet augments colorectal carcinogenesis, whereas caloric restriction reduces 
colorectal tumour incidence (Steinbach, Kumar et al. 1993; Premoselli, Sesca et al. 1998; 
Baltgalvis, Berger et al. 2009; Erdelyi, Levenkova et al. 2009). Based on these 
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observations, it was decided to use a high fat diet in the present experiment in order to 
increment the carcinogenesis process in the animal model used as well as assess whether 
the type of fat was important. 
 
The biological mechanisms by which obesity has been linked to colorectal cancer may be 
by the fact that excess adipose tissue has been associated with a chronic state of systemic 
low-grade inflammation (Mohanty, Hamouda et al. 2000; Wajchenberg 2000; Esposito, 
Nappo et al. 2002). The relation between obesity and inflammation was demonstrated by 
the finding that adipocytes constitutively express the pro-inflammatory cytokine tumour 
necrosis factor (TNF-"), and that TNF-" expression in adipocytes of obese rodents is 
markedly increased (Hotamisligil, Shargill et al. 1993). Although the immune system plays 
a fundamental role in antitumour immunity, under certain circumstances it can also aid 
tumour development and progression (Donohoe, Pidgeon et al. 2010). 
 
1.1.4.2. Dietary Fibre 
 
A systematic review of 13 case-control studies supports the hypothesis that intake of 
dietary fibre may be protective against colorectal cancer (Howe, Ghadirian et al. 1992) by 
a consistent reduction in colorectal cancer risk in the highest fibre intake quintile compared 
with the lowest (odds ratio [OR] 0.53; 95% CI 0.47-0.61). However, large cohort studies 
have been less consistent. The European Prospective Investigation in Cancer and Nutrition 
study suggested that dietary fibre was protective (Bingham, Day et al. 2003), whilst the 
Pooling Project of Prospective Studies of Diet and Cancer found no association between 
fibre intake and colorectal cancer risk (Park, Hunter et al. 2005). 
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1.1.4.3. Meat Consumption 
 
Ecologic data from 27 countries showed a strong correlation between colorectal cancer 
incidence and average per capita meat consumption (Ognjanovic, Yamamoto et al. 2006). 
This is supported by case-control and cohort studies, and the World Health Organization 
concluded that the consumption of red meat is likely to be associated with CRC 
(Scheppach, Bingham et al. 1999). This decision is consistent with systematic reviews that 
report an increased risk of CRC in those in the highest red and processed meat categories 
compared with the lowest (Norat and Riboli 2001; Sandhu, White et al. 2001). There have 
been several biologic explanations for this apparent association, and the most common 
ones are the high-fat intake; the formation of heterocyclic amines and polycyclic aromatic 
hydrocarbons during high-temperature cooking; formation of N-nitroso compounds; and 
heme iron as a promoter of carcinogenesis (Ferguson 2010)  
 
1.1.4.4. Fruits and Vegetable Intake 
 
Fruits and vegetables are an important source of antioxidants and fibre and have been 
reported to reduce the risk of a variety of cancers. The impact on colorectal cancer is less 
clear with both positive and negative studies (Voorrips, Goldbohm et al. 2000; Terry, 
Giovannucci et al. 2001). A systematic review identified 28 case-control and 12 cohort 
studies evaluating vegetable and/or fruit intake and colorectal cancer risk (Riboli and Norat 
2003). Overall the case-control studies reported a reduction in colorectal cancer risk for 
both fruit and vegetables but there was no statistically significant association in cohort 
studies. 
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1.1.4.5. Alcohol 
 
Alcohol is associated with a variety of cancers including the oral cavity, pharynx, larynx, 
and oesophagus (Boffetta and Hashibe 2006). Alcohol may have a general effect on 
increasing the risk of neoplasia due to direct genotoxic effects, production of reactive 
oxygen species, and interference with folate metabolism (Boffetta and Hashibe 2006). A 
review of 16 cohort studies found that there was an increased risk of colorectal cancer in 
those in the highest compared to the lowest alcohol intake category (Moskal, Norat et al. 
2007).  
 
1.1.4.6. Physical Activity 
 
A sedentary lifestyle increases the risk of a number of chronic diseases including cancer 
and is associated with reduced survival (Warburton and Bredin 2006). The reasons for this 
are unclear but exercise has effects on the immune function, hormones and prostaglandin 
synthesis (Quadrilatero and Hoffman-Goetz 2003). Physical activity may influence these 
molecules to protect against colorectal cancer as may the effects of exercise on gut transit 
time. A review of 19 cohort studies found that increased physical-activity consistently 
reduced the risk of colorectal cancer (Samad, Taylor et al. 2005). 
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1.2. INFLAMMATION AND COLORECTAL CANCER 
 
1.2.1. Overview of Inflammation 
 
In response to injury, a multifactorial network of chemicals signals initiate and maintain a 
host response designed to heal the afflicted tissue. This involves activation and directed 
migration of leukocytes (neutrophils, monocytes and eosinophils) from the venous system 
to sites of damage, and tissue mast cells also have a significant role (Grivennikov, Greten 
et al. 2010). For neutrophils, a four-step mechanism is believed to coordinate recruitment 
of these inflammatory cells to sites of tissue injury and to the provisional extracellular 
matrix that forms a scaffolding upon which fibroblast and endothelial cells proliferate and 
migrate, thus providing a nidus for reconstruction of the normal microenvironment 
(Coussens and Werb 2002). 
 
A family of chemotactic cytokines, named chemokines, which possess a relatively high 
degree of specificity for chemoattraction of specific leulocyte populations, recruits 
downstream effectors cells and dictates the natural evolution of the inflammatory response 
(Grivennikov and Karin 2010). The profile of cytokine/chemokines persisting at an 
inflammatory site is important in the development of chronic disease. The pro-
inflammatory cytokine TNF-" controls inflammatory cell populations. As well as 
mediating many of the other aspects of the inflammatory process. The key concept is that 
normal inflammation, for example, inflammation associated with wound healing, is usually 
self-limiting. However, dysregulation of any of the converging factors can lead to 
abnormalities and ultimately, pathogenesis (Coussens and Werb 2002).   
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The presence of leukocytes within tumours, observed in the 19th century by Rudolf 
Vichow, provided the first indication of a possible link between inflammation and cancer. 
It is only during the last decade that clear evidence has been obtained that inflammation 
plays a critical role in tumorigenesis, and some of the underlying mechanisms have been 
elucidated (Karin 2006). A role for inflammation in tumorigenesis is now generally 
accepted, and it has become evident that an inflammatory microenvironment is an essential 
component of all tumours, including some in which a direct causal relationship with 
inflammation is not yet proven (Mantovani, Allavena et al. 2008). 
 
Several types of inflammation differing by cause, mechanism, outcome, and intensity can 
promote cancer development and progression. The inflammatory response triggered by 
infection precedes tumour development and is a part of normal host defence, whose goal is 
pathogen elimination. However, in tumorigenesis pathogens subvert host immunity and 
establish persistent infections associated with low-grade but chronic inflammation 
(Grivennikov and Karin 2010).  
 
1.2.2. Chronic Inflammation Associated with Cancer 
 
Epidemiological data demonstrate a strong connection between chronic inflammation and 
developing cancer. Both endogenous (inherited diseases and obesity) and exogenous 
(acquired infections) inducers of inflammation contribute to chronic inflammation-
associated cancer (Mantovani, Allavena et al. 2008; Medzhitov 2008). Several chronic 
inflammatory diseases lead to increased risk of cancer. Inflammatory bowel diseases 
(Crohn’s disease and ulcerative colitis) are associated with increased rates of colon 
adenocarcinomas (Ekbom, Helmick et al. 1990; Gillen, Andrews et al. 1994; Gillen, 
Walmsley et al. 1994). However, not all chronic inflammatory diseases increase cancer 
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risk equally. Ulcerative colitis imposes much greater risk for colitis-associated cancer then 
Crohn’s disease (Grivennikov, Greten et al. 2010). Even cancers that evolve without 
underlying chronic inflammation exhibit tumour-associated inflammation and contain 
inflammatory infiltrates. Oncogene activation (Ras and Myc), or cell senescence induced 
by DNA damage or oncogene activation, can enhance the transcription of pro-
inflammatory genes, coding for cytokines and chemokines (Ancrile, Lim et al. 2007; 
Mantovani, Allavena et al. 2008).  
 
However, it remains to be determined whether chronic inflammation can cause tumour-
initiating genetic alterations or can only act in conjunction with carcinogen exposure. In 
the case of colitis-associated cancer, it was suggested that chronic inflammation and 
colonic injury can directly cause DNA alterations (Meira, Bugni et al. 2008). However, 
chronic inflammation and loss of protective mucus can also increase intestinal permeability 
for environmental toxins and mutagens, which induce mutations in stem cells that give rise 
to cancer (Sakaguchi, Brand et al. 2001).  Furthermore, inflammation can stimulate the 
proliferation of cells that harbour oncogenic mutations induced by carcinogens rather than 
induce mutations themselves. Nonetheless, inflammation can result in the production of 
reactive oxygen and nitrogen species (ROS and RNI) by immune cells as well as immune 
mediated stimulation of ROS production in pre-malignant cells, induction of mutagenic 
enzymes, and inactivation of DNA damage gatekeeper pathways, such as the mismatch 
repair response or p53 (Niu, Wright et al. 2005; Colotta, Allavena et al. 2009; Takai, 
Toyoshima et al. 2009). Inflammation may also lead to epigenetic modifications including 
DNA and histone methylation that eventually lead to silencing of tumour suppressor loci 
(Cooper and Foster 2009). In summary, it remains to be fully established whether 
inflammation alone can result in tumour initiation, but there is ample evidence that 
inflammation is tumour promoting. 
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1.2.3. Inflammation and Tumour Growth 
 
Tumour growth or tumour promotion is the sum total of malignant cell proliferation vs. 
malignant cell death. Both processes are strongly impacted by inflammation and 
inflammatory cytokines produced by tumour infiltrating immune cells, such as IL-6 and 
TNF-", can serve as mitogens and survival factors for pre-malignant and fully established 
cancer cells (Grivennikov, Greten et al. 2010). Inflammation also contributes to the 
induction of angiogenesis, which is crucial for supplying the growing tumour with 
necessary nutrients and oxygen (Zumsteg and Christofori 2009).  
 
Much of the growth stimulating cross-talk between immune and malignant cells is 
mediated by cytokines that activate the oncogenic transcription factors NF-kB. Activation 
of NF-kB is found in over 50% of all cancers (Karin 2006) and is a pre-requisite for the 
expression of a variety of target genes important for tumorigenesis, including anti-
apoptotic genes (c-IAP, Bcl-xl, Bcl-2, c-FLIP), proliferative genes (Cyclins, c-Myc), 
stress-response genes, chemokines, and pro-angiogenic molecules (VEGF, bFGF, 
CXCL12) (Karin 2008; Naugler and Karin 2008).On the contrary , in immune cells,    NF-
kB promotes the production of pro-inflammatory cytokines, which mediate NF-kB 
activation in cancer cells, including IL-1, TNF, IL-6, and IL-2 (Karin 2008; Naugler and 
Karin 2008; Grivennikov and Karin 2010).  
 
Cytokines are signalling molecules that are key mediators of inflammation or an immune 
response. These signalling molecules have a wide variety of cellular functions and are 
stimulated when tissue homeostasis is altered. Cytokines can be generally classified as pro-
inflammatory (IL-1, IL-6, IL-15, IL-17, IL-23, and TNF-") or anti-inflammatory (IL-4, IL-
10, IL-13, TGF-#, IFN-") (Schetter, Heegaard et al. 2010). Depending on the balance of 
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cytokines, their collective effect can be either pro- or anti-tumorigenic. Upon binding their 
membrane receptor, cytokines activate signal transduction pathways that lead to apoptosis, 
cell proliferation, angiogenesis, and cellular senescence. In general, constitutive exposure 
to high levels of pro-inflammatory cytokines is thought to be pro-tumorigenic. For 
example, TNF-" is a pro-inflammatory cytokine for which there is convincing evidence of 
a role in tumours promotion (Balkwill 2009). TNF-" knockout mice are more resistant to 
certain tumours (Pasparakis, Alexopoulou et al. 1996). IL-6 is another pro-inflammatory 
cytokine that has been implicated in pro-tumorigenic activity for many cancers, and has 
been found to be required for colitis-associated colon cancer in a mouse model 
(Grivennikov, Karin et al. 2009). 
 
As a result, it is evident that inflammatory cells can have a powerful effect on tumour 
development. Early in the neoplastic process, these cells are powerful tumour promoters, 
producing an attractive environment for tumour growth, facilitating genomic instability 
and promoting angiogenesis. The inflammatory cells, and the chemokines and cytokines 
that they produce, influence the whole tumour organ, regulating the growth, migration, and 
differentiation of all cell types in the tumour microenvironment. 
 
1.2.4. Diet and Inflammation 
 
It is known and accepted that obesity is associated with low-grade chronic inflammation 
and that inflammation contributes to risk of other diseases linked to obesity. Circulating 
and adipose derived cytokines such as tumour necrosis factor-" or IL-6 have been shown 
to be elevated in obese humans (Kern, Ranganathan et al. 2001). In animal models, several 
studies have demonstrated that diet-induced obesity is associated with increased expression 
of a number of pro-inflammatory cytokines or biomarkers of inflammation in adipose 
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tissue (Xu, Barnes et al. 2003; Brake, Smith et al. 2006).  The mechanisms underlying 
obesity-associated inflammation are not fully defined, however it is known that a high-fat 
diet induces expression of adhesion molecules in adipose tissue, which are associated with 
leukocyte migration and adherence (Brake, Smith et al. 2006). Din et al. (Ding, Chi et al. 
2010) have shown that high fat diets and bacteria interact to promote pro-inflammatory 
changes in the small intestine, which preceded weight gain and obesity. The 
gastrointestinal tract is another potential source of inflammation associated with diet or 
obesity that has not been extensively explored.  
 
Consumption of the n-3 polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid 
(C20:5 n-3) and docosahexaenoic acid (C22:6 n-3), as mainly present in fish, may be 
associated with anti-inflammatory effects (Calder 1997; Calder 2006).The key link 
between PUFAs and inflammation is that eicosanoids, which are among the mediators and 
regulators of inflammation, are generated from 20-carbon PUFAs. In section 1.4.2 the 
metabolism of PUFAs are discussed into more detail as well as the formation of 
eicosanoids. Because inflammatory cells typically contain a high proportion of the n-6 
PUFA arachidonic acid (C20:4 n-6) and low proportions of other 20-carbon PUFAs, 
arachidonic acid is usually the major substrate for eicosanoid synthesis. Eicosanoids, 
which include prostaglandins (PGs), thromboxanes, leukotrienes, and other oxidized 
derivatives, are generated from arachidonic acid are involved in modulating the intensity 
and duration of inflammatory responses (Figure 1.6) (Lewis, Austen et al. 1990; Tilley, 
Coffman et al. 2001). 
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Figure 1.6 Arachidonic acid (AA) pathways. AA can be converted to prostaglandins (PG) or 
leukotrieness (LT), depending on the enzymes that are present. Each metabolite affects its 
biological action through receptors. COX: Cyclooxygenase; LOX: Lipoxigenase; TX: 
Thromboxane; HETE: Hydroxyeicosatetraenoic acid; HPETE: Hydroperoxyeicosatetraenoic acid. 
(Yoon and Baek 2005). 
 
 
Recent studies have shown that prostaglandin E2 (PGE2) induces cycloxygenase 2 (COX-
2) in fibroblasts cells and so up-regulates its own production, and induces the production of 
IL-6 by macrophages, inhibits 5-lipoxygenase and so decreases production of the 4-series 
LTs, and induces l5-LOX and so promotes the formation of lipoxins, which have been 
found to have an anti-inflammatory or inflammation resolving effect (Calder 2006).  
 
However, increased consumption of n-3 PUFAs, such as EPA and DHA, results in 
increased proportions of those fatty acids in inflammatory cell phospholipids (Caughey, 
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Mantzioris et al. 1996; Healy, Wallace et al. 2000; Yaqoob, Pala et al. 2000). Because less 
substrate is available for synthesis of eicosanoids from arachidonic acid, fish oil 
supplementation of the human diet has been shown to result in decreased production of 
PGE2 (Endres, Ghorbani et al. 1989; Caughey, Mantzioris et al. 1996; Trebble, Wootton et 
al. 2003).  
 
In addition to long-chain n-3 PUFAs modulating the generation of eicosanoids from 
arachidonic acid and to EPA acting as a substrate for the generation of alternative 
eicosanoids, recent studies have identified a novel group of mediators, termed E-series 
resolvins, formed from EPA by COX-2 that appear to exert anti-inflammatory or 
inflammation resolving actions (Serhan, Clish et al. 2000; Serhan, Hong et al. 2002). 
DHA-derived mediators termed D-series resolvins, docosatrienes and neuroprotectins, also 
produced by COX-2 have been identified and also appear to be anti-inflammatory 
(Mukherjee, Marcheselli et al. 2004). Although the action in antagonizing arachidonic acid 
is the main key anti-inflammatory effect of n-3 PUFAs, these fatty acids have several other 
anti-inflammatory effects, such as decreased leukocyte chemotaxis, decreased production 
of reactive oxygen species and pro-inflammatory cytokines, and decreased adhesion 
molecule expression, which might result from altered eicosanoid production or might be 
independent of this (Mukherjee, Marcheselli et al. 2004). 
 
Diets containing a variety of fresh fruits and vegetables, whole grains, nuts, legumes and 
plant-based foods are rich in phytochemicals, and they have also shown to be protective 
against diseases and in lowering inflammation (Sanchez-Moreno, Cano et al. 2004). In 
fact, dietary vegetables and fruits have been regarded as rich sources of chemopreventive 
agents and potent anti-inflammatory properties. Food phytochemicals such as curcumin, 
EGCG, resveratol, genistein and isothiocyanates, with strong anti-inflammatory activity, 
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have been shown to inhibit carcinogenesis in preclinical animal models. Epidemiological 
studies have been clearly documented that the frequent consumption of diet high in fruits 
and vegetables has been linked to a lower risk of many types of cancers including prostate, 
colon, oral cavity, stomach, lung and esophagus (Chen, Yu et al. 2000; Chan and 
Giovannucci 2001). 
 
The nuclear factor-erythroid 2-related factor 2 (Nrf2) is a transcription factor mediating the 
antioxidant response and acting as the major signalling pathway for many food 
phytochemicals to exert their anti-inflammatory effect (Khor, Yu et al. 2008). There is a 
growing body of evidence that the Nrf2 signalling pathway is closely involved with the 
regulation of inflammation. Khor et al. (Khor, Yu et al. 2008) have shown that Nrf2-
deficient mice have increased susceptibility to DSS-induced colitis, and have also loss of 
colonic crypts, massive infiltration of inflammatory cells and anal breeding. In addition, 
immunocytochemical staining of nitrotyrosine, a biomarker of inflammation, was more 
intense in Nrf2-deficient mice. Concomitantly, more intense induction of pro-inflammatory 
biomarkers, such as IL-1#, IL-6, and TNF-", as well as pro-inflammatory mediators like 
inducible nitric oxide synthetase (iNOS) and COX-2, was observed in Nrf2-deficient mice 
(Khor, Huang et al. 2006).      
 
It is postulated that attenuation of inflammation through induction of anti-oxidative 
enzymes and suppression of pro-inflammatory mediators in an Nrf2-dependent manner in 
acute inflammation animal models, results in decreased sensitivity of wild-type mice 
towards inflammatory oxidative damage (Khor, Yu et al. 2008). In vivo data have 
indicated that ablation of Nrf2 resulted in increased expression of pro-inflammatory 
mediators like IL-1#, IL-6, COX-2, which are modulated by NF-kB (Khor, Yu et al. 2008) 
. Despite these findings, the possible mechanism linking Nrf2 and inflammation is still 
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unclear. Phytochemicals can also affect inflammation by other pathways such as the 
arachidonic acid (AA)-dependent pathways (cycloxygenase, COX; lipooxygenase, LOX; 
and phospholipase A2, PLA2) (Yoon and Baek 2005). 
 
Several phytochemicals have been reported to inhibit PLA2. Quercitin, flavonoids and 
retinoids have been shown to inhibit the activity of different isoforms of PLA2 in several 
cell types and animal models via direct interaction with the enzyme (Lindahl and Tagesson 
1993; Kim, Pham et al. 2001). Hong et al. (Hong, Bose et al. 2004) have shown that 
curcumin inhibited COX and LOX enzymes, supporting the hypothesis that 
phytochemicals might simultaneously affect multiple targets in one or more pathways. 
Several phytochemicals exert multiple cellular effects involving one or more signalling 
pathways. These effects may be synergistic, additive, or even antagonistic depending on 
the cell type, the concentration of the phytochemical and its surrounding environment. A 
better understanding of these cellular effects is vital to properly utilize the phytochemicals 
as promising agents that promote health and prevent disease.  
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1.3. APCMIN/+ MOUSE MODEL OF COLORECTAL CANCER 
 
1.3.1. Basic concepts 
 
The study of experimental colon carcinogenesis in rodents has had a remarkably long 
history, dating back almost 80 years, and the study of human disease has been greatly 
facilitated by the use of animal model systems (Rosenberg, Giardina et al. 2009). Mutant 
strains of mice have largely come from three sources: naturally occurring variation; 
phenotypic screening following germline mutagenesis; and targeted mutation of cloned 
genes (Shoemaker, Gould et al. 1997). N-ethyl-N-nitrosourea (ENU), the most potent 
known germline mutagen in the mouse, has been used to induce germline mutations 
resulting in mouse models for a variety of human disorders. It was through phenotypic 
screening following ENU mutagenesis that the Min mutant mouse was discovered (Moser, 
Dove et al. 1992). The ApcMin/+ mouse is the pioneer genetic model for colorectal cancer, 
although admittedly it primarily serves as a model for small intestinal cancers. This 
genetically engineered model is widely used, and patterns the human condition familial 
adenomatous polyposis (Tammariello and Milner 2010). 
 
1.3.2. Genetic and Phenotype characteristics in ApcMin/+ Mouse Model 
 
ApcMin (Min= multiple intestinal neoplasia) is an autosomal dominant mutation that 
predisposes mice to develop adenomas throughout the intestinal tract. On the C57BL/6J 
genetic background, Min/+ mice develop, on average, more than 50 tumours throughout 
the entire length of the intestinal tract and rarely live past 150 days of age (Su, Kinzler et 
al. 1992). Since all intestinal tumours in C57BL/6J Min/+ mice are benign adenomas, the 
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premature death of these animals is associated with secondary effects of tumour growth, 
including severe chronic anaemia and intestinal blockage. 
 
The phenotypic similarities between FAP patients and Min mice led scientists to examine 
whether the Min phenotype is due to germline mutation of the mouse APC gene. Genetic 
mapping localized Min to the region of mouse chromosome 18 that also carries APC. 
Sequence analysis of the entire 8535 bp APC cDNA identified a nonsense mutation in 
Min/+ mice that results from a T/A: A/T transversion at nucleotide 2549 (codon 850) of 
APC (Corpet and Pierre 2003; Yamada and Mori 2007). 
 
A number of genes that modify intestinal tumorigenesis have been identified using APC 
mutant mice. Deletion in the genes related to arachidonic acid metabolism has been shown 
to suppress intestinal tumorigenesis, whereas deletions in genes related to genomic stability 
increases tumorigenesis in APC mutant mice (Edelmann, Yang et al. 1999; Kuraguchi, 
Yang et al. 2001). The phenotype and genetic similarities between Min mice and humans 
with FAP make Min an excellent animal model for chemopreventive studies of colorectal 
cancer because it mimics the rapid development of adenomatous polyposis in humans. 
However, adenocarcinomas are seldom observed in this model, and no typical aberrant 
crypt foci (ACF) arise above the intestinal mucosa. Consequently, the ACF to carcionoma 
progression is not established in this model. Moreover, the K-ras mutations observed in 
many human tumours were not detected in Min mouse polyps (Shoemaker, Gould et al. 
1997), and p53 inactivation, considered  to play an important role in the conversion of 
adenomas to adenocarcinomas in humans, does not raise tumour number in Min mice nor 
indicate evidence of malignant transformation (Fazeli, Steen et al. 1997; Yamada and Mori 
2007).  
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The human and mouse APC genes are 86 and 90% identical at the nucleotide and amino 
acid levels, respectively. Min/+ mice and FAP patients share several phenotypic 
characteristics, most notably the presence of multiple intestinal tumours. In Min/+ mice, 
most of these tumours occur in the small intestine, whereas in humans, tumours of the 
colon tend to be much more prevalent (Mai, Colbert et al. 2003). Regarding the intestinal 
tumour formation in Min mice, work from a number of laboratories has led to an 
understanding of tissue development in the mouse intestine (Shoemaker, Gould et al. 
1997). Intestinal crypts in adult mice are clonal units, whereas early in postnatal 
development intestinal crypts are polyclonal. Another important change that occurs in the 
mouse intestine during the first several weeks of life include a significant increase in crypt 
number, suggesting the tumours are initiated early in life (Shoemaker, Gould et al. 1997). 
Dietary treatments are typically begun in the mice by the age of 4-5 weeks, when tumours 
may already be present. Only a few studies have exposed the animals in utero, when 
neoplastic foci may not be already present. The timing also mimics some clinical 
intervention trials, when dietary interventions are given to adults likely to have some Min 
polyps remaining after the visible ones have been removed. In most mouse studies it is the 
number of tumours in the small intestine that is the primary end point, although some 
authors have split the small intestine between proximal, mid and distal parts, and showed 
differences on the protective effect according to the region of the intestine (Corpet and 
Pierre 2003). 
 
In ApcMin/+ mice, the number of colonic microadenomas per area was reported to be 
higher than that of adenomatous lesions in the small intestine, suggesting that the loss of 
APC occurs frequently in colonic crypts as well as in the epithelium of the small intestine 
(Yamada, Hata et al. 2002). Despite the frequent development of microadenomas, the 
number of macroscopic colonic tumours is much less than that of small intestinal tumours. 
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Interestingly, the size of microadenomas in the colon of ApcMin/+ mice does not increase 
with time. Based on the multistep carcinogenesis theory in the colon, the findings indicate 
that there are at least two distinct stages for intestinal tumorigenesis in ApcMin/+ mice 
(Yamada and Mori 2007). In contrast to colonic lesions, the adenomatous lesions in the 
small intestine show various sizes, and the mean size of the lesions is significantly larger 
than in the colon (Yamada, Hata et al. 2002). As the loss of APC is also involved in the 
earliest lesions in the small intestine, it is possible that in the small intestine, the loss of 
function of APC results in the formation of microadenomas that could develop directly into 
intestinal tumours by aging. This findings suggests that the mechanism of tumorigenesis 
involved in the small intestine may differ from those in the colon (Yamada and Mori 
2007). 
 
1.3.3. Other types of ApcMin/+ Mouse Model of Colorectal Cancer 
 
After the discovery that the Min mouse phenotype was caused by truncated APC in 
position 850, other mice have been genetically modified so that one or more oncogenes 
hold a germline mutation (truncated APC in positions 716, 1309, or 1638, and mutated 
MSH2 or MLH1). As in humans, different mutations lead to different phenotypes, for 
instance more adenomas are found in the gut of Apc716 mutant mice (250 polyps ± 95) 
than in classical Min mice (40 ± 20) (Corpet and Pierre 2003). Apc1638 mice tend to 
develop the least amount of tumours all together, and Apc1309 develop a slightly higher 
number of polyps than the ApcMin/+ mouse (Smits, Kielman et al. 1999). While there are 
no perfect models, varieties of the APC model incorporate conditions that reflect 
phenotypic responses in humans.  
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1.4. FATTY ACIDS AND COLORECTAL CANCER 
 
1.4.1. Definition 
 
Triacylglycerols make up the largest proportion of dietary lipids consumed by humans. A 
triacylglycerol is composed of three fatty acids esterified to a glycerol molecule in one of 
three stereochemically distinct bonding positions. These fatty acids are generally 
nonbranched hydrocarbon chains with an even number of carbons ranging from 4 to 26 
carbons atoms (Shils, Shike et al. 2006). In addition to differences in chain length, fatty 
acids vary in the number and arrangement of double bonds along the hydrocarbon chain. 
Double bonds identified relative to the methyl end use the terms “n” or “%” to indicate 
distance of the first bond along the carbon chain. Addition of further double bonds 
produces a polyunsaturated fatty acid (PUFA) (Wall, Ross et al. 2010). Fatty acids of 18 
carbon atoms or greater that possess more than one double bond contain the first bond of 
their series only at the n-9, n-6 or n-3 position(Shils, Shike et al. 2006). The human body 
can produce all but two of the fatty acids it requires. Thus, linoleic acid (LA, C18:2n-6), 
precursor of the n-6 series of fatty acids, and "-linolenic acid (ALA, C18:3n-3), precursor 
of the n-3 series of fatty acids, are essential in the human diet (Wall, Ross et al. 2010). A 
dietary (n-6):(n-3) ratio of 4:1 is recommended as optimal. However, actual dietary intakes 
of these fatty acids are in excess of 15-16:1, particularly in Western countries, due to 
increased consumption of LA-rich vegetable oils (sunflower, safflower, and corn oils) and 
animal fat (Simopoulos 2003). Figure 1.7 shows the chemical structures of EPA, DHA, LA 
and ALA acid. In parallel with increased LA intakes, increased rates of many diseases that 
involve inflammatory process have occurred, including cancer. This imbalance can be 
corrected by increasing the consumption of foods rich in n-3 fatty acids such as 
eicosapentaenoic acid (EPA, C20:5n-3) and docosahexaenoic acid (DHA, C22:6n-3). 
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Marine fish are the principal sources of EPA and DHA. However, the content of marine n-
3 fatty acids varies greatly according to the species of fish (Paulsen, Elvsaas et al. 1997). 
An alternative approach might be to replace n-6 PUFAs with mono-unsaturated fatty acids 
such as oleic acid (C18:1). It is interesting to note that high intakes of n-6 PUFAs has 
recently been shown to be associated with increased risk of ulcerative colitis, supporting 
the concept that type of PUFA may affect inflammation in the colon (de Silva, Olsen et al. 
2010). 
 
 
          
 
           
 
           
 
            
Figure 1.7 Chemical structures of EPA, DHA, Linoleic acid and "-Linolenic acid.         
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20:5 (n-3) 
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18:3 (n-3) 
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1.4.2. Metabolism of Fatty Acids 
 
Although mammalian cells cannot synthesize LA and ALA, they can metabolize them into 
more physiologically active compounds by the introduction of further double bonds 
(desaturation) via desaturases and by lengthening the acyl chain (elongation) via elongases. 
The Figure 1.8 shows the metabolism of n-6 and n-3 fatty acids. LA is converted into !-
linolenic acid (C18:3n-6) via the action of desaturase, and !-linolenic acid is elongated via 
elongase to dihome-!-linolenic acid (C20:3n-6), which is further converted to arachidonic 
acid (AA, C20:4n-6). Arachidonic acid is either metabolized to docosatetraenoic acid 
(C22:4n-6) or to eicosanoids via cycloxygenase (COX) and lipoxygenase (LOX) (Wall, 
Ross et al. 2010). 
 
Figure 1.8 Metabolism of n-6 fatty acids and n-3 fatty acids (Wall, Ross et al. 2010). 
 
 50
Using the same series of enzymes as those used to metabolize n-6 PUFAs, ALA is 
converted to stearidonic acid (C18:4n-3), and then elongated to eicosatetraenoic acid 
(C20:4n-3), which is converted to EPA via desaturase. EPA is either metabolized to DHA  
or to eicosanoids via COX and LOX. In mammals, the pathway of desaturation and 
elongation of n-6 and n-3 fatty acids occurs mainly in the liver. Since LA and ALA are 
metabolized by the same set of enzymes, competition exists between these two fatty acids, 
with an excess of one causing a decrease in the metabolism of the other. Normally, 
desaturases and elongases exhibit affinity to metabolize n-3 over n-6 PUFAs, provided that 
both exist in a physiological ratio of 1:1-4. However, the higher concentration of LA 
typically found in the Western diet results in a greater conversion of LA to arachidonic 
acid (Simopoulos 2003). Nonetheless, increasing ALA intake appears to result in 
significant enhancements in the EPA content of plasma phospholipids (Mantzioris, James 
et al. 1994). Furthermore, decreasing the LA content of the diet has been shown to result in 
increased metabolism of ALA to its longer chain derivatives. For example, a recent study 
showed that decreasing LA in the diet to an optimal LA:ALA ratio of 4:1 resulted in higher 
plasma phospholipid EPA and a 40% lower arachidonic acid: EPA ratio than a diet 
containing a LA:ALA ratio of 10:1 (Liou, King et al. 2007). Approximately 8-20% of 
ALA is converted to EPA in humans, while conversion of ALA to DHA is less and 
estimated to be around 0.5-9% (Burdge 2006). Consequently, this route is unlikely to 
provide sufficient levels of EPA and DHA for optimal human health, which emphasizes 
the importance of dietary intake of EPA and particularly DHA. 
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1.4.3. Animal and Epidemiological evidence of the effects of Fatty Acids 
 
In several animal models, such as carcinogenic induced models using DMH (1,2-
dymethylhydrazine) and AOM (azoxymethane), the ApcMin/+, and implantation of 
tumour cells, fatty acids has shown to be protective against colorectal cancer (Chang, 
Chapkin et al. 1997; Calder, Davis et al. 1998; Paulsen, Ø.Elvsaas et al. 2007). Such 
studies also provide evidence for the relative protective effects of different fatty acids, such 
that EPA and DHA provide most protection compared with a sunflower or safflower oil, or 
even an olive oil diet (Lund 2006).   
 
Several studies done in chemically induced mice/rats have also demonstrated a positive 
effect of fish oil on preventing tumour development in the colon (Reddy and Sugie 1988; 
Latham, Lund et al. 1999; Latham, Lund et al. 2001; Rao, Hirose et al. 2001). One recent 
example is the study performed by van Beelen et al. (van Beelen, Spenkelink et al. 2009) 
in which AOM-induced rats were treated with 20% by weight of fish oil diet for 8 weeks. 
They found that animals given fish oil had only half the total number of aberrant crypt foci 
compared to the animals given the corn oil diet, but also had a significantly lower number 
of large aberrant crypt foci. In the rat DMH model, fish oil suppressed cell proliferation 
and increased apoptosis relative to corn oil-fed animals when fed after exposure to the 
carcinogen (Latham, Lund et al. 1999).  Experiments in ApcMin/+ mouse have also 
demonstrated that n-3 PUFA have an anti-carcinogenic effect (Paulsen, Namork et al. 
2000; Bommareddy, Zhang et al. 2009). 
 
One of the dietary habits that may reduce colorectal cancer risk is the consumption of fish. 
Several observational studies have shown that fish consumption could be related to a 
decreased risk of colorectal cancer. Recently, a meta-analysis of 19 prospective cohort 
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studies showed a borderline significant 12% decrease in the relative risk of colorectal 
cancer 0.88 (95% CI 0.78-1.00) in a comparison of high fish consumption with low fish 
consumption (Geelen, Schouten et al. 2007). The largest contribution study to this meta-
analysis was the European Prospective Investigation into Cancer (EPIC) study, which 
supported the evidence that increased intake of fish reduce risk of colorectal cancer (Norat, 
Bingham et al. 2005). However, the evidence of an inverse association between colon 
cancer and fish intake is less consistent than the evidence of a positive association with red 
meat (WCRF 1997). A 22-year prospective study of n-3 fatty acid intake and colorectal 
cancer risk in men was recently published by Hall et al. (Hall, Chavarro et al. 2008). They 
have found that intake of fish and long-chain n-3 fatty acids from fish may decrease the 
risk for colorectal cancer. 
 
Despite the possible positive effect of fish consumption on prevention of colorectal cancer, 
contradictory results were also observed. Pot et al. (Pot, Majsak-Newman et al. 2009) 
performed a multicentre randomized controlled trial to investigate the effects of a six 
months intervention with oil-rich or lean fish on markers of colorectal cancer. However, no 
preventive effect was observed.   
 
The World Cancer Research Report of 2007 (WCRF 2007) have assessed 19 cohort studies 
and 55 case-control studies on fish and colorectal cancer. They found that 9 cohort studies 
showed decreased risk for the highest intake group when compared to the lowest intake 
group, however only two were statistically significant. They concluded that a substantial 
amount of data is available but the results are inconsistent, therefore, the evidence 
suggesting that eating fish protects against colorectal cancer was limited. Many of these 
studies were however limited by a generally low intake of fish in the populations studied.  
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1.4.4. Chemopreventive Mechanism of Fatty Acids 
 
Several studies indicate that diets high in saturated fatty acids (beef tallow and lard) and n-
6 PUFAs (corn oil or safflower) increase the concentration of colonic luminal secondary 
bile acids (which act as promoters in colon carcinogenesis), whereas dietary fish oil high in 
n-3 PUFAs had no such enhancing effect (Reddy 1995).  The mechanisms by which n-3 
PUFA may inhibit the promotion and progression stages of carcinogenesis include 1) 
suppression of AA-derived eicosanoid biosynthesis, which results in altered immune 
response to cancer cells and modulation of inflammation, cell proliferation, apoptosis, 
metastasis, and angiogenesis; 2) influences on transcription factor activity, gene 
expression, and signal transduction, which leads to changes in metabolism, cell growth, 
and differentiation; 3) alteration of estrogen metabolism, which leads to reduce estrogen-
stimulated cell growth; 4) increased or decreased production of free radicals and reactive 
oxygen species; and 5) mechanisms involving insulin sensitivity and membrane fluidity 
(Larsson, Kumlin et al. 2004). In the present review I will focus on the suppression of AA-
derived eicosanoid production mechanism, as it is directly related to the scope of my 
experiment, and it is directly related to inflammation, and consequently carcinogenesis.   
 
As previous mentioned in section 1.2.4, one of the more important functions of PUFAs is 
related to their enzymatic conversion into eicosanoids, which are short-lived, hormone-like 
lipids with chain lengths of 20 carbon atoms. Eicosanoids are biologically potent and have 
a wide array of activities: they modulate inflammatory and immune responses and play a 
critical role in platelet aggregations, cellular growth, and cell differentiation. The precursor 
fatty acids for the formation of eicosanoids are dihomo-!-linolenic acid, AA and EPA. LA 
and ALA are the predominant plant-derived dietary PUFAs and are the precursors of 
dihomo-!-linolenic acid, AA and EPA. The production of eicosanoids begins with the 
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liberation of PUFAs from membrane phospholipids by the action of various 
phospholipases. Since inflammatory cells typically contain a high proportion of AA and 
low proportions of EPA, AA is usually the major substrate for eicosanoids synthesis, and 
for COX and LOX (Calder 2001). Metabolism of AA by COX gives rise to the 2-series 
protaglandins (PGs), and the 2-series thromboxanes (TXs). Metabolism of AA by 5-LOX 
pathway gives rise to hydroxyl and hudroperoxy derivates and to 4-series leukotrienes. The 
eicosanoids derived from AA are generally ascribed to be pro-inflammatory (Bagga, Wang 
et al. 2003). 
 
For example, PGE2 induces production of the proinflammatory cytokine IL-6 in 
macrophages and causes pain and vasodilation (Bagga, Wang et al. 2003). Leukotriene B4 
is a potent chemotactic agent for leukocytes and an activator of neutrophils. It also leads to 
the production of inflammatory cytokines such as TNF-", IL-1#, and IL-6 by macrophages 
(Nataraj, Thomas et al. 2001). Indeed, a common characteristic of chronic inflammatory 
diseases is excessive production of AA-derived eicosanoids (Calder 2001). 
 
EPA also acts as a substrate for COX and LOX enzymes and gives rise to a different 
family of eicosanoids, the 3-series PGs and TXs, the 5-series leukotrienes (LTs), and the 
hydroxyl-EPAs. The eicosanoids derived from EPA are considered to be less inflammatory 
or even anti-inflammatory, compared to eicosanoids derived from AA (Robinson and 
Stone 2006). The 5-series LTs from EPA are 10 to 100-fold less potent as a neutrophil 
chemotactic agent than the 4-series LTs from AA, and thus a much weaker inducer of 
inflammation (Lee, Menica-Huerta et al. 1984). Moreover, Bagga et al. (Bagga, Wang et 
al. 2003) demonstrated that PGE3 was a less potent inducer of IL-6 production by 
macrophages than PGE2. 
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DHA can be metabolized to resolvins via LOX-initiated mechanisms. Resolvins are 
endogenous, local acting mediators possessing potent anti-inflammatory and 
immunoregulatory properties. At the cellular level, these include reducing neutrophil 
infiltration and regulating the cytokine-chemokine axis and reactive oxygen species, as 
well as lowering the magnitude of he inflammatory response (Serhan, Lu et al. 2007). 
 
Overexpression of COX-2 plays an important role in colon carcinogenesis and it has been 
implicated in the regulation of apoptosis of rat intestinal epithelial cells and at high 
concentrations it may suppress apoptosis (Tsujii and DuBois 1995). Elevated levels of 
COX-2 have been observed in human colon tumours and chemically induced colon 
tumours in rodents (Kargman, O'Neill et al. 1995; DuBois, Radhika et al. 1996). Studies 
have shown that a high fat enhanced AOM-induced expression of COX-2 and eicosanoids 
formation from AA in colon tumours of rats, whereas the high fat fish oil inhibited the 
levels of COX-2 (Rao, Hirose et al. 2001). The inhibition of eicosanoids production 
through the modulation of COX-2 activity may be important for the ability of n-3 PUFAs 
to inhibit colon tumorigenesis. In colon tumours, lowering the levels of PGs may be 
enough to slow growth by inhibiting proliferation and induction of apoptosis and thus 
tumour inhibition. Moreover, the reduction in generation of AA-derived mediators that 
accompanies n-3 PUFAs consumption has led to the idea that fish oil is anti-inflammatory 
(Calder 2006).   
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1.5. PHYTOCHEMICAL AND COLORECTAL CANCER 
 
1.5.1. Definition 
 
The “phyto” of the word phytochemicals is derived from the Greek word phyto, which 
means plant. Therefore, phytochemicals are plant chemicals. Phytochemicals are defined 
as bioactive non-nutrient plant compounds in fruits, vegetables, grains, and other plant 
foods that have been linked to reducing the risk of major chronic diseases. It is estimated 
that >5000 individual phytochemicals have been identified in fruits, vegetables, and grains, 
but a large percentage still remain unknown and need to be identified before we can fully 
understand the health benefits of phytochemicals in whole foods (Surh 2003). However, 
more and more convincing evidence suggests that the benefits of phytochemicals in fruits 
and vegetables may be even greater than is currently understood.  
 
The phytochemicals can be divided into subgroups of carotenoids, alkaloids, nitrogen-
containing compounds, organosulphur containing compounds and phenolics (Figure 1.9). 
The most studied of the phytochemicals are the phenolics. A benzene ring with at least one 
hydroxyl substitute is the common denominator of all phenolics, and based on additional 
structural component the phenolics can be futher divided into phenolic acids, flavonoids, 
stilbenes, coumarins and tannins (Liu 2004).  
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Figure 1.9 Classification of phytochemicals and dietary foods used in the present 
study. 
 
It is estimated that the total intake of phenolics in our diet is composed of one third 
phenolic acids and two thirds of flavonoids (Liu 2004), and the main sources are fruits, 
beverages such as tea, coffee, wine and fruit juices, chocolate and, to a lesser extent, 
vegetables, cereals and legumes seeds (Scalbert, Morand et al. 2002). The phytochemicals 
used in this study are mostly classified as phenolic acids or flavonoids. Flavonoids have 
been identified in fruits, vegetables, and other plant foods and have been linked to reducing 
the risk of major chronic diseases. Differences in the generic structure classify them as 
flavonols (quercetin, kaempferol, myricetin), flavones (luteolin, apigenin), flavonols 
(catechin, epicatechin, epigallocatechin, epicatechin gallate, epigallocatechin gallate), 
P 
H 
Y 
T 
O 
C 
H 
E 
M 
I 
C 
A 
L 
S 
Phenolics 
Carotenoids 
Organosulphur 
compounds
Nitrogen-containing 
compounds
Alkaloids 
Flavonoids 
(cocoa, berries) 
 
Stilbenes 
 
Tanins 
 
Coumarins 
Phenolic 
acids 
(coffee, walnuts, 
turmeric, thyme) 
 58
flavanones (naringenin), anthocyanidins, and isoflavonoids (genistein) are common 
flavonoids in the diet. Phenolic acids can be subdivided into two major groups, 
hydroxybenzoic acids and hydroxycinnamic acids. 
 
1.5.2. Metabolism of Phenolics 
 
Indirect evidence of the benefits of phenolic absorption through the gut barrier is the 
increase in the antioxidant capacity of the plasma following the consumption of phenolic-
rich foods. Once absorbed in the small intestine, phytochemicals are transported to the 
liver or direct to the circulation depending on the solubility (Yeum and Russell 2002). The 
liver is the main site of metabolism of xenobiotics, however small amounts can be 
metabolized by the intestinal mucosa. Many phytochemicals share metabolic pathways 
with xenobiotics, and are thus handled by the same enzymes (the Phase I, II and III 
enzymes) (Scalbert and Williamson 2000). These phytochemicals are reconjugated in the 
enterocytes or liver. Phytochemicals are seldom consumed and absorbed in sufficient 
quantity to saturate their metabolic pathways, and hence they are, by and large metabolized 
in the intestine and found conjugated in tissue other than intestine and liver (Scalbert and 
Williamson 2000). Recovery in urine after ingestion of given amounts of a particular 
polyphenol allows the comparison of the bioavailability of the different molecules present 
in diets (Scalbert, Morand et al. 2002). The few existing studies show that the quantities of 
polyphenols found intact in urine vary from one phenolic compound to another. Most 
dietary phenolics are quickly eliminated in both urine and bile after ingestion. In man, a 
post-prandial peak is observed 1-2h after ingestion of various flavonols and flavanols but is 
longer for isoflavones while other polyphenols are only absorbed after partial degradation 
by the colon microflora (Scalbert and Williamson 2000).     
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Phenolics are extensively metabolised either in the tissues, once they are absorbed through 
the gut barrier, or, for the non-absorbed fraction and the fraction re-excreted in the bile, by 
the colonic microflora (Scalbert and Williamson 2000). All phenolics are conjugated to 
form O-glucuronides, sulphate esters and O-methylether, however very little is known 
about the biological properties of these metabolites. Phenolics, once they reach the colon, 
are extensively metabolised by the microflora. The flavonoid glycosides such as rutin, that 
are not absorbed in the upper part of the intestinal tract, can be hydrolysed and the 
aglycone absorbed (Bokkenheuser, Shackleton et al. 1987).  
 
1.5.3. Epidemiological Evidence 
 
Vegetables and fruits, nuts and seeds, and herbs and spices, wherever they grow or can be 
cultivated, have always been part of human diets. In the past, vegetables were the main 
source of many vitamins, and fruits the main source of energy for hunters and pastoral 
peoples. However, recently, the consumption of vegetables and fruits has been decreasing 
because of the higher consumption of other foods and food products commonly used in a 
Western diet. Evidence that vegetables and fruits might be protective against some cancers 
emerged in a greater depth in the 1990’s (WCRF 1997). However, the evidence for a large 
preventive effect of vegetable and fruits came primarily from case-control studies, which 
can be readily biased by differences in recall of past diet by patients with cancer and 
healthy control subjects (Willett 2010). Prospective studies largely avoid bias because of 
recall and selective participation, but results of large prospective cohort studies of diet and 
cancer began to come together, and these did not confirm the strong inverse associations 
found in most case-control studies (Willett 2010). 
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Riboli and Norat (Riboli and Norat 2003) have published in 2003 a meta-analysis of 
epidemiologic studies of the protective effect of fruit and vegetable on colorectal cancer 
risk. They found 28 case-control and 12 cohort studies on colorectal cancer, and only three 
case-control studies reported a significant protective effect of high vegetable intake and the 
remaining reported no association. In the case of fruits, only two of the case-control studies 
reported significant protective effects of citrus fruits. Their conclusion was that the pooled 
relative risk indicates that there is a moderate but significantly decreased risk of colorectal 
cancer with high intake of vegetables and fruit for all studies combined. That protective 
effect was significantly stronger in case-control studies, while cohort studies did not 
support the hypothesis of a protective effect of vegetable and fruit consumption on 
colorectal cancer. 
 
Miller et al. (Miller, Lesko et al. 2010) have published a very recent review of the 
epidemiological evidence of the protective effects from dietary patterns on colorectal 
cancer mostly form cohort studies. A total of 16 articles published up to January 2009 were 
included in the review, 10 were cohort, and 6 were case-control studies. They found 1 
cohort and 2 case-control studies reporting the beneficial effects of high intake of fruits and 
vegetables against colorectal cancer. However, they concluded that the association of fruits 
and vegetables with colorectal cancer risk were modest and not consistently statistically 
significant, which is in agreement with much of the previous literature. 
 
Furthermore, a European cohort study performed by Boffetta et al. (Boffetta, Couto et al. 
2010) of nearly 400 000 men and woman who developed approximately 30 000 cancers at 
all sites combined over nearly 9 years of follow-up showed a 4% lower incidence of all 
cancers combined for an increment of 200g of total fruits and vegetables per day.  
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The results from the European Prospective Investigation into Cancer and Nutrition (EPIC) 
related to colorectal cancer was published by van Duijnhoven et al. (van Duijnhoven, 
Bueno-De-Mesquita et al. 2009). They found that higher consumption of fruit and 
vegetables may protect against the development of colorectal cancer, especially colon 
cancer. They also concluded that the association was stronger in never and former 
smokers, whereas current smokers showed a positive association.  
 
1.5.4. Coffee 
 
Coffee (Coffea robusta)  is one of the most widely consumed beverages in the world and is 
the major contributor of redox active phytochemicals in the diet (Tosetti, Noonan et al. 
2009). The main constituents of coffee include caffeine, diterpenes, phenolic acids, and 
melanoids and acrylamide produced during roasting of coffee beans (Bekedam, Loots et al. 
2008). Coffee can potentially impact on the aetiology of cancer of various sites along 
multiple pathways, ranging from carcinogenesis to cellular apoptosis (Arab 2010). 
However, the World Cancer Research Report (WCRF), addressed only the relationships 
between coffee and risk of pancreatic and kidney cancer (WCRF 2007). The effect of 
coffee on colorectal cancer prevention has been contradictory. Case-control studies showed 
a potential effect of coffee against colorectal cancer (Tavani and Vecchia 2004). While 
some cohort studies showed no association (Tavani and Vecchia 2004), others showed a 
positive effect (Oba, Shimizu et al. 2006; Lee, Inoue et al. 2007). Coffee has been shown 
to have anti-inflammatory effect (Paur, Balstad et al. 2010), however a lack of effect has 
been reported in relation to carcinogenesis in animal models of colorectal cancer 
(Oikarinen, Erlund et al. 2007; Park, Davis et al. 2010). 
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1.5.5. Walnuts 
 
Walnuts (Juglans regia) are the subject of increasing interest as a source of phytochemicals 
mainly due to the fact that their regular consumption has been reported to reduce the risk of 
coronary heart disease (Blomhoff, Carlsen et al. 2006) and some types of cancers (Mathew, 
Peters et al. 2004). Walnuts are good sources of essential fatty acids (linoleic acid is its 
major fatty acid), tocopherols and tocotrienols, proteins, fibre, melatonin, sterols, folate, 
tannins and other phenolics (Pereira, Oliveira et al. 2008). Among several nut types, 
walnuts have the highest content of phenolics and most of the compounds are located in 
the pellicles (Blomhoff, Carlsen et al. 2006). Despite some studies showing a positive 
association between regular consumption of nut and reduced incidence of several chronic 
diseases, the World Cancer Research Report (WCRF) considered the evidence was too 
limited in amount, consistency, or quality to draw any conclusions (WCRF 2007). 
Nevertheless, an anti-cancer effect of walnuts has been demonstrated in MDA-MB 231 
human breast cancers implanted into nude mice (Hardman and Ion 2008). 
 
1.5.6. Cocoa 
 
Cocoa (Theobroma cacao L.) is rich in soluble flavonoids (catechin and epicatechin), 
which are reducing agents, and one of their effects is protection against oxidative stress, an 
imbalance between the concentrations of reactive oxygen species (ROS) and the defence 
mechanisms of the body (Maskarinec 2009). Cocoa also has high concentration of 
procyanidins (polymeric condensation products of catechins) formed during fermentation. 
These bioactive compounds constitute 60% of the total phenolics content in cocoa products 
(Hammerstone, Lazarus et al. 2000). The majority of the human studies on cocoa products 
and disease risk have reported on cardiovascular disease (Cooper, Donovan et al. 2008). 
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However, in experimental settings, catechins and procyanidins have been shown to 
influence the immune response by modulating the activation of NF-kB, and consequently 
might be preventing cancer by damping inflammation (Maskarinec 2009).     
 
1.5.7. Turmeric and Thyme 
 
Turmeric is prepared from the root of the Curcuma longa plant, a member of the ginger 
family, and curcumin is its principal constituent, and is one of the principal ingredients in 
curry powder. Curcumin is in modern use worldwide as a cooking spice, flavouring agent 
and colorant. The active ingredient of curcumin is diferuloylmethane, a hydrophobic 
phenolic with a characteristic yellow colour (Epstein, Sanderson et al. 2010). Curcumin 
has chemo-preventive and therapeutic properties against many tumours in in vitro and in 
vivo models and has been tested in a number of clinical trials (Khor, Keum et al. 2006).  
The safety, tolerability and non-toxicity of curcumin at high doses have been established, 
and in human trials, only minor side effects have been reported (Anand, Kunnumakkara et 
al. 2007; Johnson and Mukhtar 2007). In colon cancer cell lines, curcumin has shown anti-
inflammatory (Chen and Xu 2005), pro-apoptotic (Song, Mao et al. 2005), and anti-cancer 
effects (Chen and Xu 2005; Song, Mao et al. 2005). In animal models curcumin has also 
been shown to have chemopreventive efficacy in several studies (Rao, Rivenson et al. 
1995; Pereira, Grubbs et al. 1996; Collett, Robson et al. 2001; Kim and Hellerstein 2007).   
 
Thyme is among the commercially available spices with the highest total antioxidant 
capacity, and rosmarinic acid is among the phytochemical compounds present in thyme. 
Thyme has been reported to reduce inflammation in a model of colitis (Bukovska, Cikos et 
al. 2007).  
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1.5.8. Berries 
 
Berries such as blackberries, cranberries, strawberries, raspberries and blueberries contain 
significant amounts of phenolics, especially flavonoids. Anthocyanins are particularly 
prevalent in berries, reaching concentrations in excess of 10g/kg in some cultivars (Coates, 
Popa et al. 2007). Moreover, anthocyanins can modify cancer biomarkers in vitro (Coates, 
Popa et al. 2007), and also inhibit cancer cell growth in culture (Kamei, Kojima et al. 
1996). In the present study, the berries used in the experimental diet were bilberries 
(Vaccinium myrtillus L) and blackcurrant (Ribes nigrum). Bilberries and blackcurrants are 
rich in redox active compounds especially anthocyanins, which give rise to the colour, but 
also contain flavonols, phenolic acids, stilbenes, catechins and lignans (Hakkinen, 
Karenlampi et al. 1999; Sandell, Laaksonen et al. 2009). Several in vivo studies have 
demonstrated the anti-carcinogenic effect of berries in different models of colorectal 
cancer (Hagiwara, Miyashita et al. 2001; Gee, Hara et al. 2002; Bobe, Wang et al. 2006). 
Regarding the substantial amount of inconsistent evidence from several cohort studies on 
the protective effect of fruits, the World Cancer Research Report (WCRF) concluded there 
is limited evidence suggesting that fruits protect against colorectal cancer (WCRF 2007). 
 
1.5.9. Chemopreventive Mechanism of Phytochemicals 
 
The need for biologically active compounds with low profiles of adverse reactions 
compared to pharmacological drugs has triggered an extensive investigation of plants and 
phytochemicals and their mechanisms of action. The biological activities of these 
phytochemicals are often determined by their physical and chemical properties, which in 
turn are determined by the structures of the compounds, the type of functional groups 
present and the utilized concentration. Several phytochemicals exert multiple cellular 
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effects involving one or more signalling pathways. These effects can be synergistic, 
additive or even antagonistic depending on the cell type, the concentration of the 
phytochemical and its surrounding environment (Issa, Volate et al. 2006). 
 
There is growing evidence that a number of different classes of food constituents such as 
flavonoids, can regulate the process of cell proliferation and death in vitro, and in 
colorectal crypts in vivo (Johnson 2002). The flavonoids consumed in the diet are 
metabolized and the metabolites appear in the circulation soon after consumption, but the 
epithelial tissues of the gastrointestinal tract are probably exposed to much higher local 
concentrations (Halliwell, Zhao et al. 2000).   
 
As discussed in section 1.1.2.2 an important pathway involved in the regulation of cell 
proliferation in colorectal epithelia is that involving the intracellular protein #-catenin 
(Byun, Karimi et al. 2005). In normal epithelial cells there is a relatively large and stable 
pool of #-catenin immobilized by interactions with cytoskeletal proteins, and a small labile 
pool in the cytoplasm. However, in cancer cells the balance is altered in favour of the 
cytoplasmic pool because the regulatory mechanism for #-catenin is disrupted by various 
mutations or epigenetic events (Gregorieff and Clevers 2005).  
 
The survival of most cancer cells depends critically upon their ability to divide 
continuously, and to evade apoptosis (Pierini, Gee et al. 2008). A variety of different 
flavonoids have been shown to inhibit proliferation and enhance apoptosis in vitro. Despite 
the great variety of naturally occurring compounds shown to be active in vitro, it has 
proven much more difficult to establish that food-borne flavonoids increase apoptosis in 
animals or humans (Johnson 2002).  
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Many dietary chemopreventive  polyphenols, including quercetin, EGCG, curcumin, 
resveratrol and others, are believed to evoke their inhibitory effect on carcinogenesis 
though the induction of apoptosis (Surh 2003). Ramos (Ramos 2008) has described in her 
review how phytochemicals can affect apoptosis by describing the effect of EGCG which 
induces ROS generation and may mediate apoptosis by inducing DNA fragmentation, 
activation of caspases-3 and -9, release of the apoptogenic cytochrome c, Smac and 
apoptosis-inducing factor (AIF), in concert with diminished levels of anti-apoptotic 
proteins such as Bcl-2 and myeloid cell leukaemia-1 (Mcl-1). Polyphenol treatment of 
several cancer cell lines induced apoptosis through activation of proteins related to 
programmed-cell death pathways such as caspases-3, -9 and -8, as well as through the 
inhibition of other proteins such as the inhibitor of apoptosis protein-2 (c-IAP2), X-linked 
IAP, Bcl-2, Bcl-xl and Bid (Hayakawa, Saeki et al. 2001; Nishikawa, Nakajima et al. 
2006). Moreover, promotion of apoptotic cell death by EGCG in the sarcoma 180 cell line 
was induced through G2/M cell cycle arrest, down-regulation of Bcl-2 and c-myc, up 
regulation of p53 and Bax (Manna, Banerjee et al. 2006).  Hastak et al. (Hastak, Agarwal 
et al. 2005) has demonstrated that inactivation of p53 by using small interfering RNA 
generated resistance against EGCG-induced apoptosis primarily via a p53-dependent 
pathway which involved the function of both p21 and Bax. Curcumin activated caspases-3, 
-7, -8 and -9 in several colon cancer cell lines, but a reduced activation of caspases related 
to the mitochondrial pathway together with a partial blocking of AIF (Rashmi, Santhosh 
Kumar et al. 2003). 
 
There are several other chemopreventive mechanisms of phytochemicals against 
carcinogenesis. Possibly different mechanisms will be associated with particular 
phytochemicals and may affect tumorigenesis at different stages of cancer development 
(initiation, promotion, and progression). Another possible mechanism by which 
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phytochemicals may suppress tumour development may be involved in their antioxidants 
properties.  
 
During all the stages of cancer development many key proteins related to cellular 
antioxidant defences,  cellular proliferation and survival transduction pathways are up-
regulated or down-regulated (Ramos 2008). A better understanding of these mechanisms is 
vital to properly utilize the phytochemicals as promising agents that promote health and 
prevent diseases (Ramos 2008; Randi, Edefonti et al. 2010). 
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2. AIMS OF THE STUDY  
 
It is known that colorectal cancer is enhanced by a high fat diet, which plays an important 
role on tumour development. The present thesis was proposed to test the hypothesis that 
the effect of a high fat diet on the development of colorectal cancer would vary according 
to the type of fat consumed by ApcMin/+ mouse. Moreover, this thesis was also proposed 
to test the hypothesis that phytochemicals would have positive effect by preventing 
colorectal cancer development. To test these hypothesis, two separate animal experiments 
were performed, one to evaluate the effects of a high fat diet (25%) rich in dietary n-3 fatty 
acids (fish oil diet, FO) or n-6 fatty acids (corn oil diet, CO) on colorectal cancer 
development in ApcMin/+ mouse model. The aim of the second experiment was to test the 
hypothesis that a high anti-oxidant phytochemical mix would protect against intestinal 
cancer development in ApcMin/+ mouse. Both experiments had the same control (palm oil 
diet, PO) and the same endpoints. The following effects were analysed: 
 
! Effect of sex, genotype and diet on body and organs weight. 
! Effect of genotype and diet on mitosis, apoptosis and crypt length in the small and 
large intestine as early markers of cancer risk. 
! Effect of genotype and diet on cytokine levels, as a marker of inflammatory status, in 
the small and large intestine, and in the plasma. 
! Effect of diet on tumour size and tumour number in the small and large intestine. 
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3. MATERIAL AND METHODS 
 
In this chapter the details regarding the diet composition used in both experiments is 
presented. The mouse breeding programme is also described, as well as the experimental 
design. Moreover, it describes the methods of the analysis done in the present study, such 
as body weight, tissue and blood collection; DNA extraction; polymerase chain reaction; 
fatty acids measurement; cell proliferation and apoptosis; protein assay; scoring tumour 
size and number; and cytokines measurements are described in detail. The statistical 
method used to analyse the data in the study is also presented in the chapter.      
 
3.1. DIET  
 
The treatment diets were supplied by Special Diets Services (Essex, UK). The composition 
of the diet is summarized in Table 3.1 and the fatty acids content in Table 3.2. All the 
treatment diets had 20 % energy as protein, 55 % energy as carbohydrate, and 25% energy 
as fat.  The palm oil group was used as control diet, which contained the following fatty 
acids: 500 mg/g saturated, 400 mg/g monounsaturated, and 100 mg/g polyunsaturated. The 
corn oil diet contained 130 mg/g saturated, 270 mg/g monounsaturated, and 600 mg/g 
polyunsaturated. The fish oil used for the preparation of the fish oil diet contained 202 
mg/g of EPA and 260 mg/g of DHA and the weight of fish oil was 11.25g/kg diet. 
Consequently, for each kilo of the treatment fish oil diet the content of EPA and DHA was 
112.5 x 0.202g = 22.7g and 112.5 x 0.260g = 29.3g, respectively, a total of 52g/kg diet.  
 
Palm oil was chosen as a control diet because it hasn’t previously been shown to have a 
specific carcinogenic effect in animal models of colorectal cancer. However, corn oil has 
been shown to be carcinogenic (Whelan and McEntee 2004), while fish oil had 
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demonstrated protective effects on colorectal cancer in several experiments (Paulsen, 
Elvsaas et al. 1997; West, Clark et al. 2010) . The average intake of diet was 2.8g per 
mouse/day, and the average intake of EPA+DHA for animals fed the fish oil diet was 
145.6 mg/mouse/day (63.6 mg/mouse/day of EPA and 82 mg/mouse/day of DHA).  
 
The amount of EPA + DHA in this diet was high compared to the dietary 
recommendations for humans whether calculated based on per kg body weight or per kg 
diet. 
 
Firstly the amount of EPA+DHA given to the mice per kg of body weight is converted to 
the same dose for a human with an average weight of 70kg. Each mouse weighed on 
average 20g (0.02kg) and ingested 0.146g of EPA+DHA per day or 7.3g/kg body weight. 
Converting the same dose of fatty acids to a human with an average weight of 70kg, the 
amount would be equivalent to 509.6 g of EPA+DHA per day. Considering the present 
recommendation of EPA and DHA for a healthy adult being around 500mg/day, or a 
maximum of 2-3g per day in specific cases, it demonstrates that the dose used per kg of 
body weight in the experiment was extremely high.   
 
Alternatively it can be argued on the basis of dietary content and that the amount of EPA 
and DHA in the mouse diet was 52 g/Kg diet. Humans eat approx. 500g/d dry weight of 
food (Denomme, Stark et al. 2005).  A high EPA+DHA supplement may provide as much 
as 3g of EPA+DHA per day (Engeset, Alsaker et al. 2005) which would be equivalent to 
6g/Kg dry weight. Alternatively a Norwegian traditional diet contains about 200g/d fish of 
which about half is oily fish plus fish roe and cod liver oil. Oil-rich fish may contain about 
2g/100g EPA+DHA so such people would be eating perhaps over 2g EPA+DHA per day. 
On this basis the diet had about ten times the concentration in an ideal human diet. 
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The phytochemical diet had palm oil as a source of fat, but also contained 100g/kg of 
phytochemical mix containing coffee (Coffea robusta), cocoa (Theobroma cacao L.), 
turmeric (Curcuma domestica), thyme (Thymus pulegioides), walnuts (Juglans regia), and 
mix of bilberries and blackcurrant (Vaccinium myrtillus and Ribes nigrum). The content of 
phenols in the phytochemical diet was calculated by the Phenol-Explorer, which is a 
comprehensive electronic database on polyphenol content in foods Table 3.3  (Neveu, 
Perez-Jiménez et al. 2010). 
 
The phytochemical mix was added in place of cellulose (100g/kg)  as previous studies have 
shown that 10% non-fermentable polysaccharides have no effect on adenoma number in 
the small intestine or colon (Moser, Dove et al. 1992), leaving all other nutrients 
unchanged except those added as part of the phytochemical mix.  
 
The phytochemical mix was constituted by six different food ingredients with the 
following quantities: coffee (31% of 100g/kg of diet), cocoa (31% of 100g/kg of diet), and 
walnuts (31% of 100g/kg of diet). Only a small part of the mix was constituted by turmeric 
and thyme (3.1% of 100g/kg of diet) and berries (0.16% of 100g/kg of diet). According to 
the phytochemical classification (Liu 2004), the mix used in the present diet was mainly 
rich in phenolic acids and flavonoids, which are a subgroup of phenolics.  
 
The content of phytochemicals in the diet was 442 mg of flavonoids, phenolic acids and 
other polyphenols/ kg of diet. As the average food consumption was 2.8g per mouse, the 
animals consumed a total of 442 x 2.8/1000 mg =1.2 mg of polyphenols per day, which 
equals to 62 mg of polyphenols/ kg of mouse body weight. Converting the same amount of 
phytochemicals ingested by the mice to a human weighing 70kg, it would be equivalent to 
4.3 g of polyphenols per day. A study performed by Saura-Calixto et al. (Saura-Calixto, 
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Serrano et al. 2007) found that the content of total polyphenols in a whole Spanish diet was 
between 2.6 and 3. 02 g/person/day, Therefore in this part of the study the intake was not 
unduly high compared to human consumption. The concentration in the human diet is 
approx. 3 g/500g dry weight or 6 g/kg while the mouse diet contained only 0.4g so on this 
basis the intake was low compared to the Spanish diet. 
 
The content of Vitamin E (33IU/kg), zinc (10mg/kg) and selenium (150µg/kg) were 
reduced to a minimum level in all diets because of its possible protective effect against 
colorectal cancer (Kucharzewski, Braziewicz et al. 2003; Peters and Takata 2008). 
 
The phytochemical mix used in the present study was chosen based on the study performed 
by Paur et al (Paur, Austenaa et al. 2008). They have screened 35 dietary plant extracts 
looking for the best candidates that would modulate basal or induced NF-kB in vitro and in 
vivo. The reason they have chosen NF-kB as the molecular target is because this protein 
has been identified as a promising therapeutic target both in cancer and chronic 
inflammation. At the end of their study, they found five efficient inhibitors of NF-kB, and 
ten extracts with the dual effect of increasing basal and inhibiting LPS/TNF-" induced NF-
kB activity. Based on that, the phytochemical mix used for the present experiment was 
formulated with the expectation that it would be a good mixture of chemopreventive 
phytochemicals likely to oppose the promotion of tumorigenesis in the ApcMin/+ mouse 
model. Paur et al. (Paur, Balstad et al. 2010) have also used a mix of phytochemicals from 
dietary plants in an animal study. However, they have used a single dose of the dietary 
extracts via oral gavage corresponding to an amount of 1.38g of the dietary plant.  
 
Dietary plants contain a vast number of phytochemicals that are divided into several 
subgroups. However, in the present study the phytochemicals present in the phytochemical 
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mix belong mainly to the phenolic group, which is also subdivided into phenolic acids, 
flavonoids, stilbenes, lignans, and coumarins (Liu 2004). The foods used in the formulation 
of the phytochemical mix are mainly a source of phenolic acids and flavonoids.  
 
 
Diet composition Palm oil Corn oil Fish oil Phytochemical 
 gm% kcal% gm% kcal% gm% kcal% gm% kcal% 
Protein 20 20 20 20 20 20 20 20 
Carbohydrate 55 55 55 55 55 55 55 55 
Fat 11.25 25 11.25 25 11.25 25 11.25 25 
Other 11 1 11 1 11 1 11 1 
Total 100 100 100 100 100 100 100 100 
kcal/gm 4.1  4.1  4.1  4.1  
         
 gm kcal gm kcal gm kcal gm kcal 
Casein, Iatic 200 800 200 800 200 800 200 800 
L-cystine 3 12 3 12 3 12 3 12 
Corn starch 272.61 1194.6 272.61 1194.6 272.61 1194.6 272.61 1194.6 
Maltodextrin 91.66 366.64 91.66 366.64 91.66 366.64 91.66 366.64 
Sucrose 162.98 651.92 162.98 651.92 162.98 651.92 162.98 651.92 
Cellulose 100 0 100 0 100 0 0 0 
Soybean oil 31.25 281.25 31.25 281.25 31.25 281.25 31.25 281.25 
Palm oil 81.5 733.5 0 0 0 0 81.5 733.5 
Corn oil 0 0 81.5 733.5 0 0 0 0 
Fish oil 0 0 0 0 81.5 733.5 0 0 
Phytochemical 
mix 
0 0 0 0 0 0 100 0 
Mineral mix  10 0 10 0 10 0 10 0 
DiCalcium 
phosphate 
13 0 13 0 13 0 13 0 
Calcium 
Carbonate 
5.5 0 5.5 0 5.5 0 5.5 0 
Potassion citrate 16.5 0 16.5 0 16.5 0 16.5 0 
Vitamin mix 10 40 10 40 10 40 10 40 
Choline bitartrate 2 0 2 0 2 0 2 0 
Total 1000 4079.91 1000 4079.91 1000 4079.91 1000 4079.91 
Table 3.1 Dietary composition of the treatment diets given to ApcMin/+ and wild-type mice for 10 weeks. 
 
 
 
 
 
 
 
 
C:D 
 
Fatty Acids Palm oil Diet 
(%) 
Corn oil Diet 
(%) 
Fish oil Diet 
(%) 
Phytochemical 
Diet (%) 
C14:0 Myristic acid 0.87 0.27 0.21 0.28 
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C14:1 Myristoleic acid 0.52 0.21 0.23 0.17 
C16:0 Palmitic acid 33.10 11.42 27.71 27.04 
C18:0 Stearic acid 5.97 2.35 6.75 4.10 
C16:1 Palmitoleic acid 0.01 0.04 7.16 0.02 
C18:1 Oleic acid 33.15 30.11 18.02 29.67 
C18:2 Linoleic acid 22.13 62.21 15.62 30.09 
C18:3 Gama-Linolenic acid 1.82 2.65 2.25 4.15 
C20:0 Arachidic acid 0.44 0.43 0.39 0.34 
C20:1 Gadoleic acid 0.11 0.08 0.55 0.15 
C20:2 Eicosedienoic acid 0.06 0.04 0.11 0.03 
C20:4 Arachidonic acid 0.01 0.02 0.58 0.02 
C20:3 Eicosatrienoic acid 0.02 0.00 0.02 0.00 
C22:0 Behenic acid 0.21 0.20 0.17 0.12 
C22:1 Erucic acid 0.02 0.00 0.39 0.00 
C20:5 Eicosapentaenoic acid - EPA 0.03 0.16 9.71 0.19 
C24:0 Lignoceric acid 0.01 0.09 0.10 0.02 
C24:1 Nervonic acid 0.01 0.00 0.20 0.00 
C22:6 Docosahexaenoic acid - DHA 0.01 0.07 4.77 0.13 
Table 3.2 Fatty acids content of the treatment diets. 
  
 
Ingredients Flavonoids 
 
Phenolic acids 
 
Other 
polyphenols 
 
Stilbenes 
 
Cocoa (Theobroma cacao L.) 159.62 11.56 0.14 0 
Coffee (Coffea robusta) 0 63.83 0 0 
Turmeric (Curcuma longa) 0 0 169.52 0 
Thyme (Thymus spp) 0 27.41 0 0 
Walnuts (Juglans regia) 0 8.89 0 0 
Bilberry (Vaccinium myrtillus) 0.002 0.004 0 0.001 
Blackcurrant (Ribes nigrum) 0.96 0.02 0 0 
Total  160.58 111.71 169.66 0.001 
Table 3.3 Total content of flavonoids, phenolic acids, other polyphenols and stilbenes in the phytochemical 
dietary group. Values are presented as mg/kg of diet. Values were calculated based on the Database on 
Polyphenol content in Foods. 
 
 
3.2. MOUSE BREEDING 
 
The ApcMin/+ mouse is a transgenic model of human intestinal tumorigenesis that bears a 
germline mutation at codon 850 of the mouse homologue of the human Adenomatous 
Polyposis Coli gene, which is frequently mutated in human colon cancer. By age 4-5 
months, these mice bear numerous visible tumours in the intestinal tract and usually die 
due to intestinal blockage, bleeding, and severe anemia (Moser, Dove et al. 1992). Fifteen 
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males Min heterozygote mice (C57BL/6L ApcMin/+) and thirty females inbred C57BL/6L 
were obtained from Jackson Laboratory in USA. Animals arrived at the Disease Modeling 
Unit (DMU) at the University of East Anglia (UEA) at eight weeks of age. Fifteen 
breeding ‘pairs’ (one C57BL/6L ApcMin/+ male and two inbred C57BL/6L females per 
cage) were set up two weeks after the animal’s arrival. The Min mutation cannot be 
propagated through the female, because anemia and intestinal adenomas interfere with 
pregnancy (Paulsen, Ø.Elvsaas et al. 2007). As reproductive performance generally 
decreases with age, breeders who did not produce litters within six to eight week had the 
males exchanged between the female’s breeders. Also, if the male breeder was visually 
sick, it was also replaced by a younger breeder. All mice used in the experiment were 
related within the number of generations necessary for securing their status as inbred. The 
animals were housed in plastic cages with temperature (23 ± 2C) and humidity (40-60%) 
controlled with a 12h light-dark light cycle. All mice had continual access to food and 
water and were observed daily for health status. The total number of mice for the 
experiment was obtained from 69 breeding cages during a period of twelve months. 
Offspring were genotyped by polymerase chain reaction, and then used as breeder or put 
on the treatment diet.   
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3.3. EXPERIMENTAL DESIGN 
 
 
 
 
 
 
 
 
 
The animal experiment was carried out according to a protocol approved by the DMU 
ethical committee at the UEA and covered by Prof Ian Johnson’s Home Ofice Project 
Licence. A total of 128 mice were randomly assigned to four different diet groups 
(n=32/group): palm oil as control diet; corn oil; fish oil; or phytochemical (Figure 3.1). The 
composition of the diet is described in section 2.1. Each dietary group had 16 ApcMin/+ 
mice and 16 wild-type mice, half males and half females. The animals were allowed to 
consume the diets ad libitum for 10 weeks. At the end of the 10 weeks, animals were 
anaesthetized by inhalation of Isoflurane (IsoFlo – Abbott Animal-Health, Abbott 
Laboratories Ltd. Queensborough, Kent, UK), opened ventrally and blood collected by 
cardiac puncture before cervical dislocation to ensure death prior to organ removal for 
further analysis. The animal experiment was designed to have the data analyzed as two 
separate studies. One study focusing on the effects of fatty acids on gastrointestinal cancer, 
and the other study on the effects of phytochemical. Due to ethical reasons and the need to 
reduce the total number of animals used in the experiment, as requested by the Home 
Office, it was decided to have only one control group (PO diet), which was shared between 
 
Figure 3.1  Study design 
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both studies.  Tail snips were taken at weaning for the genotype analysis by polymerase 
chain reaction (PCR). 
 
 
3.4. BODY WEIGHT, TISSUE AND BLOOD COLLECTION 
 
During the experiment the animals were weighed at the beginning of the study, at week 5 
and at the end, week 10 before being killed. Blood was centrifuged at 14,000 rpm for 5 
min., the plasma collected and transferred into another labeled microfuge tube and stored 
at -80°C for future analysis. Spleen, liver, heart, kidney, stomach, and caecum were 
removed, weighed, immediately put on dry ice, and stored at -80°C until further analysis. 
The intestines were also removed for scoring the tumours as described in section 2.10.  
 
 
3.5. DNA EXTRACTION 
 
The DNA was extracted from the tail snips by using the GenElute Mammalian Genomic 
DNA Miniprep Kit (Sigma-Aldrich). The tail snip after having being thawed slightly was 
placed in a 1.5mL microcentrifuge tube, and 180µL of lysis solution was added, followed 
by 20µL of the Proteinase K solution to the rodent tail. After vortexing, the sample was 
incubated at 55°C until the tail tissue was completely digested. The sample was vortexed 
again after the digestion was completed. 200µL of lysis solution was added to the sample 
and vortexed. 500µL of the Column Preparation Solution was added to each pre-assembled 
GenElute Miniprep Binding Column and centrifuged at 12,000 x g for 1 min. 200µL of 
ethanol was added to the lysate. The entire contents of lysate was transferred into the 
treated binding column and centrifuged at 6500 x g for 1 min. The collection tube was 
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discarded and the binding column was placed in a new 2 mL collection tube. 500µL of 
Wash Solution was added to the binding column and centrifuged for 1 min at 6500 x g. 
The collection tube was discarded and the binding column was placed in a new 2 mL 
collection tube. Another 500µL of Wash Solution was added to the binding column and 
centrifuged for 3 min at maximum speed 16,000 x g to dry the binding column. The 
column was centrifuged for one additional minute at maximum speed. The flow-through 
liquid was discarded and the binding column was placed in a new 2 mL collection tube. 
200µL of the Elution Solution was added directly to the center of the binding column and 
centrifuged for 1 min at 6,500 x g to elute the DNA. The pure genomic DNA was frozen in 
-20°C until further analysis.  
 
 
3.6. POLYMERASE CHAIN REACTION (PCR) 
 
PCR is an in vitro DNA amplification that involves a repeated cycling process of defined 
stages, termed denaturation, annealing, and extension. The reagents required for the PCR 
include DNA polymerase, each of four nucleotides (dNTPs), a primer, magnesium source, 
buffer solution and DNA template (Maurer 2006). The DNA to be amplified was isolated 
from tail snips of mice as described in section 3.5.  
 
The PCR method used in the present study has been previously described by Leu at al. 
(Hu, Le Leu et al. 2007). 5 µL of genomic DNA was amplified in a 57.7 µL reaction 
volume per sample containing final concentrations of 100 µM oIMR0033, 100 µL 
oIMR0034, 100 µL oIMR0758 (Table 3.4, primers purchased from Sigma, UK), 2.5 µM 
each of dATP, dCTP, dGTP, dTTP (Promega Corporation, USA), 24µM MgCl2, 5x Green 
GoTaq Flexi Reaction Buffer (Promega Corporation, USA), autoclaved water, 5 U/µL Taq 
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polymerase (Promega Corporation, USA). The amplification conditions were 36 cycles of 
3 min at 94°C, 30 seconds at 94°C, 1 min at 55°C, 1 min at 72°C, followed by a final 
extension at 72°C for 2 min. 
 
The primers oIMR0033 and oIMR0034 were used to amplify the wild-type allele and 
primers oIMR0034 and oIMR0758 was used to amplify the disrupted allele. The 
ApcMin/+ mice could be identified by the wild-type allele generated a 600bp fragment and 
the disrupted allele generated a 340bp fragment. 
 
When DNA is heated in excess of 94-95°C for at least 60 seconds, the double strands come 
apart to produce two single strands. This process is called denaturation, which allows the 
primers to bind to the DNA template (annealing), whose sequences are complementary to 
the primers. In the next stage the temperature is reduced to 35-60°C for 30-120 seconds. 
Subsequently, the polymerase makes a complementary copy of the template DNA started 
from each primer, thereby creating a double strand of the target region. Known as 
extension, this step usually takes places at 72°C for 60-180 seconds. In the next cycle, the 
DNA produced from the previous cycle becomes new template to produce a double new 
DNA (Maurer 2006) 
 
The PCR products were visualized by eletrophoresis. The prepared 1.5% agarose gel 
(Promega Corporation, USA) on a supporting plate is submerged into a chamber 
containing electrophoresis buffer (TAE 1x). The wells were created in the agarose gel with 
the aid of a comb inserted into the cooling agarose. Into the wells, samples with have been 
mixed with a loading dye were loaded. Eletrophoresis was carried out for 45min at room 
temperature followed by staining with ethidium bromide (Sigma-Aldrich, UK). A 
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successful PCR amplification results a strong band of targeted amplified product with faint 
bands of residual nucleotides and primers (Figure 3.2). 
 
 
Figure 3.2  PCR products from DNA from mice tails runned on 1,5% agarose gel. 
 
Primer Sequence Primer type 
oIMR0033 5’-GCC ATC CCT TCA CGT TAG Wild-type 
oIMR0034 5’-TTC CAC TTT GGC ATA AGG C Common 
oIMR0758 5’-TTC  TGA GAA AGA CAG AAG TTA Mutant 
Table 3 4 Primers used in amplification and sequencing of the samples. 
 
 
3.7. FATTY ACIDS MEASUREMENT 
 
Lipids were extracted using the Bligh and Dyer method (Bligh and Dyer 1959). Diets were 
homogenised in water. In a pre-labelled and pre-weighed vial 250 µL of sample was added 
to 550 µL water, 800 µL Butylated hydroxyltoluene/Chloroform (10 mg BHT/ 100 ml 
CHCL3) and 1.6 mL Methanol (MeOH). Samples were vortexed and centrifuged at 2,000 
rpm at 4°C for 7 min. The bottom layer was removed and put into a pre-weighed vial and 
dried under oxygen-free nitrogen.  Then, 1 mL of BHT/CHCL3 was added to the dried 
extracts and re-drying the remainder for total lipid analysis. The vacuum tank was 
assembled with 2 dram vials in place for each sample and a syringe was placed above the 
cartridge column of dram ‘vial 1’. The syringe was rinsed with chloroform without 
allowing it to run dry. Then 1 mL chloroform was added to the syringe followed by the 0.5 
Lader 
Min/+ 
+/+ 
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mL total lipid extract sub-sample. 1 mL chloroform was added, then 2 mL 
chloroform/methanol (49:1). The syringe was moved to a second position on the vacuum 
and the phospholipid fraction collected by washing with 2.5 mL methanol and added to the 
syringe until dry. Samples were then dried under oxygen free nitrogen and stored at -20°C.   
 
The extracted phospholipid and total lipid samples were then converted to fatty acid 
methyl esters (FAMES) by acid methylation prior to gas chromatography (GC) analysis. 
Firstly 0.5 ml ‘dry’ toluene was added to dried lipid extractions and vortexed to dissolve 
the lipids.  Then 1 ml of 2%(v/v) sulphuric acid in methanol was added and the solution 
was heated at 50 °C for 2h. After cooling 1ml neutralising solution (0.025M KHCO3, 0.5M 
K2CO3) and 1ml dry hexane were added and the solution was vortexed. The sample was 
centrifuged at 1000rpm for 2 min at room temperate with low brake and the upper phase 
collected in a dram vial.  The methylated sample was dried under oxygen-free nitrogen at 
40 °C and resuspended in 150 µl hexane.  The sample was then transferred to a gas 
chromatography vial and stored at -20 °C. Lipids were quantified by gas chromatography 
(GC) using Trace MS plus with GC ultra and triplus autosampler (Thermo Electron 
Corporation).  GC column specifications were 30m x 0.22 mm x 0.25mm (SG BPX70) and 
samples were injected split flow 22 ml/min.  Program temperature was 140 °C to 200 °C at 
5 °C/min for 11 min, then to 220 °C at 10 °C/min for 5 min with a helium flow rate at 
constant pressure (1 ml/min).   Samples were calibrated using a standard FAME mix 
(Supelco PA-USA, F.A.M.E Mix GLC-10) and each peak using mass spectrometer data to 
predict the compound using NIST mass spectral library with search program (version 2.0). 
Areas beneath each peak were converted to percentages of the total area of all fatty acid 
methyl ester peaks; those found not to be a fatty acid methyl ester were omitted from the 
total area calculation.  
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3.8. CELL PROLIFERATION AND APOPTOSIS 
 
 
Figure 3.3 Picture of crypt dissected, mitosis and apoptosis analysis. (a) Crypt dissected. (b) 
Mitosis at x40 objective. (c) Apoptosis at x40 objective. 
 
The number of mitotic and apoptotic cells in the gut tissue were determined using the 
morphological criteria method (Smith, Lund et al. 1998; Latham, Lund et al. 1999). After 
the animals have been sacrificed, the gut was removed and washed with PBS. The intestine 
was divided into proximal, middle, and distal small intestine, and colon. Samples from the 
distal small intestine and colon was removed and fixed in ethanol:acetic acid (75:25) prior 
staining. A small section (2-4mm2) of tissue was transferred to a pre-labelled vial 
containing about 2mls of 50% (aq) ethanol for 15min at room temperature. Afterwards, 
50% ethanol was removed and added 2 mls of distilled water for 10 minutes at room 
temperature. Water was removed and 2mls of 1N HCL was added and vial was in the 
water bath at 60°C for 7 min. The tissue was rinsed with water, then added 2 mls of 
feulgens reagent for 20-40 min at room temperature. Tissue was rinsed again with water, 
and 2 mls of 45% (aq) acetic acid was added for storage prior to micro-dissection. 
 
Under a standard dissection microscope, the muscle layers were teased from the gut 
mucosa and thin strips of crypts micro-dissected from the tissue using a fine gauge needle. 
The strips were then lightly compressed under a cover slip to separate and flatten the 
crypts, and 10 randomly chosen intact crypts per animal (320 crypts/group) were viewed 
(a) (b) (c)
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under a light microscope. Apoptotic cells were identified by the presence of condensed 
chromatin and spherical apoptotic bodies containing nuclear material. Nuclei, which were 
visibly in prophase, metaphase, anaphase, and telophase, were classified as mitosis. The 
length of each crypt was determined by comparison with a calibrated linear eyepiece 
graticule and the positions of mitotic and apoptotic nuclei were recorded and allocated to 
one of the 10 equally spaced longitudinal compartments. All crypts were analyzed blinded 
to the groups from which the samples were obtained. (Figure 3.3). 
 
 
3.9. PROTEIN ASSAY 
 
The protein assay was done using the standard procedure for microtiter plates by the 
Bradford method (Bradford 1976). Firstly, the Dye Reagent Concentrate was prepared by 
diluting 1 part of dye and 4 parts of water, and then filtered through a Whatman #1 filter to 
remove any un-dissolved particles. 5 dilutions of a protein standard were prepared and the 
linear range of the microtiter plate assay was 0.05 mg/ml to 0.5 mg/ml. The samples were 
assayed in duplicates.  10 µL of each standard and sample solution was added into separate 
microtiter plate wells. For plasma samples it was used at a dilution factor of 1:1000. Tissue 
samples were previously homogenized by using ‘Protease Inhibitor cocktail’ (Sigma-UK), 
and a dilution factor of 1:500 was used for the protein assay. 200 µL of diluted dye reagent 
was added to each well. The samples and reagent were mixed using a microplate mixer.  
The microtiter plate was incubated at room temperature for at least 5 min. Absorbance was 
measured at 595nm. 
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3.10. SCORING OF TUMOURS 
 
 
Figure 3.4 Picture of the intestinal tract from ApcMin/+ mouse. (A) Without scoring the tumours. 
(B) Scoring tumour size and number with Image Pro.   
 
After mice were killed, the small intestine and colon were isolated and rinsed with cold 
phosphate buffered saline (PBS). The small intestine was divided into three equal sections 
(proximal, middle, distal) and the colon was left uncut. A gut cutting device was used to 
cut the gut longitudinally (Rudling, Hassan et al. 2006). The stainless steel rods were 
threaded through the segments and then placed over a piece of filter paper in the device. 
The lid of the device was then fitted and its angled bars used to guide a scalpel blade to 
longitudinally dissect the tissues.  
 
Proximal 
Middle 
Distal 
Colon Proximal 
Middle 
Distal 
Colon 
(A) (B) 
Small intestine Small intestine 
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The tissue was gently held to ensure that it did not move with the knife. The lid was then 
removed. The tissue was dampened with a gloved fingertip, dipped into PBS and rubbed 
along the segments. Rods were then rolled side to side to open up the gut and spread it flat 
on the filter paper, which was placed on dry ice briefly to freeze. On freezing the tumours 
displayed a distinct white color denser than normal tissue. Afterwards a picture was taken 
using a camera (Canon 350D) and the tumours were scored by size and location (proximal, 
middle, and distal small intestine and colon) using image analysis software Image Pro 
(Figure 3.4) (Media Cybernetics, Inc., USA). Gut area and gut length was also recorded.  
 
 
3.11. CYTOKINE MEASUREMENTS 
  
Cytokines were detected using a sandwich immunoassay based protein array system 
(Mouse Cytokine/Chemokine Multiplex Immunoassay Kit, MILLIPLEX MAP Mouse 
Cytokine/Chemokine Panel (Cat# MPXHCYTO-70K, Milllipore, Billerica, USA) with 21 
distinctly coloured bead sets for Interleukin (IL) 1", IL-1#, IL-2, IL-4, IL-5, IL-6, IL-10, 
IL-12p40, IL-12p70, IL-15,  IL17, !-immunoprotein 10 (IP-10), granolyte/macrophage 
colony-stimulating factor  (GM-CSF), macrophage inflammatory protein 1 (MCP-1), 
keratinocyte derived chemokine (KC), tumour necrosis factor-alpha (TNF"), monokine 
induced by interferon gamma (MIG), vascular endothelial growth factor (VEGF), 
macrophage inflammatory protein-1 alpha (MIP-1"). Cytokine detection was performed 
according to the manufacturer's instruction. All reagents were allowed to warm to room 
temperature and were prepared before starting the assay. The microtiter filter plate was 
prewet by adding 200 µL of wash buffer into each well, which was sealed and shaken on a 
plate shaker for 10 min at room temperature. The wash buffer was removed by vacuum. 
And 25 µL of each standard and controls were added into the wells. Then, 25 µL of 
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appropriate matrix solution was added to the background, standards, and control wells. 
When plasma was assayed the diluted ‘Serum Matrix’ provided in the kit was used. When 
tissue was assayed the Tissue Extraction Reagent I (Sigma) was used as matrix solution. 25 
µL of sample was added into the appropriate wells. The bottle with the premixed beads 
was vortexed and 25 µL was added into each well. The plate was sealed and incubated 
with agitation on a plate shaker overnight incubation at 4°C. Next day, the fluid was gently 
removed by vacuum and the plate washed 2 times by adding 200 µL of wash buffer and 
removing by vacuum. Then 25 µL of detection antibodies was added into each well, and 
the plate was sealed and incubated with agitation on a plate shaker for 1 hour at room 
temperature. After the incubation, 25 µL of streptavidin-phycoerythrin was added into each 
well containing the 25 µL of detection antibodies. The plate was sealed and incubated with 
agitation on a plate shaker for 30 minutes at room temperature. The fluid was then gently 
removed by vacuum and washed 2 times by adding 200 µL of wash buffer into each well. 
After having wiped any excess of fluid on the bottom of the plate with a tissue, 150 µL of 
sheath fluid was added into all wells. To resuspend the beads the plate was shaken for 5 
min before running the plate on the Luminex machine. The Bio-Plex 100 System with the 
BIORAD manager acquisition program (BIORAD manager 4.1) was used to run the 
samples and process the data. Controls, standards and the samples were run in duplicates.  
 
 
3.12. STATISTICAL ANALYSIS 
 
Results are reported as means ± SD, means ± SE, or median and 95% CI. The models 
applied to analyse the data were the analysis of variance (ANOVA), non-parametric tests, 
and the standard diagnostics (outlier removal, checks for leverage, influence and normality 
of residuals). If the assumption of normality failed, a Kruskal-Wallis and Mann-Whitney 
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ANOVA on ranks was done. Post hoc analyses were done with the Tukey’s method. 
Significance was set at p < 0.05. The statistical packages used were the statistical package 
for the social sciences (SPSS) software version 18 (SPSS, Chicago, IL, USA).  
 
Analysis of variance is a procedure for assigning sample variance to different sources and 
deciding whether the variation arises within or among different population groups. In the 
present study one-way and two-way ANOVA was used when appropriate.  A one-way 
ANOVA means that there is only one independent variable, and that the independent 
variable has two or more level, while the two-way ANOVA test indicates two independent 
variables. The assumptions for ANOVA is that the dependent variable should be a 
continuous variable that is normally distributed, the groups should be mutually exclusive 
(independent of each other), and the groups should have equal variances (homogeneity of 
variance requirement) (McKillup 2005). ANOVA was used to analyze the following data: 
body and organs weight; apoptosis and cell proliferation; as well as the tumour 
development. 
 
Non-parametric test was also used in the present experiment. Non-parametric tests do not 
use the predictable distribution of sample means, which is the basis of most parametric 
tests, to infer whether samples are from the same population. Consequently non-parametric 
tests are generally not as powerful as their parametric equivalents. When data are 
significantly skewed, thus failing the assumption of a normal distribution, non-parametric 
techniques might be used (Munro 2005). In the present experiment, the non-parametric test 
was used to analyze data from the cytokines profile, which were not normally distributed. 
Two commonly used techniques are the Mann-Whitney U, which was used to compare two 
groups, and the Kruskal-Wallis H, which was used to compared two or more groups 
(which is analogous to the parametric technique analysis of variance).  
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4. FATTY ACIDS STUDY 
 
In this chapter the results and the discussion of the animal intervention using ApcMin/+ 
mouse model to study the effects of fatty acids on the development of colorectal cancer are 
presented. A high-fat diet (25% kcal) rich in corn oil (n-6 fatty acids) and fish oil (n-3 fatty 
acids) were the treatment diets tested, while a high-fat diet rich in palm oil was used as the 
control group. Wild-type animals (n=16) and ApcMin/+ animals (n=16) were exposed to 
the treatment diet for 10 weeks. The endpoints evaluated were body and organs weight, 
mitosis and apoptosis, local and systemic inflammation, as well as tumour development.  
 
4.1. RESULTS 
 
4.1.1. Effects on body and organs weight 
 
Animals were fed ad lib and the average consumption of diet was 19.41g/animal/week for 
PO group, 17.40g/animal/week for CO group, and 19.60g/animal/week for the FO group. 
Female mice were smaller and gained less weight than males. The initial, second and final 
weight did not differ from each other by genotype of the animals. However, a two-way 
ANOVA showed significant interaction for initial weight between genotype and diet, 
p=0.02. There was also a statistically significant main effect for diet, p=0.02. Animals 
from the fish oil group were significantly heavier at the start of the experiment (16.91 ± 
2.89g), compared to animals fed the palm oil (12.47 ± 4.46g). In addition, animals fed the 
fish oil were significantly older (37.58 ± 4.12 days) than animals fed the palm oil (30.96 ± 
6.77 days) and the corn oil diet (31.78 ± 6.30 days). Also, mice from the fish oil group had 
a significant smaller body weight change during the treatment (7.41 ± 2.76g) than the other 
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groups (palm oil = 10.95 ± 3.81g; corn oil = 9.99 ± 5.51g). Table 4.1 summarizes the age, 
body and organs weight according to sex and genotype of the animals. 
 
There was no significant difference between the dietary groups for all the organs (heart, 
liver, spleen, kidney, stomach, and caecum) (Table 4.2). However, there was a significant 
interaction between genotype and diet for kidney, but no main effect was observed. 
Moreover, Figure 4.1 shows that ApcMin/+ mice had significantly larger spleens compared 
to wild-type animals.  
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Variables  Sex  Genotype  
Male Female ApcMin/+ Wild-type 
Age (days) 34.32 ± 5.97 a 33.46 ± 7.33 a 33.58 ± 6.45 a 34.21 ± 6.94 a 
Initial  body weight (g)  16.08 ± 4.39 a 13.38 ± 3.94 b 14.42 ± 4.59 a 15.06 ± 4.14 a 
Final body weight (g) 26.88 ± 2.18 a 20.60 ± 1.98 b 23.14 ± 3.41 a 24.38 ± 4.05 a 
Change in body weight (g)  10.79 ± 4.50 a 7.22 ± 3.85 b 8.71 ± 4.38 a 9.32 ± 4.72 a 
Stomach (g) 4.87 ± 1.11 x10-3 a 5.98 ± 1.30 x10-3 b 5.57 ± 1.28 x10-3 a 5.27 ± 1.36 x10-3 a 
Caecum (g) 2.80 ± 1.01 x10-3 a 3.24 ± 1.00 x10-3 b 3.00 ± 0.91 x10-3 a 3.03 ± 1.14 x10-3 a 
Liver (g) 4.45 ± 0.69 x10-2 a 4.54 ± 0.51 x10-2 a 4.61 ± 0.71 x10-2 a 4.47 ± 0.46 x10-2 a 
Heart (g) 5.04 ± 0.93 x10-3 a 5.30 ± 0.81 x10-3 a 5.28 ± 0.81 x10-3 a 5.06 ± 0.93 x10-3 a 
Spleen (g) 5.83 ± 3.43 x10-3 a 7.93 ± 5.47 x10-3 b 8.97 ± 4.34 x10-3 a 4.66 ± 3.94 x10-3 b 
Kidney (g) 1.19 ± 0.10 x10-2 a 1.27 ± 0.08 x10-2 b 1.22 ± 0.09 x10-2 a 1.24 ± 0.10 x10-2 a 
 
Table 4.1 Age, body and organ weight by sex and genotype. Values are mean ± SD. Values within a row were analysed by sex and strain. Values having a different superscript 
are significantly different by one-way analysis of variance, p<0.05. Sex n= 63, Genotype n= 61-65. All organs weight was corrected for body weight.  
 
 
 
Variables Diet Significant effects 
 Palm oil Corn oil   Fish oil Geno Diet Geno*Diet 
Age (days) 30.96 ± 6.77 a 31.78 ± 6.30 a 37.58 ± 4.12 b ns 0.03 ns 
Initial  body weight (g)  12.47 ± 4.46 a 13.34 ± 4.35 a 16.91 ± 2.89 b ns 0.02 0.02 
Final body weight (g) 23.42 ± 3.94 23.33 ± 3.77 24.32 ± 3.67 ns ns ns 
Change in body weight (g)  10.95 ± 3.81 9.99 ± 5.51 7.41 ± 2.76 ns ns ns 
Heart (g) 5.45 ± 0.98 x10-3   4.28 ± 0.76 x 10-2   4.91 ± 0.69 x 10-3   ns ns ns 
Liver (g) 4.37 ± 0.47 x10-2  1.24 ± 0.09 x 10-2   4.28 ± 0.76 x 10-2   ns ns ns 
Spleen (g) 7.36 ± 5.92 x10-3  6.50 ± 3.71 x 10-3  6.50 ± 3.02 x 10-3  0.000 ns ns 
Kidney (g) 1.24 ± 0.09 x10-2  1.21 ± 1.26 x 10-3  1.24 ± 0.09 x 10-2   ns ns 0.023 
Stomach (g) 5.34 ± 1.29 x10-3   4.93 ± 0.95 x 10-3   5.33 ± 1.26 x 10-3  ns ns ns 
Caecum (g) 2.50 ± 0.58 x10-3  2.58 ± 0.59 x 10-3   2.95 ± 0.95 x 10-3   ns ns ns 
 
Table 4.2 Effect of dietary palm oil, corn oil and fish oil  on organ weight of experimental animals. Values are mean ± SD, n=31-32.  ApcMin/+ and wild-type mice combined. 
Significant effects of genotype (Geno), ApcMin/+ and wild-type, and diet were identified by two-way analysis of variance p<0.05. NS, not significant. All organs weight was 
corrected for body weight. 
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Figure 4.1 The effect of genotype on spleen weight after the 10 weeks of treatment, male and female mice 
combined (mean ± SEM, n=61-65). * one-way analysis of variance showed significant difference  p<0.01.   
 
 
 
4.1.2. Effects on mitosis, apoptosis and crypt length 
 
ApcMin/+ mice fed the palm oil diet showed a significantly greater cell proliferation in 
both distal small intestine (2.99 ± 0.28 mitotic cell/ crypt ) and colon (1.58 ± 0.15 mitotic 
cell/ crypt) compared with the wild-type mice ( distal SI =2.06 ± 0.17 mitotic cell/ crypt 
and colon =0.98 ± 0.18 mitotic cell/ crypt). However, this effect of genotype was only seen 
in the palm oil group. Cell proliferation was found significantly lower in the colon tissue of 
ApcMin/+ mice fed the corn oil and fish oil diet, compared to animals fed the palm oil 
(Figure 4.2). No difference was observed in cell proliferation in the colon tissue in any of 
the groups for the wild-type mice. However, in the distal tissue, wild-type animals fed the 
corn oil diet had a significant increase in cell proliferation compared to the fish oil and 
palm oil group (Figure 4.2). 
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The number of apoptotic cells/crypt in the distal colon was higher in the ApcMin/+ mice 
fed the corn oil, and to a lesser extent fish oil, when compared to the wild-type within the 
same diet (Figure 4.3). No differences were observed between genotype for the animals fed 
the palm oil diet. Also, no significant effect was found within either the ApcMin/+ and 
wild-type mice by the different treatment diet. In the colon tissue, no significant effect was 
found regarding the level of apoptosis. 
 
The different dietary treatments had no significant effect on crypt length between strains 
(Figure 4.4). Although there was a significant increase in crypt length for all ApcMin/+ 
mice compared to wild-type mice, both in the distal tissue (p=0.01) and in the colon 
(p=0.03). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 93
0
0,5
1
1,5
2
2,5
3
3,5
PO (n-9) CO (n-6) FO (n-3)
m
ito
tic
 c
el
l/c
ry
pt
WT APC
  
 
0
0,5
1
1,5
2
PO (n-9) CO (n-6) FO (n-3)
m
ito
tic
 c
el
l/c
ry
pt
WT APC
 
Figure 4.2  Effects of palm oil (PO), corn oil (CO) and fish oil (FO) on cell proliferation in the distal (a), and 
in the colon (b) of wild-type and ApcMin/+ mice. The values represent the mean (n=32) and standard error of 
the mean. The values not sharing the same symbol are significantly different (p<0.05) by two-way ANOVA 
general linear model. Data analysed within the same diet by different genotype and is significantly different 
is indicated by *. Data that is significantly different when analysed  within the same genotype by different 
diet is indicated by †. Ten crypts were analyzed per animal. 
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Figure 4.3  Effects of palm oil (PO), corn oil (CO) and fish oil (FO) on cell apoptosis in the distal (a), and in 
the colon (b) of wild-type and ApcMin/+ mice. The values represent the mean (n=32) and standard error of 
the mean. The values not sharing the same symbol are significantly different (p<0.05) by two-way ANOVA 
general linear model. Data analyzed within the same diet by different genotype (*). Data analyzed within the 
same genotype by different diet (†). Ten crypts were analyzed per animal. 
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Figure 4.4  Effects of palm oil (PO), corn oil (CO) and fish oil (FO) on crypt length in the distal (a), and in 
the colon (b) of wild-type and ApcMin/+ mice. The values represent the mean in mm on eyepiece scale 
(n=32) and standard error of the mean. Each unit equals 40"m. No significant effect was observed by two-
way ANOVA general linear model. Ten crypts were analyzed per animal. 
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4.1.3. Effects on local and systemic inflammation 
 
4.1.3.1. Distal - small intestine tissue 
 
The effect of dietary treatment on cytokines levels from the distal tissue was significant for 
most of the cytokines measured when wild-type and ApcMin/+ were combined ( INF!, IL-
1", IL-2, IL-5, IL-10, IL-12p40,IL-12p70, IL-15, IP-10, KC, GMC-SF, TNF", MIP-1" and 
VEGF. While the cytokines IL-4, IL-6, IL-17, IL-1#, MCP-1, and MIG were not 
significant (Table 4.3).  
 
Analyzing the data within each diet by the genotype (Table 4.4) showed that ApcMin/+ 
mice treated with palm oil had significant higher levels of KC (p=0.03) and IL-1# (p=0.01) 
compared with the wild-type. However the wild-type had higher IL-5 (p=0.00). In the corn 
oil diet, ApcMin/+ mice also had higher KC (p=0.00) and MIG (p=0.04) when compared 
to the wild-type. While, the wild-type animals had higher levels of IL-12p40 (p=0.00), IL-
12p70 (p=0.02) and IP-10 (p=0.00) than the ApcMin/+ mice fed the corn oil diet. 
Moreover, the fish oil treatment seemed to increase the levels of IL-15 (p=0.02), KC 
(p=0.00), IL-1# (p=0.00), and MIG (p=0.00) in the ApcMin/+ mice, while IL-12p40 
(p=0.04) and IP-10 (p=0.02) were decreased. In Table 4.4 is summarized the effects of the 
diets on cytokines by each genotype. 
 
In Table 4.5 the effects of different treatment diet by each genotype is summarized. The 
effects of dietary treatments within the wild-type animals was significantly different for IL-
5, IL-10, IL-12p40,IL-12p70, IL-15, IP-10, KC, TNF", MIP-1" and  VEGF, at a p-value 
equal or lower then 0.02. Wild-type animals fed the corn oil and fish oil treatment diet had 
significantly decreased levels of IL-5, IL-10, IL-15, KC, and TNF", compared to mice fed 
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the palm oil diet. However, corn oil and fish oil diet increased the levels of IL-12p40 and 
IP-10 in wild-type mice. Moreover, the fish oil diet significantly increased the levels of IL-
12p70, and MIP-1" in wild-type animals compared to those fed the palm oil. Animals fed 
corn oil diet has lower levels of VEGF compared to animals fed the palm oil and fish oil.  
  
On the other hand, within the ApcMin/+ mice the majority of the cytokines also appeared 
to be significantly affected by diet. Animals fed the fish oil diet had increased levels of 
IFN!, IL-12p40, IP-10, MIP-1", but lower levels of IL-5 and GMC-SF compared to 
ApcMin/+ mice fed the palm oil diet. Animal fed the corn oil diet significantly reduced the 
levels of IL-2, IL-12p40, IL-12p70, IL-1# and VEGF compared to mice fed the palm oil 
diet. When mice fed the corn oil and the fish oil diets were compared, the main significant 
differences observed were that fish oil increased the levels of IL-1", IL-2, IL-5, IL-12p40, 
IL-12p70, IL-15, IP-10, IL-1#, MIP-1", and VEGF. The only cytokine reduced with fish 
oil compared to corn oil was GMC-SF. ApcMin/+ mice had no significant effect on the 
levels of IL-4,IL-6, IL-10,IL-17, KC, TNF-", MCP-1 and MIG in any of the treatment 
diets. 
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Table 4.3 Effect of dietary palm oil (n=28), corn oil (n=30) and fish oil (n=27) on cytokines levels (pg/mg 
protein) in the distal tissue of the small intestine in mice after 10-week treatment. (A) Anti-inflammatory 
cytokines; (P) pro-inflammatory cytokines. Values are presented as median and 95% confidence interval. 
ApcMin/+ and wild-type mice combined. p-value of Kruskal-Wallis test.  Values having different superscript 
are significantly different by post-hoc Mann-Whitney test p<0.05. 
 
4.1.3.2. Colon - large intestine tissue 
 
Animals fed the palm oil had a higher level of IL-6 (p=0.04) compared to the corn oil and 
fish oil diet. However, TNF" (p=0.04) and MCP-1 (p=0.05) were higher in animals treated 
with the fish oil diet comparing to animals fed the palm oil diet (Table 4.6).  There was no 
significant difference for palm oil, corn oil, and fish oil when data was analyzed by strain 
(Table 4.7). Analyzing all wild-type mice by the different dietary treatment, no statistical 
difference where shown. However, within the ApcMin mice, fish oil diet showed higher 
levels of IL-1# (p=0.05) and TNF" (p=0.26), and a lower level of IL-6 (p=0.02) compared 
to the animals fed the palm oil diet (Table 4.8).  
  
Cytokines 
Palm oil 
Median (95% CI) 
pg/mg protein 
Corn oil 
Median (95% CI) 
pg/mg protein 
Fish oil 
Median (95% CI) 
pg/mg protein 
  
p-value 
(A) IFN-! 0.08(0.03-0.10) a 0.06(0.00-0.21) ab 0.14(0.11-0.18) b 0.01 
(P) IL-1" 0.46(0.37-0.62) a 0.37(0.30-0.78) a 0.87(0.50-1.25) b 0.02 
(P) IL-2 0.16(0.11-0.19) ac 0.08(0.01-0.10) b 0.28(0.10-0.38) c 0.00 
(A) IL-4 0.03(0.02-0.05) a 0.02(0.004-0.04) a 0.03(0.02-0.04) a 0.18 
(P) IL-5 0.01(0.004-0.13) a 0.003(0.002-0.004) b 0.002(0.002-0.003) c 0.001 
(P) IL-6 0.26(0.19-0.32) a 0.24(0.14-0.29) a 0.21(0.14-0.33) a 0.75 
(A) IL-10 1.58(0.60-2.17) a 1.01(0.82-1.21) a 0.71(0.56-0.83) b 0.001 
(P) IL-12p40 0.77(0.004-1.34) a 0.34(0.002-1.70) a 2.29(1.62-4.16) b 0.001 
(P) IL-12p70 1.03(0.78-1.16) a 0.64(0.35-1.17) a 1.50(1.16-3.08) b 0.001 
(P) IL-15 0.48(0.01-0.92) ac 0.004(0.003-0.20) b 0.004(0.003-0.95) bc 0.01 
(P) IL-17 0.23(0.16-0.38) a 0.19(0.11-0.24) a 0.21(0.13-0.26) a 0.20 
(A) IP-10 1.59(0.91-2.57) a 1.54(1.09-2.91) a 3.15(2.66-3.93) b 0.001 
(P) KC 0.57(0.44-0.85) ac 0.29(0.22-0.54) b 0.37(0.28-0.74) bc 0.02 
(P) GMC-SF 0.003(0.002-0.003) a 0.003(0.002-0.004) a 0.002(0.002-0.003) b 0.02 
(P) TNF-" 0.13(0.12-0.20) ac 0.07(0.02-0.13) b 0.13(0.08-0.16) c 0.001 
(P) IL-1# 0.63(0.44-0.99) a 0.46(0.22-0.74) a 0.62(0.42-0.98) a 0.13 
(P) MCP1 0.63(0.44-0.90) a 0.50(0.41-0.71) a 0.77(0.69-0.86) a 0.20 
(A) MIG 26.38(16.49-38.46) a 24.01(11.03 -36.44) a 23.53(12.40-37.27) a 0.76 
(P) MIP1" 0.22(0.12-0.26) a 0.12(0.01-0.27) a 0.57(0.45-0.64) b 0.001 
(P) VEGF 2.59(2.29-3.67) ac 1.18(1.01-1.71) b 2.89(2.01-4.88) c 0.001 
 99 
  
Cytokines 
Palm oil   Corn oil   Fish oil   
Wild-type (n=14) 
Median (95% CI) 
pg/mg protein 
ApcMin (n=14) 
Median (95% CI) 
pg/mg protein 
p-
value 
Wild-type(n=15) 
Median (95% CI) 
pg/mg protein 
ApcMin (n=15) 
Median (95% CI) 
pg/mg protein 
p-
value 
Wild-type (n=13) 
Median (95% CI) 
pg/mg protein 
ApcMin (n=14) 
Median (95% CI) 
pg/mg protein 
p-
value 
(A) IFN! 0.06  (0.004-0.35) 0.08  (0.003-0.10) 0.33 0.16  (0.003-0.63) 0.004  (0.002-0.16) 0.14 0.17  (0.11-0.35) 0.13  (0.07- 0.18) 0.06 
(P) IL-1" 0.41  (0.25-0.59) 0.60  (0.31-1.13) 0.09 0.51  (0.004-1.88) 0.32  (0.004-0.54) 0.19 0.79  (0.24-1.99) 0.88  (0.46- 1.35) 0.59 
(P) IL-2 0.15  (0.004-0.19) 0.16  (0.11-0.50) 0.09 0.03  (0.004-0.14) 0.09  (0.01-0.10) 0.46 0.19  (0.003-0.41) 0.33  (0.13- 0.38) 0.22 
(A) IL-4 0.04  (0.01-0.07) 0.03  (0.01-0.06) 0.46 0.01  (0.003-0.08) 0.02  (0.002-0.04) 0.29 0.03  (0.02-0.05) 0.03  (0.02- 0.06) 0.62 
(P) IL-5 0.09  (0.004-0.25) 0.003  (0.003-0.21) 0.00 0.0033  (0.003-0.004) 0.0027  (0.002-0.02) 0.57 0.0030  (0.0025-0.0033) 0.0024  (0.0021- 0.0029) 0.03 
(P) IL-6 0.26  (0.08-0.42) 0.26  (0.16-0.47) 0.89 0.23  (0.06- 0.29) 0.26  (0.11-0.34) 0.54 0.21  (0.11-0.45) 0.20  (0.10- 0.36) 0.80 
(A) IL-10 1.97  (0.60-2.66) 0.89  (0.35-2.17) 0.60 1.00  (0.74- 1.12) 1.01  (0.82-1.94) 0.25 0.74  (0.45-0.92) 0.68  (0.50- 0.88) 0.93 
(P) IL-12p40 0.31  (0.003-4.44) 1.10  (0.003-1.43) 0.52 2.07  (0.31-8.03) 0.002  (0.002-0.37) 0.001 3.88  (1.91-7.05) 1.66  (1.44- 3.46) 0.04 
(P) IL-12p70 1.01  (0.54-1.34) 1.11  (0.63-1.56) 0.52 1.09  (0.64-2.50) 0.38  (0.25-0.65) 0.02 2.80  (1.17-3.58) 1.23  (0.90- 3.18) 0.08 
(P) IL-15 0.43  (0.004-1.28) 0.59  (0.00-1.06) 0.89 0.003  (0.003- 0.01) 0.20  (0.002-0.55) 0.25 0.003  (0.002-0.61) 0.96  (0.002- 1.45) 0.02 
(P) IL-17 0.21  (0.14-0.48) 0.25  (0.12-0.52) 0.67 0.13  (0.00-0.22) 0.23  (0.16-0.29) 0.08 0.18  (0.08-0.31) 0.22  (0.13- 0.30) 0.35 
(A) IP-10 0.91  (0.57-2.89) 1.96  (1.02-2.81) 0.12 3.22  (1.53-4.94) 0.98  (0.78-1.55) 0.001 3.85  (3.02-4.66) 2.76  (2.26- 3.80) 0.02 
(P) KC 0.47  (0.25-0.87) 0.71  (0.49-1.24) 0.03 0.22  (0.003- 0.30) 0.68  (0.29-0.87) 0.001 0.32  (0.14-0.37) 0.76  (0.34- 1.28) 0.001 
(P) GMC-SF 0.003 (0.002-0.004) 0.003  (0.002-0.003) 0.29 0.003  (0.002-0.004) 0.002  (0.002-0.15) 0.91 0.003 (0.002-0.003) 0.002  (0.002- 0.002) 0.001 
(P) TNF" 0.17  (0.11-0.26) 0.13  (0.09-0.24) 0.29 0.05  (0.004- 0.15) 0.08  (0.02-0.21) 0.22 0.10  (0.08-0.16) 0.13  (0.04- 0.18) 0.66 
(P) IL-1# 0.48  (0.25-0.80) 1.03  (0.44-1.27) 0.01 0.56  (0.15- 0.81) 0.45  (0.35-0.76) 0.78 0.44  (0.30-0.62) 1.32  (0.55- 2.16) 0.001 
(P) MCP1 0.50  (0.32-0.79) 0.79  (0.44-1.01) 0.15 0.59  (0.26- 0.93) 0.45  (0.41-0.83) 0.66 0.72  (0.57-0.88) 0.81  (0.72- 1.08) 0.13 
(A) MIG 20.17  (1.67-48.14) 33.03  (18.67-53.58) 0.21 11.03 (1.18-32.44) 35.66  (16.51-42.13) 0.04 16.76 (6.23-23.53) 35.25  (22.26- 59.32) 0.001 
(P) MIP1" 0.21  (0.004-0.27) 0.22  (0.08-0.40) 0.43 0.01  (0.003- 0.80) 0.13  (0.07-0.27) 0.49 0.51  (0.35-0.64) 0.61  (0.43- 0.86) 0.10 
(P) VEGF 2.50  (1.31-3.99) 2.95 (2.29-6.16) 0.08 1.09  (0.08-1.72) 1.48  (1.07-2.03) 0.15 2.64  (1.69-7.97) 3.08  (1.86- 4.88) 0.80 
 
Table 4.4 Effect of palm oil (PO), corn oil (CO), and fish oil (FO) on cytokine level (pg/mg protein) in the distal tissue of the small intestine of wild-type (WT) and ApcMin (APC) 
mice. (A) Anti-inflammatory cytokines; (P) pro-inflammatory cytokines.  Values are presented as median and 95% confidence interval (CI). Significant p-value (p<0.05) was 
identified by Mann-Whitney test.  
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Cytokines 
Wild-type  
 
p-
value 
ApcMin/+ 
p-value 
Palm oil  (n=14) 
Median (95% CI) 
pg/mg protein 
Corn oil (n=15) 
Median (95% CI) 
pg/mg protein 
Fish oil (n=13) 
Median (95% CI) 
pg/mg protein 
 Palm oil  (n=14) 
Median (95% CI) 
pg/mg protein 
Corn oil (n=15) 
Median (95% CI) 
pg/mg protein 
Fish oil (n=14) 
Median (95% CI) 
pg/mg protein 
(A) IFN! 0.06  (0.004-0.35) 0.16  (0.003-0.63) 0.17  (0.11-0.35) ns 0.08  (0.00-0.10) a 0.004  (0.002-0.16) ab 0.13  (0.07- 0.18) b 0.03 
(P) IL-1" 0.41  (0.25-0.59) 0.51  (0.004-1.88) 0.79  (0.24-1.99) ns 0.60  (0.31-1.13) ac 0.32  (0.004-0.54) a b 0.88  (0.46- 1.35)c 0.001 
(P) IL-2 0.15  (0.004-0.19) 0.03  (0.004-0.14) 0.19  (0.003-0.41) ns 0.16  (0.11-0.50) ac 0.09  (0.01-0.10) b 0.33  (0.13- 0.38) c 0.001 
(A) IL-4 0.04  (0.01-0.07) 0.01  (0.003-0.08) 0.03  (0.02-0.05) ns 0.03  (0.01-0.06) 0.02  (0.002-0.04) 0.03  (0.02- 0.06) Ns 
(P) IL-5 0.09  (0.004-0.25) a 0.003  (0.003-0.004) b 0.003  (0.002-0.003) c 0.001 0.003  (0.003-0.21) a 0.002  (0.002-0.02) a 0.002 (0.0021- 0.0029) b 0.001 
(P) IL-6 0.26  (0.08-0.42) 0.23  (0.06- 0.29) 0.21  (0.11-0.45) ns 0.26  (0.16-0.47) 0.26  (0.11-0.34) 0.20  (0.10- 0.36) Ns 
(A) IL-10 1.97  (0.60-2.66) a 1.00  (0.74- 1.12) b 0.74  (0.45-0.92) b 0.001 0.89  (0.35-2.17) 1.01  (0.82-1.94) 0.68  (0.50- 0.88) Ns 
(P) IL-12p40 0.31  (0.003-4.44) a 2.07  (0.31-8.03) b 3.88  (1.91-7.05) b 0.01 1.10  (0.003-1.43) a 0.002  (0.002-0.37) b 1.66  (1.44- 3.46) c 0.001 
(P) IL-12p70 1.01  (0.54-1.34) a 1.09  (0.64-2.50) a 2.80  (1.17-3.58) b 0.001 1.11  (0.63-1.56) ac 0.38  (0.25-0.65) b 1.23  (0.90- 3.18) c 0.001 
(P) IL-15 0.43  (0.004-1.28) a 0.003  (0.003- 0.01) b 0.003  (0.002-0.61) b 0.001 0.59  (0.00-1.06) ac 0.20  (0.002-0.55) ab 0.96  (0.002- 1.45) c 0.04 
(P) IL-17 0.21  (0.14-0.48) 0.13  (0.00-0.22) 0.18  (0.08-0.31) ns 0.25  (0.12-0.52) 0.23  (0.16-0.29) 0.22  (0.13- 0.30) ns 
(A) IP-10 0.91  (0.57-2.89) a 3.22  (1.53-4.94) b 3.85  (3.02-4.66) b 0.001 1.96  (1.02-2.81) a 0.98  (0.78-1.55) a 2.76  (2.26- 3.80) b 0.001 
(P) KC 0.47  (0.25-0.87) a 0.22  (0.00- 0.30) b 0.32  (0.14-0.37) b 0.001 0.71  (0.49-1.24) 0.68  (0.29-0.87) 0.76  (0.34- 1.28) ns 
(P) GMC-SF 0.003  (0.002-0.004) 0.003  (0.002-0.004) 0.003  (0.002-0.003) ns 0.003  (0.002-0.003) a 0.002  (0.002-0.15) a 0.002  (0.002- 0.002) b 0.001 
(P) TNF" 0.17  (0.11-0.26) ac 0.05  (0.004- 0.15) b 0.10  (0.08-0.16) c 0.001 0.13  (0.09-0.24) 0.08  (0.02-0.21) 0.13  (0.04- 0.18) ns 
(P) IL-1# 0.48  (0.25-0.80) 0.56  (0.15- 0.81) 0.44  (0.30-0.62) ns 1.03  (0.44-1.27) ac 0.45  (0.35-0.76) b 1.32  (0.55- 2.16) c 0.001 
(P) MCP1 0.50  (0.32-0.79) 0.59  (0.26- 0.93) 0.72  (0.57-0.88) ns 0.79  (0.44-1.01) 0.45  (0.41-0.83) 0.81  (0.72- 1.08) ns 
(A) MIG 20.17  (1.67-48.14) 11.03 (1.18-32.44) 16.76 (6.23-23.53) ns 33.03  (18.67-53.58) 35.66  (16.51-42.13) 35.25  (22.26- 59.32) ns 
(P) MIP1" 0.21  (0.00-0.27) a 0.01  (0.003- 0.80) ab 0.51  (0.35-0.64) b 0.02 0.22  (0.08-0.40) a 0.13  (0.07-0.27) a 0.61  (0.43- 0.86) b 0.001 
(P) VEGF 2.50  (1.31-3.99) ac 1.09  (0.08-1.72) b 2.64  (1.69-7.97) c 0.001 2.95 (2.29-6.16) ac 1.48  (1.07-2.03) b 3.08  (1.86- 4.88) c 0.001 
 
Table 4.5 Effect of strain on cytokine level (pg/mg protein) in the distal tissue of the small intestine according to the diet treatment. (A) Anti-inflammatory cytokines; (P) pro-
inflammatory cytokines.  Values are presented as median and 95% confidence interval. *Significant p-value (p<0.05) was identified by Kruskal-Wallis test. Values having different 
superscript are significantly different by post-hoc Mann-Whitney test p<0,0
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Cytokines 
Palm oil 
Median (95% CI) 
pg/mg protein 
Corn oil 
Median (95% CI) 
pg/mg protein 
Fish oil 
Median (95% CI) 
pg/mg protein 
 
p-value 
(P) GMC-SF 0.02 (0.01-0.09) 0.01 (0.01-0.10) 0.01 (0.01-0.06) 0.60 
(P) IL-1# 0.02 (0.01-0.10) 0.07 (0.01-0.21) 0.12 (0.01-0.18) 0.10 
(P) IL-6 1.00 (0.17-6.13) a 0.52 (0.04-1.03) b 0.36 (0.05-1.16) b 0.04 
(P) TNF" 0.01 (0.00-0.98) a 0.30 (0.01-4.31) ab 0.28 (0.01-3.40) b 0.04 
(P) MCP-1 0.55 (0.43-0.62) a 0.66 (0.45-0.83) ab 0.81 (0.48-1.46) b 0.05 
 
Table 4.6 Effect of dietary palm oil (n=16), corn oil (n=16) and fish oil (n=16) on cytokines levels (pg/mg protein) in the colon tissue of the large intestine in mice after 10-week 
treatment. (P) pro-inflammatory cytokines. Values are presented as median and 95% confidence interval. Male ApcMin/+ and wild-type mice combined. *P-value of Kruskal-Wallis 
test.  Values having different superscript are significantly different by post-hoc Mann-Whitney test p<0,05. 
 
 
 
Cytokines 
Palm oil 
p-value 
Corn oil 
p-value 
Fish oil 
p-value 
Wild-type (n=8) 
Median (95% CI) 
pg/mg protein 
ApcMin/+ (n=8) 
Median (95% CI) 
pg/mg protein 
Wild-type (n=8) 
Median (95% CI) 
pg/mg protein 
ApcMin/+ (n=8) 
Median (95% CI) 
pg/mg protein 
Wild-type (n=6) 
Median (95% CI) 
pg/mg protein 
ApcMin/+ (n=10) 
Median (95% CI) 
pg/mg protein 
(P) GMC-SF 0.02 (0.01-0.10) 0.02 (0.01-0.18) 0.75 0.01 (0.01-0.13) 0.04 (0.01-0.13) 0.25 0.01 (0.01-0.02) 0.03 (0.01-0.19) 0.66 
(P) IL-1# 0.02 (0.01-0.27) 0.02 (0.01-0.20) 0.75 0.02 (0.01-0.29) 0.09 (0.02-0.26) 0.46 0.08 (0.01-0.18) 0.12 (0.01-0.22) 0.23 
(P) IL-6 1.00 (0.03-8.63) 1.00 (0.09-11.46) 0.24 1.00 (0.04-12.31) 0.34 (0.04-5.75) 0.53 0.22 (0.05-1.00) 0.69 (0.04-1.29) 0.38 
(P) TNF" 0.01 (0.00-7.95) 0.01 (0.00-1.18) 0.60 0.01 (0.00-7.74) 0.37 (0.00-6.31) 0.60 0.88 (0.01-3.40) 0.28 (0.01-5.39) 0.59 
(P) MCP-1 0.55 (0.29-1.17) 0.55 (0.39-0.60) 0.60 0.53 (0.21-1.03) 0.74 (0.30-0.87) 0.34 0.79 (0.48-1.11) 0.81 (0.41-1.74) 0.83 
 
Table 4.7 Effect of diet on cytokine level (pg/mg protein) in the colon tissue of the large intestine by diet.  (P) pro-inflammatory cytokines. Values are presented as median and 95% 
confidence interval (CI). Significant p-value (p<0.05) was identified by Kruskal-Wallis test.   
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Cytokines 
Wild-type  
 
p-value 
ApcMin/+ 
p-value 
Palm oil (n=8) 
Median (95% CI) 
pg/mg protein 
Corn oil (n=8) 
Median (95% CI) 
pg/mg protein 
Fish oil (n=6) 
Median (95% CI) 
pg/mg protein 
Palm oil (n=8) 
Median (95% CI) 
pg/mg protein 
Corn oil (n=8) 
Median (95% CI) 
pg/mg protein 
Fish oil (n=10) 
Median (95% CI) 
pg/mg protein 
(P) GMC-SF 0.02 (0.01-0.10) 0.01 (0.01-0.13) 0.01 (0.01-0.02) 0.51 0.02 (0.01-0.18) 0.04 (0.01-0.13) 0.03 (0.01-0.19) 0.97 
(P) IL-1# 0.02 (0.01-0.27) 0.02 (0.01-0.29) 0.08 (0.01-0.18) 0.86 0.02 (0.01-0.20) 0.09 (0.02-0.26) 0.12 (0.01-0.22) 0.07 
(P) IL-6 1.00 (0.03-8.63) 1.00 (0.04-12.31) 0.22 (0.05-1.00) 0.58 1.00 (0.09-11.46) a 0.34 (0.04-5.75) b 0.69 (0.04-1.29) b 0.04 
(P) TNF" 0.01 (0.00-7.95) 0.01 (0.00-7.74) 0.88 (0.01-3.40) 0.63 0.01 (0.00-1.18) 0.37 (0.00-6.31) 0.28 (0.01-5.39) 0.08 
(P) MCP-1 0.55 (0.29-1.17) 0.53 (0.21-1.03) 0.79 (0.48-1.11) 0.23 0.55 (0.39-0.60) 0.74 (0.30-0.87) 0.81 (0.41-1.74) 0.14 
 
Table 4.8 Effect of strain on cytokine level (pg/mg protein) in the colon tissue of the large intestine according to the diet treatment. (P) pro-inflammatory cytokines.  Values are 
presented as median and 95% confidence interval. Significant p-Value (p<0,05) was identified by Kruskal-Wallis test.
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4.1.3.3. Plasma 
 
The concentration of IL-1", IL-5, IL-6, and MCP-1 were significantly different (p<0.05) 
when all animals were combined (ApcMin/+ and wild-type mice) and compared between 
the dietary treatments (Table 4.9).  Animals treated with fish oil had higher levels of IL-5 
(p=0.01) and MCP-1 (p=0.00) when compared to the corn oil and palm oil group. IL-6 
(p=0.03) and GM-CSF (p=0.03) were also higher in the fish oil group, but only compared 
with animals fed the corn oil diet.  IL-1" was significant lower (p=0.02) in the fish oil 
group compared to corn oil and palm oil. 
 
 
Cytokines 
 
Palm oil 
Median (95% CI) 
pg/ml 
Corn oil 
Median (95% CI) 
pg/ml 
Fish oil 
Median (95% CI) 
pg/ml 
 
p-value 
(A) IFN! 3.20 (3.07-3.20) 3.20 (2.46-3.20) 3.20 (3.20-3.20) 0.98 
(P) IL-1" 45.96 (3.20-97.19)ac 83.67 (3.20-175.78) a 38.21 (3.20-56.23) bc 0.05 
(P) IL-2 3.20 (3.20-15.85) 3.20 (3.20-3.20) 3.20 (3.20-13.38) 0.07 
(A) IL-4 3.20 (1.79-3.20) 3.20 (2.46-3.20) 3.20 (1.23-3.20) 0.28 
(P) IL-5 8.99 (4.58-13.24) a 6.02 (4.36-11.01) a 11.20 (6.54-18.31) b 0.01 
(P) IL-6 9.89 (3.20-30.00) ac 3.20 (3.20-7.67) b 10.50 (3.20-17.73) c 0.03 
(A) IL-10 3.20 (3.20-10.73) 3.20 (3.20-3.20) 3.20 (3.20-17.05) 0.12 
(P) IL-12p40 58.74 (3.75-116.16) 51.33 (13.99-64.81) 39.88 (16.87-86.17) 0.36 
(P) IL-12p70 3.20 (3.20-478.92) 3.20 (3.20-24.66) 3.20 (3.20-496.29) 0.91 
(P) IL-15 57.81 (3.20-211.73) 3.20 (3.20-101.02) 3.20 (3.20-187.11) 0.43 
(P) IL-17 3.20 (3.20-53.09) 3.20 (3.20-3.20) 3.20 (3.20-53.59) 0.13 
(A) IP-10 200.30 (169.59-268.32) 215.61 (183.45-282.66) 257.30 (216.71-286.36) 0.23 
(P) KC 77.99 (3.20-127.49) 74.64 (5.35-78.29) 43.91 (3.20-118.13) 0.17 
(P) GMC-SF 3.20 (3.20-41.24) ab 3.20 (3.20-3.20) a 3.20 (3.20-63.63) b 0.07 
(P) TNF" 3.20 (1.37-3.20) 3.20 (1.93-3.20) 3.20 (0.91-3.20) 1.00 
(P) IL-1# 3.20 (3.20-17.68) 5.04 (3.38-32.54) 8.54 (2.97-32.54) 0.33 
(P) MCP1 14.27 (5.22-41.78) a 19.93 (9.31-30.26) a 42.98 (30.34-59.06) b 0.00 
(A) MIG 144.09 (120.62-311.93) 157.04 (111.82-185.84) 157.15 (124.67-205.98) 0.13 
(P) MIP1" 3.20 (3.20-24.42) 3.20 (3.20-13.73) 5.37 (3.20-10.16) 0.91 
(P) VEGF 3.20 (0.65-3.20) 3.20 (0.68-3.20) 3.20 (0.83-3.20) 0.69 
 
Table 4.9 Effect of dietary palm oil (n=29), corn oil (n=29) and fish oil (n=29) on cytokines levels (pg/ml) in 
the plasma of mice after 10-week treatment. (A) Anti-inflammatory cytokines; (P) pro-inflammatory 
cytokines. Values are presented as median and 95% confidence interval. Male ApcMin/+ and wild-type mice 
combined. *P-value of Kruskal-Wallis test.  Values having different superscript are significantly different by 
post-hoc Mann-Whitney test p<0,05. 
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When the cytokines were analysed for each dietary treatment by strain, the following 
results were observed (Table 4.10). In the palm oil group, IL-2 (p=0.02) was significantly 
higher in the wild-type mice compared to the ApcMin/+ mice. Moreover, wild-type mice 
also showed a trend to have higher concentration of MCP-1 (p=0.09) compared to the 
ApcMin/+ mice also fed the palm oil diet. ApcMin/+ mice from the corn oil group had 
significantly (p=0.03) higher levels of IL-6 and KC compared to the wild-type animals. 
However, the wild-type animals fed the corn oil diet, showed a trend towards high 
concentrations of MCP-1 (p=0.09) and MIG (p=0.08) compared to ApcMin mice fed the 
same diet. Animals treated with fish oil were only different for IL-17, which was higher in 
the wild-type (p=0.02) compared to the ApcMin/+ mice. 
 
When the cytokines were analysed by strain the following results were observed (Table 
4.11). Within the wild-type animals, the fish oil treatment increased the levels of IL-4 
(p=0.04) and IL-17 (p=0.00) compared to animals fed the palm oil. Wild-type animals fed 
the corn oil diet decreased the levels of IL-6 (p=0.03) and KC (p=0.01) compared to 
animal fed the palm oil diet. When mice fed the corn oil diet were compared to mice fed 
the fish oil diet, the levels of IL-4 (p=0.04), IL-6 (p=0.01), IL-17 (p=0.05) were 
significantly higher for the fish oil group.  
 
Within the ApcMin/+ mice, animals fed the fish oil diet had levels of IL-5 (p=0.02), IL-1# 
(p=0.03), and MCP-1 (p=0.007) higher than the animals fed the corn oil diet. When 
comparing the levels of cytokines in animals fed the fish oil and corn oil diet, only MCP-1 
was significant (p=0.01) higher for the fish oil group. No significant effect was observed 
for ApcMin/+ animals fed the corn oil diet compared to palm oil. 
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Cytokines 
 
Palm oil Corn oil Fish oil 
Wild-type 
Median (95% CI) 
pg/ml 
ApcMin/+
Median (95% CI) 
pg/ml 
Wild-type 
Median (95% CI) 
pg/ml 
ApcMin/+
Median (95% CI) 
pg/ml 
Wild-type 
Median (95% CI) 
pg/ml 
ApcMin/+ 
Median (95% CI) 
pg/ml 
(A) IFN! 3.20 (2.25-3.20) 3.20 (1.58-3.42) 3.20 (1.12-3.20) 3.20 (2.28-3.44) 3.20 (3.20-3.20) 3.20 (2.65-3.20) 
(P) IL-1" 50.64 (3.20-408.51) 35.49 (3.20-85.90) 111.37 (3.20-265.83) 41.67 (3.20-249.97) 40.11 (3.20-90.16) 27.11 (3.20-56.23) 
(P) IL-2 3.20 (3.20-21.21)a 3.20 (1.79-15.85) b 3.20 (2.51-3.20) 3.20 (3.20-22.70) 3.20 (3.20-22.06) 3.20 (3.20-25.69) 
(A) IL-4 3.20 (1.09-3.20) 3.20 (1.16-3.20) 3.20 (0.81-3.20) 3.20 (1.09-3.20) 3.20 (0.54-131.73) 3.20 (0.89-3.20) 
(P) IL-5 9.87 (5.48-15.64) 5.25 (3.42-15.26) 6.02 (3.72-12.05) 5.77 (3.71-12.60) 9.02 (5.27-20.82) 13.15 (5.93-18.31) 
(P) IL-6 28.64 (3.20-62.01) 7.10 (3.20-18.79) 3.20 (1.68-3.20) a 7.22 (3.20-20.77) b 11.21 (3.20-42.66) 8.49 (3.19-54.47) 
(A) IL-10 3.20 (3.20-12.99) 3.20 (3.20-12.20) 3.20 (3.20-3.20) 3.20 (3.20-8.67) 3.20 (3.20-34.92) 3.20 (3.20-17.05) 
(P) IL-12p40 58.74 (3.20-215.81) 66.74 (3.20-116.75) 49.70 (3.20-103.82) 51.84 (5.48-81.60) 24.40 (3.20-120.30) 48.90 (16.87-108.41) 
(P) IL-12p70 18.13 (3.20-534.56) 3.20 (3.20-494.83) 3.20 (3.20-523.79) 3.20 (3.20-520.46) 3.20 (3.20—555.38) 3.20 (3.20-544.99) 
(P) IL-15 64.75 (3.20-318.12) 41.31 (3.20-316.07) 3.20 (3.20-226.81) 3.20 (3.20-223.22) 29.54 (3.20-351.51) 3.20 (3.20-187.11) 
(P) IL-17 3.20 (1.08-53.37) 3.20 (3.20-53.48) 3.20 (3.20-53.09) 3.20 (0.54-53.34) 3.20 (3.20-55.16) a 3.20 (3.20-53.59) b 
(A) IP-10 200.83 (167.65-321.32) 192.41 (163.47-268.32) 215.61 (199.18-298.39) 227.91 (160.30-348.67) 257.30 (165.13-297.86) 250.53 (200.85-328.67) 
(P) KC 77.99 (3.20-143.42) 72.44 (3.20-155.49) 46.43 (3.20-76.25) a 78.13 (3.20-127.51) b 54.86 (3.20-148.61) 33.58 (3.20-125.19) 
(P) GMC-SF 3.20 (3.20-49.51) 3.20 (3.20-67.85) 3.20 (3.20-3.20) 3.20 (3.20-3.20) 3.20 (3.20-63.63) 3.20 (3.20-103.47) 
(P) TNF" 3.20 (1.37-3.20) 3.20 (0.75-3.20) 3.20 (3.20-3.20) 2.30 (0.85-3.20) 3.20 (1.36-3.20) 1.51 (0.51-3.20) 
(P) IL-1# 4.27 (3.20-35.22) 3.20 (2.94-19.53) 5.04 (3.38-27.66) 7.15 (3.20-39.46) 5.84 (2.34-36.11) 16.13 (2.97-45.27) 
(P) MCP1 31.05 (3.20-49.19) a 12.77 (3.20-41.78) b 23.64 (6.73-56.02) a 16.67 (3.20-35.39) b 52.62 (3.20-82.50) 41.17 (9.07-59.06) 
(A) MIG 127.20 (105.75-688.79) 149.97 (110.56-360.71) 184.00 (151.26-301.02) a 116.07 (73.65-185.84) b 155.22 (101.52-263.50) 160.78 (102.58-202.07) 
(P) MIP1" 3.20 (3.20-28.11) 6.17 (3.20-35.67) 3.20 (3.20-13.73) 3.20 (3.20-49.06) 5.68 (3.20-24.42) 4.29 (3.20-9.00) 
(P) VEGF 3.20 (0.26-3.20) 3.20 (0.44-3.20) 3.20 (0.44-3.20) 3.20 (0.54-3.20) 3.20 (0.32-3.20) 3.20 (0.66-3.20) 
 
Table 4.10 Effect of palm oil (WT n=13; APC n=16), corn oil (WT n=15; APC n=14), or fish oil (WT n=13; APC n=16) on cytokine level in the plasma of wild-type and 
ApcMin/+ mice. (A) Anti-inflammatory cytokines; (P) pro-inflammatory cytokines. Values are presented as median (pg/ml) and 95% confidence interval (CI). Values having 
different superscript are significantly different (p<0.05) by Mann-Whitney test within the diet.
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Cytokines 
 
Wild-type ApcMin/+  
WT 
p 
 
APC 
p 
Palm oil 
Median (95% CI) 
pg/ml 
Corn oil 
Median (95% CI) 
pg/ml 
Fish oil 
Median (95% CI) 
pg/ml 
Palm oil
Median (95% CI) 
pg/ml 
Corn oil
Median (95% CI) 
pg/ml 
Fish oil
Median (95% CI) 
pg/ml 
(A) IFN! 3.20 (2.25-3.20) 3.20 (1.12-3.20) 3.20 (3.20-3.20) 3.20 (1.58-3.42) 3.20 (2.28-3.44) 3.20 (2.65-3.20) 0.94 0.92 
(P) IL-1" 50.64 (3.20-408.51) 111.37 (3.20-265.83) 40.11 (3.20-90.16) 35.49 (3.20-85.90) 41.67 (3.20-249.97) 27.11 (3.20-56.23) 0.21 0.11 
(P) IL-2 3.20 (3.20-21.21) 3.20 (2.51-3.20) 3.20 (3.20-22.06) 3.20 (1.79-15.85)  3.20 (3.20-22.70) 3.20 (3.20-25.69) 0.14 0.14 
(A) IL-4 3.20 (1.09-3.20) a 3.20 (0.81-3.20) a 3.20 (0.54-131.73) b 3.20 (1.16-3.20) 3.20 (1.09-3.20) 3.20 (0.89-3.20) 0.05 1.00 
(P) IL-5 9.87 (5.48-15.64) 6.02 (3.72-12.05) 9.02 (5.27-20.82) 5.25 (3.42-15.26) a 5.77 (3.71-12.60) ab 13.15 (5.93-18.31) b 0.11 0.05 
(P) IL-6 28.64 (3.20-62.01) a 3.20 (1.68-3.20) b 11.21 (3.20-42.66) ac 7.10 (3.20-18.79) 7.22 (3.20-20.77)  8.49 (3.19-54.47) 0.01 0.83 
(A) IL-10 3.20 (3.20-12.99) 3.20 (3.20-3.20) 3.20 (3.20-34.92) 3.20 (3.20-12.20) 3.20 (3.20-8.67) 3.20 (3.20-17.05) 0.16 0.58 
(P) IL-12p40 58.74 (3.20-215.81) 49.70 (3.20-103.82) 24.40 (3.20-120.30) 66.74 (3.20-116.75) 51.84 (5.48-81.60) 48.90 (16.87-108.41) 0.45 0.46 
(P) IL-12p70 18.13 (3.20-534.56) 3.20 (3.20-523.79) 3.20 (3.20—555.38) 3.20 (3.20-494.83) 3.20 (3.20-520.46) 3.20 (3.20-544.99) 0.87 0.72 
(P) IL-15 64.75 (3.20-318.12) 3.20 (3.20-226.81) 29.54 (3.20-351.51) 41.31 (3.20-316.07) 3.20 (3.20-223.22) 3.20 (3.20-187.11) 0.85 0.30 
(P) IL-17 3.20 (1.08-53.37) ab 3.20 (3.20-53.09) b 3.20 (3.20-55.16) c 3.20 (3.20-53.48) 3.20 (0.54-53.34) 3.20 (3.20-53.59)  0.01 0.86 
(A) IP-10 200.83 (167.65-321.32) 215.61 (199.18-298.39) 257.30 (165.13-297.86) 192.41 (163.47-268.32) 227.91 (160.30-348.67) 250.53 (200.85-328.67) 0.99 0.11 
(P) KC 77.99 (3.20-143.42) ac 46.43 (3.20-76.25) b 54.86 (3.20-148.61) ba 72.44 (3.20-155.49) 78.13 (3.20-127.51)  33.58 (3.20-125.19) 0.04 0.81 
(P) GMC-SF 3.20 (3.20-49.51) 3.20 (3.20-3.20) 3.20 (3.20-63.63) 3.20 (3.20-67.85) 3.20 (3.20-3.20) 3.20 (3.20-103.47) 0.31 0.22 
(P) TNF" 3.20 (1.37-3.20) 3.20 (3.20-3.20) 3.20 (1.36-3.20) 3.20 (0.75-3.20) 2.30 (0.85-3.20) 1.51 (0.51-3.20) 0.84 0.87 
(P) IL-1# 4.27 (3.20-35.22) 5.04 (3.38-27.66) 5.84 (2.34-36.11) 3.20 (2.94-19.53) a 7.15 (3.20-39.46) ab 16.13 (2.97-45.27) b 0.93 0.05 
(P) MCP1 31.05 (3.20-49.19)  23.64 (6.73-56.02)  52.62 (3.20-82.50) 12.77 (3.20-41.78) a 16.67 (3.20-35.39) a 41.17 (9.07-59.06) b 0.15 0.01 
(A) MIG 127.20 (105.75-688.79) 184.00 (151.26-301.02) 155.22 (101.52-263.50) 149.97 (110.56-360.71) 116.07 (73.65-185.84)  160.78 (102.58-202.07) 0.37 0.20 
(P) MIP1" 3.20 (3.20-28.11) 3.20 (3.20-13.73) 5.68 (3.20-24.42) 6.17 (3.20-35.67) 3.20 (3.20-49.06) 4.29 (3.20-9.00) 0.90 0.65 
(P) VEGF 3.20 (0.26-3.20) 3.20 (0.44-3.20) 3.20 (0.32-3.20) 3.20 (0.44-3.20) 3.20 (0.54-3.20) 3.20 (0.66-3.20) 0.81 0.80 
 
Table 4.11 Effect of genotype on cytokine level in the plasma of wild-type and ApcMin/+ mice. Values are presented as median (pg/ml) and 95% confidence interval (CI). (A) 
Anti-inflammatory cytokines; (P) pro-inflammatory cytokines. Values having different superscript are significantly different (p<0.05) by Kruskal-Wallis test. (WT: wild-type; 
APC: ApcMin/+; P: p-value). 
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4.1.4. Effects on tumour development 
 
Tumour development was measured only in the ApcMin/+ mice because wild-type animals 
did not develop tumours either in the small intestine nor colon.  
 
4.1.4.1. Effect of diet on tumour size 
 
Tumour size varied according to the treatment diet (Figure 4.5). Animals fed fish oil (1.00 
± 0.40 mm2) had smaller tumour size compared to the control palm oil (1.51 ± 0.81 mm2) 
and to the animals fed corn oil (1.42 ± 0.71 mm2), p=0.0001 and p=0.005 respectively.  
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Figure 4.5  Effect of treatment diets on mean size of tumour in the small intestine (SI) of the ApcMin/+ mice 
fed for 10 weeks. (n=16 mice/diet). Values (mean ± SD) having different superscript indicate statistically 
significant difference between the treatment groups by ANOVA at p< 0.05. 
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4.1.4.2. Effect of intestinal position on tumour size 
 
In Figure 4.6 is shown that tumour size varies with position in the small intestine. Tumours 
at the distal part of the small intestine (2.1 ± 0.45 mm2) was significantly bigger than 
tumours at the middle part (1.2 ± 0.45 mm2), p=0.0004. However, the tumour size at the 
middle part of the intestine was significantly smaller than the proximal (1.72 ± 0.92 mm2), 
p=0.0002. There was no difference in tumour size between proximal and distal. This figure 
showed that tumour size did vary with position in the small intestine.  
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Figure 4.6 Mean tumour size (mm2) according to the intestinal position in the small intestine of ApcMin/+ 
mice (n=48). Values show means and SD and those having different superscript indicate statistically 
significant difference between the treatment groups by ANOVA at p< 0.05. 
 
In the proximal part of the small intestine (Figure 4.7), tumour size was smaller for animals 
fed fish oil (1.1 ± 0.4 mm2) compared not only to the control palm oil (2.1 ± 0.9 mm2), but 
also to corn oil (1.9 ± 1.0 mm2), p<0.0001.  
 
a 
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Figure 4.8 shows the results of tumour size in the middle part of the small intestine. 
Animals fed the fish oil diet (0.9 ± 0.4 mm2) had smaller tumours compared to the control 
palm oil diet  (1.2 ± 0.5 mm2) and corn oil (1.2 ± 0.4 mm2) in both cases, p=0.0001.  
 
Figure 4.9 shows the results of tumour size at the distal part of the small intestine. Mice fed 
the fish oil diet (0.9 ± 0.4 mm2) had smaller tumour size compared to control palm oil (1.2 
± 0.6 mm2) and to corn oil (1.2 ± 0.4 mm2), p=0.0001.  
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Figure 4.7 Effect of treatment diets mean size of tumour (mm2) in the proximal part the small intestine of the 
ApcMin/+ mice fed for 10 weeks (n=16 mice/diet). Values (mean ± SD)  having different superscript indicate 
statistically significant difference between the treatment groups by ANOVA at p< 0.05. 
a 
b 
a
 110
0,00
0,20
0,40
0,60
0,80
1,00
1,20
1,40
1,60
1,80
PO CO FO
Diet
M
ea
n 
si
ze
 o
f t
um
ou
r i
n 
th
e 
m
id
dl
e 
(m
m
2)
 
Figure 4.8 Effect of treatment diets mean size of tumour (mm2) in the middle part the small intestine of the 
ApcMin/+ mice fed for 10 weeks (n=16 mice/diet). Values (mean ± SD)  having different superscript indicate 
statistically significant difference between the treatment groups by ANOVA at p< 0.05. 
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Figure 4.9 Effect of treatment diets mean size of tumour (mm2) in the distal part the small intestine of the 
ApcMin/+ mice fed for 10 weeks (n=16 mice/diet). Values (mean ± SD)  having different superscript indicate 
statistically significant difference between the treatment groups by ANOVA at p< 0.05. 
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4.1.4.3. Effect of diet on total tumour area 
 
In figure 4.10 is shown the effects of treatment diet on total tumour area across all the 
small intestine. Animals fed the corn oil (1621 mm2) and fish oil diet (1246 mm2) were not 
significant different from the palm oil group (1355 mm2) regarding total tumour area. 
 
0
200
400
600
800
1000
1200
1400
1600
1800
PO CO FO
Diet
To
ta
l t
um
ou
r a
re
a 
(m
m
2)
 
Figure 4.10 Effect of treatment diets on total tumour area (mm2) across all the small intestine of the 
ApcMin/+ mice fed for 10 weeks (n=16 mice/diet). No differences statistically significant were found 
between the treatment groups by ANOVA at p< 0.05. 
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However, when the total tumour area was categorized by the position in the small intestine, 
corn oil significantly increased the total tumour area in the proximal (471 mm2) compared 
to palm oil (287 mm2). Moreover, fish oil diet significantly reduced the total tumour area 
in the distal part of the small intestine (427 mm2) compared to palm oil (597 mm2) and 
corn oil (630 mm2) (Figure 4.11). 
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Figure 4.11  Effect of treatment diets on total tumour area (mm2) in the proximal, middle and distal parts of 
the intestinal position of the ApcMin/+ mice fed for 10 weeks (n=16 mice/diet). Values having different 
superscript indicate statistically significant difference between the treatment groups within the same intestinal 
position by ANOVA at p< 0.05. 
 
 
 
4.1.4.4. Effect of diet on total tumour number 
 
The diet treatments had no significant difference on total tumour number across all the 
small intestine (PO=1044; CO=1168; FO=1284). However, when the tumours were 
separated by different positions of the small intestine (Figure 4.12), and categorized by 
different sizes: small (<1mm2), medium (1-5mm2), and big (>5mm2) (Table 4.13), 
significant effects were observed. The incidence of total tumours in ApcMin/+ given fish 
* *
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oil was significantly greater in the middle region compared with the proximal (middle 531 
vs. proximal 308, p=0.008). Animals fed with corn oil and palm oil had significantly more 
tumours in the distal compared to proximal (palm oil: distal 427 vs. proximal 239, p=0.008 
and corn oil:  distal 543 vs. proximal 170, p=0.0001).  
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Table 4.12 Effect of treatment diets on total tumour area (mm2) in the proximal, middle and distal parts of 
the intestinal position of the ApcMin/+ mice fed for 10 weeks (n=16 mice/diet). Values having different 
superscript indicate statistically significant by ANOVA at p< 0.05. 
 
 
Considering the size of tumours, ApcMin/+ fed fish oil had significantly greater numbers 
of small tumours (<1mm2) in all regions (proximal, middle, distal) in the small intestine 
compared to control palm oil (proximal: fish oil 204 vs. palm oil 108, p=0.0001; middle: 
fish oil 360 vs. palm oil 204, p=0.0001; distal: fish oil 301 vs. palm oil 207, p=0.0002).  
 
 
P=0.008
P=0.001
P=0.008
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Tumour region 
and size 
Palm oil Corn oil Fish oil 
Proximal 
< 1 mm2 
1-5 mm2 
> 5 mm2 
 
108a 
104 a 
27a 
 
85a 
75b 
10b 
 
204 b 
98a 
6b 
Middle 
< 1 mm2 
1-5 mm2 
> 5 mm2 
 
204a 
170 
4  
 
269a 
184 
2  
 
360b 
164 
7  
Distal 
< 1 mm2 
1-5 mm2 
> 5 mm2 
 
207a 
212a 
8  
 
290b 
248a 
5  
 
301b 
141b 
5  
 
Table 4.13 Effect of palm oil, corn oil and fish oil on tumour number of ApcMin/+ mice. Values are 
presented as numbers of tumours and its percentage by each position of the small intestine. Male and female 
ApcMin/+ mice combined (n=16 animals/diet). Values having different superscript are significantly different 
by ANOVA, p<0.05. 
 
 
4.1.4.5. Effect of diet on tumour development in the colon 
 
There was no significant difference in mean tumour size in the colon (PO=0.3 ± 0.5 mm2; 
CO=2.6 ± 4.9 mm2; FO=0.8 ± 1.2mm2). The number of tumours in the colon was too small 
to perform statistical analysis. It is shown in Table 4.14 that animals fed the fish oil diet 
had greater numbers of small tumours compared to the other treatment diets, however it 
was not significant. 
 
 
Tumour size Palm oil Corn oil Fish oil 
Colon 
Total 
< 1 mm2 
1-5 mm2 
> 5 mm2 
 
11  
9  
2  
0 
 
13  
6  
2  
5  
 
29  
19 
9  
1  
 
Table 4.14 Effect of palm oil, corn oil and fish oil on tumour number and size in the colon of ApcMin/+ 
mice. Values are presented as numbers of tumours and its percentage categorized by size. Male and female 
ApcMin/+ mice combined (n=16 animals/diet). Values were too small to perform any statistical analysis.  
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4.2. DISCUSSION 
 
4.2.1. Mitosis, apoptosis and crypt length  
 
The mammalian intestinal epithelium is constantly renewed by cells derived from a rapidly 
dividing population in the crypts. Chronic hyperproliferation may be an early step in the 
progression from normal mucosa to malignant transformation. Normal colonic stem cells, 
which reside at the base of the crypt, generate the colonic mucosa that has an incredible 
rate of cell production and turnover. Cancer may therefore develop as a result of alteration 
of this process though the accumulation of mutations and damage within the controlling 
stem cells. The cellular division in cancer is driven by internal cellular events regardless of 
external stimuli (Anti, Marra et al. 1992; Salama and Platell 2009).  
 
Epidemiological studies indicate that there is an inverse association between intake of n-3 
polyunsaturated fatty acids (PUFAs) and incidence of colon cancer, although these studies 
are not uniformly conclusive (Nkondjock, Shatenstein et al. 2003). Also, cancer xenografts 
in immunosuppressed mice, as well as cell culture studies demonstrate that PUFAs may 
slow down cancer cell growth (Schonberg, Rudra et al. 1997; Clarke, Lund et al. 1999; 
Latham, Lund et al. 1999; Chen and Istfan 2000; Chamras, Ardashian et al. 2002; Diggle 
2002; Kato, Hancock et al. 2002). 
 
In the present study, the fish oil diet had no significant effect on cell proliferation in the 
distal small intestine tissue of ApcMin/+, compared to wild-type mice fed the same diet. 
The lack of positive effect of fish oil on reducing cell proliferation seems to contradict 
various studies where fish oil had positive effect on promoting an inhibition of cell 
proliferation in cell lines (Llor, Pons et al. 2003; Fukunaga, Hossain et al. 2008; Habbel, 
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Weylandt et al. 2009) and in animal studies (Chang, Chapkin et al. 1998; Calviello, 
Palozza et al. 1999; Fukunaga, Hossain et al. 2008; Kramer, Johnson et al. 2009). Even in 
normal rat colonic mucosa fish oil was shown to decrease cell proliferation when rats were 
fed low doses of purified EPA or DHA ethyl esters (1g/Kg body weight) (Calviello, 
Palozza et al. 1999). In this experiment, the cell proliferation analysis was carried out in 
healthy wild-type intestinal tissue, and in ApcMin/+ tissue, in macroscopically normal 
intestinal tissue. Cell proliferation was not measured in the tumour tissue. Perhaps, if it was 
measured it in the actual tumour tissue a significant effect of fish oil on cell proliferation in 
the carcinogenic animal model might have been found.   However, this would have been 
difficult to analyse using the methods employed in this study due to the disrupted tissue 
architecture found in tumours and thus lack of clearly defined crypts to be dissected out.  
 
The effect of fish oil in human studies also seems to be contradictory. Cheng et al. found 
no effect on crypt proliferation as measured by Ki-67 labelling with low dose of fish oil 
supplementation (100mg of EPA and 400mg of DHA per day) in patients with colorectal 
adenomas after 12 or 24 months of treatment (Cheng, Ogawa et al. 2003).  Similarly, Gee 
et al. (Gee, Watson et al. 1999) giving 1.4g of EPA and 1.0g of DHA per day for 2 weeks 
found no evidence of any effect of supplementation with fish oil in patients requiring 
surgery for carcinoma of the colon, despite the clear evidence of incorporation of EPA into 
epithelial cells. However, Courtney at al. (Courtney, Matthews et al. 2007) found a 
significantly decreased cell proliferation in patients with colorectal adenomas treated with 
highly purified EPA (2g/day) in the free fatty acid form for 3 months. Moreover, Anti et al. 
(Anti, Marra et al. 1992) reported that relatively high doses of fish oil (EPA 4.1g/day, 
DHA 3.6g/day) reduced the rate of proliferation as assessed by autoradiographic analysis 
of [H]thymidine incorporation in the flat rectal mucosa of patients with previously resected 
sporadic adenoma. In a subsequent study (Anti, Armelao et al. 1994) they reported that in 
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15 adenoma patients receiving 2.5g of fish oil per day both the frequency and spatial 
distribution of labelled cells were normalized compared to control patients given a placebo. 
These discrepancies between different studies suggest that not only the duration of 
treatment could be responsible for the different results, but also the type of EPA used in the 
experiment. Differences in efficiency of absorption and the biological activity of different 
forms of EPA and DHA may be interfering significantly in the results of several studies 
(Patten, Augustin et al. 2009). 
 
While many studies have reported the protective effect of fish oil, others report that corn 
oil, which is high in n-6 polyunsaturated fatty acids, especially linoleic acid, have strong 
tumour enhancing effects (Reddy, Burill et al. 1991). Reddy and Sugie (Reddy and Sugie 
1988) found that a 20% energy corn oil diet showed a tumour promoting effect in AOM-
treated mice in comparison with the low fat diet, whereas a 20% fish oil had no such effect. 
& recent study performed by Solanas et al. (Solanas, Grau et al. 2009) confirms the 
procarcinogenic effect of the corn oil by showing an increased mitotic index in cancer 
cells. The present results are in contrast with these previous studies. In the present 
experiment, corn oil had no significant effect on increasing cell proliferation in ApcMin/+ 
mice compared to wild-type fed the same diet. However, wild-type animals fed the corn oil 
diet showed an increase of cell proliferation compared to wild-type fed the palm oil or fish 
oil. This result is line with the results found by Pell et al. where they fed healthy rats for 
only 14 days and corn oil also increased the cell proliferation compared to the fish oil 
treatment but not compared to saturated fat (Pell, Brown et al. 1994). Thus, corn oil seems 
to increase the carcinogenic effect in healthy animals, instead of enhancing it in the animal 
model of colorectal cancer. A high fat diet rich in corn oil has been shown to promote 
colon carcinogenesis, particularly in the post-initiation or promotional phases (Reddy, 
Burill et al. 1991; Rao, Hirose et al. 2001; Dai, Liu et al. 2002). It is known that in 
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ApcMin/+ mice that tumour development occurs very early in life with the development of 
intestinal polyclonal crypts, which during the second or third weeks of life become clonal 
units (Shoemaker, Gould et al. 1997). There are several explanations that suggest the 
initiation of tumour in ApcMin/+ mice, but it may be that the polycolonal nature of 
intestinal crypts in young mice may mean that there is a larger population of target cells 
per crypt that can acquire a tumour-initiating mutation prior to 14 days of age. This means 
that when the treatment diets were given at weaning (21d) to ApcMin/+ mice the tissue 
will already be in a pre-neoplastic state such that any post-initiation carcinogenic effect of 
corn oil reported in the literature should be easily observable in the experiment. Wu et 
al.(Wu, Iwakiri et al. 2004) have found that corn oil did have a carcinogenic effect in an 
animal model of colorectal cancer. They found in their study that a 10% corn oil diet 
induced an increase in cell proliferation in AOM-treated rats, both in the colonic mucosa 
and in the tumours. Nevertheless, no similar effect of corn oil occurred in the experiment 
with the ApcMin/+ mice. 
 
One of the mechanisms by which corn oil may promote carcinogenesis has been 
demonstrated by Singh et al. (Singh, Hamid et al. 1997) using animal models. They have 
shown that a high fat corn oil diet enhances activities of diverse enzymes, including protein 
kinases that have been implicated directly or indirectly in colon promotion and 
progression. These kinases have been also shown to participate in ras-mediated growth-
promoting signal transduction pathways. In their study corn oil enhanced the expression of 
ras-p21, a guanine nucleotide-binding protein, in AOM-induced mice. This protein is a 
product of ras genes that function in the regulation of cell proliferation. This mechanism 
was observed in chemically induced colon cancer of mice, but perhaps corn oil might not 
have the same mechanistic effect in the ApcMin/+ mouse model, as this model has a 
different genetic modification regarding its phenotype and tumour formation.  
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Furthermore, in the current study, ApcMin/+ mice fed the palm oil diet had a 45% higher 
level of cell proliferation in intestinal distal tissues  and 60% higher in the colon, compared 
to wild-type mice from the same dietary group, which might be expected to lead to 
increased tumour number. On the contrary, Boateng et al. (Boateng, Verghese et al. 2006) 
showed that palm oil decreased the incidence of AOM induced aberrant crypt foci (ACF) 
compared to soybean oil and may therefore have a beneficial effect in reducing the 
incidence of colon cancer. While, in the present experiment, animals fed the corn oil and 
fish oil diets showed no difference between strains in their mitotic index either in the distal 
small intestine or in the colon. However, cell proliferation rates in the colon of ApcMin/+ 
mice fed the corn oil and the fish oil diet, was significant inhibited by -1.6-fold and -1.7-
fold respectively, compared to ApcMin/+ fed the palm oil. It should be remembered that 
the ApcMin/+ animal model develops its tumours mainly in the small intestine, and not in 
the colon. As a result, a decrease in the level of cell proliferation in a tissue where there is 
almost no tumour development in progress is unlikely to be relevant.  
 
Another mechanism that is important to mention is the Wnt/#-catenin pathway, already 
described in section 1.1.2.2, which also plays a critical role in the development of the 
gastrointestinal tract, especially in relation to murine models of cancers with Apc germline 
mutations. Central to this pathway is a multiprotein scaffold consisting of adenomatous 
polyposis coli (APC), which when malfunctioning allows for the accumulation of #-catenin 
in the cytoplasm. When #-catenin enters the nucleus it triggers the cell cycle.  To further 
enhance the oncogenic potential, nuclear #-catenin increases the expression of protein that 
promote cellular proliferation and resistance to apoptosis (Salama and Platell 2009). 
Nonetheless, dietary fat seems to influence Wnt/#-catenin pathways (Chang, Chapkin et al. 
1998; Fujise, Iwakiri et al. 2007). Vanamala et al. (Vanamala, Glagolenko et al. 2008) 
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found that diets containing both fish oil and pectin suppressed levels of peroxisome 
proliferator-activated receptor ! (PPAR!), and this was associated with a downregulation 
of Wtn/#-catenin in azoxymethane (AOM)-induced CRC in mice. While Jansson et al. 
(Jansson, Are et al. 2005) showed that ApcMin/+ mice had increased levels of PPAR! in 
the polyps, showing that Wnt/#-catenin signalling may play a role in the regulation of 
PPAR! function. Although fish oil didn’t have an extraordinary effect on cell proliferation 
inhibition in the present study, it did have a positive effect on the overall tumorigenesis in 
ApcMin/+ mice, which will be discussed further on.     
 
Apoptosis plays an important role in the elimination of damaged cells. There is increasing 
evidence to support the hypothesis that failure of apoptosis may be an important factor in 
the evolution of colorectal cancer. Apoptosis provides a route for elimination of stem cells 
carrying potentially procarcinogenic mutations (Latham, Lund et al. 2001).  Different 
potential mechanisms have been shown to modulate the dysregulation of apoptosis, and 
considerable controversy exists as to whether the frequency of apoptosis increases or 
decreases during the adenoma-carcinoma sequence. Although the apoptosis mechanisms 
are still unclear, many studies have demonstrated that dietary components also affect the 
modulation of colonic cytokinetics, in which fat and fiber seem to be the most significant 
dietary components affecting the intestinal mucosa (Bartsch, Nair et al. 1999). Specially, n-
3 polyunsaturated fatty acids (PUFAs) enhance colonic apoptosis, and are considered to be 
protective against colon cancer in various animal and cell experimental studies (Latham, 
Lund et al. 1999; Chen and Istfan 2000; Latham, Lund et al. 2001; Cheng, Ogawa et al. 
2003; Hofmanova, Vaculova et al. 2005; Engelbrecht, Toit-Kohn et al. 2008; Toit-Kohn, 
Louw et al. 2009). 
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In the present study, ApcMin/+ animals fed both the corn oil and fish oil diets had 
increased numbers of apoptotic cells in the distal small intestine, however the differences 
observed were not significant when compared to ApcMin/+ mice fed the palm oil diet. 
Even though the increase in apoptotic cells was insignificant, it shows an interesting 
pattern. Animals fed the fish oil diet had a 1.8-fold increase in apoptotic cells, but this 
effect was less prominent when compared to the effect of corn oil diet, which also 
increased the number of apoptotic cells in the distal small intestine tissue, but by 2.7-fold. 
This contrasts to previous studies showing a greater pro-apoptotic effect of fish oil than 
corn oil (Chang, Chapkin et al. 1997; Latham, Lund et al. 1999; Vanamala, Glagolenko et 
al. 2008; Bommareddy, Zhang et al. 2009). 
 
Latham et al. (Latham, Lund et al. 1999) found a positive effect of fish oil compared to 
corn oil on increasing the apoptosis not only in DMH-induced rats, but also in rats given a 
sham injection. Chang et al. (Chang, Chapkin et al. 1997) also found that AOM-induced 
rats fed with fish oil diet had a greater increase in apoptosis than corn oil, and this was 
observed at each level of the crypt and also in overall number of apoptotic cells/crypt in the 
proximal and distal colon. A most recent study, also done in AOM-induced rats, showed 
that animals fed with fish oil diets for 37 weeks had enhanced apoptosis levels when 
compared to animals fed the corn oil diet (Vanamala, Glagolenko et al. 2008). It has also 
been shown in the literature that fish oil is more effective in promoting apoptosis in colon 
tissue of healthy rats than corn oil (Latham, Lund et al. 2001). In contrast, Bommareddy et 
al. studied the effect of corn meal, corn oil and flaxseed oil, which is a source of the n-3 
PUFA alpha linolenic acid (ALA), on apoptosis cell in the small intestine and colon of 
ApcMin/+ mice, but no significant difference was found among the all groups 
(Bommareddy, Zhang et al. 2009). However, ALA has not shown potential benefit in many 
in vitro assessments. In the present experiment fish oil was used as a source of n-3 PUFA, 
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but even though no effect was observed on enhancing apoptosis within the ApcMin/+ mice 
fed different diets. ApcMin/+ fed the fish oil diet had significantly enhanced levels of 
apoptosis by 3.5-fold when compared to wild-type mice fed the same treatment diet. This 
enhanced apoptosis was not observed to the same extent in mice fed palm oil, but was also 
seen in those fed corn oil. 
| 
Some recent epidemiological and clear experimental data have linked a high dietary intake 
of n-6 polyunsaturated fatty acids (PUFAs), such as linoleic acid, to an increased risks of 
colon cancer (Bartsch, Nair et al. 1999). Despite this other case-control and prospective 
cohort studies have failed to show a consistent association between intake of n-6 
polyunsaturated fatty acids and colon cancer. Llor et al. (Llor, Pons et al. 2003) found that 
linoleic acid had no effect on inducing apoptosis in HT-29 and Caco-2 cells. Similar results 
were found by Habermann et al. (Habermann, Schon et al. 2010) in LT97 human colon 
adenoma and HT29 human colon adenocarcinoma, where linoleic acid failed to induce 
apoptosis in both cell types. Latham et al. (Latham, Lund et al. 1999) has also shown in 
DMH-induced colon cancer in rats that corn oil, rich in n-6 polyunsaturated fatty acids, did 
not increase apoptosis, and in fact decreased it, in either the distal and mid colon tissue 
compared to DMH-induced rats fed the fish oil. This is in contrast to the evidence 
presented in the present study where ApcMin/+ fed the corn oil diet increased the number 
of apoptotic cells in the distal small intestine per crypts by 32% compared to ApcMin/+ fed 
the fish oil diet, even though this was a not significant increase.  However, apoptosis was 
significantly increased by 5.8-fold when compared to wild-type mice also fed the corn oil 
diet. 
 
Wild-type animals fed the palm oil, corn oil or fish oil diet had no difference in the number 
of apoptotic cells in the distal small intestine in this present study. Which again contradicts 
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results found in the literature, especially regarding the effect of fish oil in healthy intestinal 
tissues which I have already mentioned (Latham, Lund et al. 1999; Latham, Lund et al. 
2001).  
  
No significant difference was observed in the numbers of apoptotic cells/crypt in the colon 
tissue of either wild-type and ApcMin/+ animals. Nevertheless, there was an apparent 
increase in apoptosis in both wild-type and ApcMin/+ mice fed the corn oil and fish oil diet 
compared to those fed the palm oil. Again these results are in contrast to those described 
previously in the colon of rats and human experiments treated with fish oil diet. It is has 
been reported in the literature that n-3 PUFAs have been found not only to increase 
apoptosis in normal rat mucosa (Calviello, Palozza et al. 1999), but also to have its 
protective effect against colorectal cancer associated with increased mucosal apoptosis in 
carcinogen-induced cancer in rats (Chang, Chapkin et al. 1998; Latham, Lund et al. 1999). 
Regarding epidemiological studies, Anti et al. (Anti, Armuzzi et al. 2001) and Martin et al. 
(Martin, Connelly et al. 2002) have described a generalized decreased level of mucosal 
apoptosis throughout the colon in subjects with colorectal adenomas, which may 
predispose these subjects to the development of polyps. Additionally, n-3 PUFAs have 
been shown to be protective in humans against colorectal cancer by modulating cell death. 
Courtney et al. (Courtney, Matthews et al. 2007) found an increase of apoptotic cells in the 
normal appearing mucosa from patients with colorectal adenomas who received EPA 
supplementation for 3 months. Furthermore, Cheng et al. (Cheng, Ogawa et al. 2003) also 
found that low dose of omega-3 fatty acid supplementation significantly increased rates of 
apoptosis in the normal colonic mucosa of patients with colorectal cancer after 2 years of 
supplementation. 
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In contrast, there are also a few studies which did not find positive effects of fish oil on 
enhancing the number of apoptotic cells in human colon tissue. For example, Pot et al. 
(Pot, Majsak-Newman et al. 2009) found no effect on apoptosis in patients with colorectal 
polyps receiving oil-rich fish or lean fish for 6 months. Moreover, Gee at al. (Gee, Watson 
et al. 1999) found no effect on colorectal cytokinetics in patients with colorectal neoplasms 
being supplemented with fish oil.   
 
The precise mechanism by which n-3 PUFA triggers apoptosis in intestinal epithelial cells 
is not yet established. Under in vitro conditions, the increased cell death brought about by 
treatment with EPA is considerably amplified by depletion of cellular glutathione and 
blocked by antioxidants (Clarke, Lund et al. 1999;Latham, Lund et al. 2001). This suggests 
that the effect of incorporating n-3 PUFA into the cellular lipid pool is to increase the 
production of reactive oxygen species, which are known to induce apoptosis in a number 
of different cell lines (Antunes and Cadenas 2001). A similar mechanism has been 
proposed to account for the induction of apoptosis in a human adenocarcinoma line by #-
carotene (Palozza, Calviello et al. 2001). A role for reactive oxygen species in the 
induction of colonic epithelial cell apoptosis in vivo is suggested by the fact that induction 
of apoptosis by dietary fish oil in the intact rat colon is also enhanced by depletion of 
glutathione (Latham, Lund et al. 2001). 
 
An alternative possible mechanism may be via the activation of PPAR!, at least in HT-29 
human colon cancer cells. Yang and Frucht (Yang and Frucht 2001) demonstrated that 
activation of the PPAP! pathway by a specific ligand (ciglitazone), induced colon cancer 
cells (HT-29) to undergo apoptosis. However, the receptor activation of PPAR! in the 
ApcMin/+ mouse enhanced tumorigenesis and increased the number of polyps (Yang and 
Frucht 2001). Fatty acids are known to bind and activate PPARs (Forman, Tontonoz et al. 
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1995; Xu, Lambert et al. 1999; Thoennes, Tate et al. 2000), and fish oil is known to be an 
agonist for PPAR!, and thus may influence apoptosis by the cyclooxygenase (COX) and 
Wnt/#-catenin pathways. Prostaglandin E2 (PGE2) formed from the n-6 PUFA arachidonic 
acid via COX, transactivates PPAR!. In addition, #-catenin, a downstream effector of the 
Wtn/#-catenin pathway, transcriptionally upregulates PPAR!. Interestingly, PGE2 can also 
upregulate #-catenin levels, which again upregulates PPAR! (He, Chan et al. 1999; Wang, 
Wang et al. 2004; Castellone, Teramoto et al. 2005).  
 
Reddy (Reddy 2004) has shown evidence that a high fat fish oil diet inhibited the levels of 
COX and the production of eicosanoids in the colon tumours, suggesting that inhibition of 
eicosanoid production through the modulation of COX activity may be important for the 
ability of n-3 PUFAs to inhibit colon tumorigenesis by inducing  apoptosis. Moreover, 
Vanamala et al.(Vanamala, Glagolenko et al. 2008) showed for the first time that 
suppression of the COX (PGE2) and Wnt/#-catenin pathways by the fish oil diet are 
associated with a concurrent suppression of the PPAR!. It should be noted that that EPA is 
also a substrate for COX but PGE3 rather than PGE2 is produced. 
 
No significant differences in crypt length were observed in the present experiment, either 
in the distal small intestine or colon of either wild-type or ApcMin/+ mice fed different 
diets, although it was observed that crypt length was higher in ApcMin/+ mice. 
 
 
4.2.2. Inflammation 
 
4.2.2.1. Small Intestine 
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In the small intestine twenty cytokines (IFN!, IL-1", IL-2, IL-4, IL-5, IL-6, IL-10, IL-
12p40, IL-12p70, IL-15, IL-17, IP-10, KC, GCM.SF, TNF", IL-1#, MCP-1, MIG, MIP-1", 
and VEGF) were measured in the tissue from the distal position after ten weeks of the 
dietary treatment. Animals (wild-type and ApcMin/+ combined) fed the corn oil diet had 
only six cytokines (30%) significantly changed, IL-2, IL-5, IL-15, KC, TNF" and VEGF, 
which were reduced compared to animals fed the palm oil diet. Analysing the levels of 
cytokines by strain from animals fed the corn oil diet, it was observed that out of 20 only 5 
cytokines were significantly different, 3 cytokines were lower (IL-12p40, IL-12p70, IP-10) 
and 2 cytokines (KC and MIG) were higher, both changes being in the ApcMin/+ mice 
compared to wild-type. Corn oil is rich in linoleic acid, which is converted to arachidonic 
acid and can be metabolized by cyclooxygenases and lipoxygenases to eiconsanoids, such 
as the proinflammatory and procarcinogenic PGE2 (Kawamori, Uchiya et al. 2003). 
Erdelyi et al. (Erdelyi, Levenkova et al. 2009) fed C57Bl/6J mice (model for sporadic 
colon cancer) a 20% corn oil diet for 3 and 6 months and analysed pro and anti-
inflammatory protein expression profiling in the mid colon. They found that after animals 
had been fed the diet for 3 months there was increased expression of IgA, C-reactive 
protein, fibrinogen, MCP-5 and MIP-1!, when compared to the control diet (5% corn oil). 
However, those changes at 3 months were no longer apparent at 6 months. Mehl et al. 
(Mehl, Davis et al. 2005) have demonstrated that ApcMin/+ mice have increased levels of 
IL-6 which could be reduced by exercise training. However, in the present study ApcMin/+ 
mice fed corn oil did not have increased levels of IL-6, but KC and MIG when compared 
to wild-type mice. Song et al. (Song, Ito et al. 1999) have studied intestinal inflammation 
in IL-10 knock-out mice and found that KC production may provide a reliable marker to 
objectively evaluate the development of inflammation. In humans with inflammatory 
bowel disease, one of the characteristic lesions is the presence of crypt abscesses, 
accumulations of neutrophils within the luminal space of the intestinal epithelial crypt. 
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While in humans IL-8 is responsible for the accumulation of neutrophils, KC is a 
chemokine in mice that is similarly capable of recruiting and activating murine neutrophils 
(Lira, Zalamea et al. 1994).  Besides, MIG (monokine induced by IFN-!) is a potent 
chemoattractant for tumour-infiltrating lymphocytes and it functions as an angiostatic 
agent in the tumour vasculature, and it has been used in chemokine gene therapy in order 
to prolong life span of mice with colon carcinoma by avoiding tumour development 
(Ruehlmann, Xiang et al. 2001). Thus, the change of the pro-inflammatory KC and the 
anti-tumour development chemokine MIG in ApcMin/+ mice fed the corn oil diet were 
proportional (200% increased compared to the wild-type mice). Not only MIG, which is 
considered to be beneficial on cancer prevention were significantly changed in these 
animals, but also IP-10, which is an anti-inflammatory cytokine. However IP-10 was 
decreased in ApcMin/+ mice compared to wild-type. IP-10 functions as a major 
chemoattractant for activated T cells and natural killer cells, and it has also been involved 
with anti-tumour activities into tumour sites and antagonizes the vascularizing effects of 
powerful angiogenic factors (Zipin-Roitman, Meshel et al. 2007). On the other hand, the 
pro-inflammatory IL-12 which activates and induces proliferation, cytotoxicity and 
cytokine production of natural killers (Borish and Steinke 2003) was reduced in ApcMin/+ 
mice fed corn oil. 
 
Animals (wild-type and ApcMin/+ combined) fed the fish oil diet were compared to those 
fed the palm oil, had 50% of the cytokines significantly different. IFN!, IL-1", IL-12p40, 
IL-12p70, IL-13, IP-10 and MIP-1" were significantly higher, whereas IL-15, IL-10, IL-15 
and GM-CSF were found lowered compared to the palm oil group. Fish oil affected 
changes in the cytokines levels by 83% more than the changes observed by the corn oil 
treatment diet. Analyzing the cytokines levels in the fish oil group by strain, it showed that 
ApcMin/+ mice had significantly lower levels of IL-12p40, IP-10, and GM-CSF, but 
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higher levels of IL-15, KC, IL-1# and MIG. Similar to the changes observed in the corn oil 
group, fish oil also decreased the levels of IL-12p40 and IP-10, and increased levels of KC 
and MIG in ApcMin/+ mice compared to wild-type. However, ApcMin/+ mice fed the fish 
oil also had decreased levels of GM-CSF and increased IL-15, IL-1#. 
 
The cytokine IL-1# which is cleaved by interleukin-1#-converting enzyme has been 
implicated as a factor in tumour progression via the expression of metastatic and 
angiogenic genes and growth factors, as well as being associated with a more virulent 
tumour phenotype (Lewis, Varghese et al. 2006). IL-1 induces expression of metastatic 
genes such as matrix metalloproteinases and stimulates nearby cells to produce angiogenic 
proteins and growth factors such as VEGF, IL-6 and TNF". However, in the present study 
animals fed the fish oil did not change the levels of VEGF, IL-6 and TNF", despite the 
significantly increased level of Il-1#. Reimund et al. (Reimund, Wittersheim et al. 1996) 
also described an increase of IL-1# in the serum and intestinal mucosa of subjects with 
chronic inflammatory bowel disease. Meydani et al. (Meydani, Lichtenstein et al. 1993) 
also studied the cytokine production capacity but in healthy subjects before and after 24 
weeks of a low or high n-3 PUFAs diet.  They found that ex-vivo production of IL-1# by 
isolated peripheral blood mononuclear cells fell significantly in the high n-3 PUFA diet, 
whereas IL-1# was significantly increased in the low n-3 PUFA diet. Based on the findings 
of these studies it is possible to observe that the levels of IL-1# might be related to disease, 
in this case colorectal cancer. Lewis et al. (Lewis, Varghese et al. 2006) have reported that 
solid tumours in which IL-1# has been shown to be up regulated includes colon cancers 
and melanomas, and patients with IL-1# producing tumors have generally bad prognoses.   
 
IL-15 is a multifunctional cytokine that stimulates T cell proliferation and activates 
cytokine production. IL-15 is also a potent inhibitor of apoptosis of both lymphocytes and 
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epithelial cells, as well as possessing a proangiogenic effect (Kuniyasu, Oue et al. 2001). In 
the present study IL-15 was found high in ApcMin/+ fedh the fish oil compared to the 
wild-type fed the same diet. Kuniyasu et al. (Kuniyasu, Oue et al. 2001) have investigated 
the role of IL-15 in the development of colorectal cancer and found that this cytokine was 
expressed in all colorectal carcinoma cell lines (TCO, Colo320, WiDr, DLD1). Moreover, 
they also found an increase between 40-80% on cell growth in those colorectal carcinoma 
cell lines. Overall this study indicates that IL-15 exhibits multiple functions in support of 
cancer cells: cell growth, cell survival under stress and anticancer drugs, cell invasion, and 
a proangiogenic effect by inducing VEGF production. Angiolillo et al. (Angiolillo, 
Kanegane et al. 1997) have administrated IL-15 subcutaneously into nude mice and they 
found that IL-15 induced a vigorous local angiogenic response. However, in the present 
study VEGF and TNF", which are also angiogenic, were not found elevated in the disease 
animal model used. 
 
Regarding the level of GMC-SF, Mroczko et al. (Mroczko, Lawicki et al. 2003) have 
investigated the level of this cytokine in colorectal cancer patients and found it to be 
significantly increased in the serum compared to healthy subjects. Moreover, the higher 
level of GMC-SF was also found in more advanced tumours. GMC-SF stimulates the 
survival of monocytes and their maturation into macrophages in vitro. Monocytes have 
several roles in the immune system including responding to inflammation signals. Terada 
et al. (Terada, Takizawa et al. 2002) studied the effect of EPA on GMC-SF-induced 
monocyte survival and macrophages and they found that EPA induced cell death of the 
monocyte via apoptosis and could be delaying the  inflammatory and immune reactions, 
which are involved in the development of disease, including colorectal cancer. In the 
present study, fish oil reduced the level of GMC-SF in ApcMin/+ mice compared to wild-
type animals. This cytokine drives hematopoietic precursor cells to become mature 
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granulocytes, macrophages, or dentritic cells. It is also used clinically to accelerate bone 
marrow recovery and increase the production of white blood cells to facilitate host defense. 
Moreover, GMC-SF’s immunostimulatory properties may be beneficial in cancer therapy 
because the presence of neoplasia is associated with macrophage dysfunction (Eubank, 
Roberts et al. 2004). Hill and Redmond (Hill and Redmond 1996) studied the 
antineoplastic effect of GM-CSF on tumour growth in a murine carcinoma model and they 
found a significant reduction on tumour growth in tumour bearing mice, and this 
antineoplastic effect also occurred during the postoperative period. In the present study the 
level of GM-CSF in tumour bearing mice was reduced for the fish oil group, and this fact 
might be affecting the macrophages defense against tumours and explain increased tumour 
number. 
 
In the animal group fed the palm oil diet, which is high in palmitic acid a saturated fat, few 
changes in the cytokine levels were found between strains. The only two significant 
changes observed were the reduction of IL-5 in ApcMin/+ mice, and the increase of KC in 
the ApcMin/+mice compared to the wild-type fed the same diet. IL-5 is a pro-
inflammatory cytokine that has been associated with colitis and which is associated with 
increased risk of colorectal cancer. Makins and Ballinger (Makins and Ballinger 2005) 
have performed an in vitro study using Caco-2 cells and they found that when the cells 
were cultured with IL-5 it potentiated IGF-II induced cellular growth by 40%. In general, 
palm oil did not seem to increase inflammation in the ApcMin/+ mice, apart from the high 
level of KC, which was consistently observed in the other treatment groups. KC is a 
chemokine member of the CXC family which is known to play a major role in 
inflammation, angiogenesis, tumorigenesis and wound healing (Dhawan and Richmond 
2002) but also in maintenance of tissue integrity in the presence of normal gut microflora 
(Rakoff-Nahoum- cell 2004). 
 131
 
Slattery et al. (Slattery, Potter et al. 1997) have demonstrated in their epidemiological 
study that palmitic acid was the second most common type of fat consumed in the diet, 
however it was not associated with the incidence of colorectal cancer. Some other studies 
have also found similar results (Neoptolemos, Husband et al. 1991; Hietanen, Bartsch et al. 
1994; Baro, Hermoso et al. 1998). Although an association may have been missed, because 
the small number of subjects did not allow statistical power to be achieved, the evidence 
seems consistent with no relationship between palmitic acid and colorectal cancer. On the 
other hand, there are some studies showing contradictory results, like the one performed by 
Sundram et al. (Sundram, Khor et al. 1989) where they showed a positive effect of palm oil 
on chemically induced mammary carcinogenesis by preventing the development of 
tumours. Clinical and epidemiologic studies have suggested a strong association between 
chronic infection, inflammation and cancer. However in the present study ApcMin/+ mice 
fed palm oil did not have increased the inflammatory markers compared to wild-type 
animals fed the same diet.     
 
When the cytokine levels in the distal small intestine of all wild-type mice were compared 
by each treatment diet it was found that animals fed the corn oil mostly decreased the 
significant cytokines (IL-5, IL-10, IL-15, KC, TNF", VEGF). Only IL-12p40 and IP-10 
was increased in the wild-type animals fed corn oil. On the other hand, animals fed fish oil 
also reduced levels of IL-5, IL-10, IL-15, KC, and TNF", but significantly increased levels 
of IL-12p40 and IL-12p70, IP-10, MIP-1". It seems that fish oil had a greater pro-
inflammatory effect on wild-type animals than corn oil. Pischon et al. (Pischon, Hankinson 
et al. 2003) performed a prospective cohort investigation in healthy volunteers to observe 
the habitual n-3 and n-6 fatty acids intake and its effect on inflammatory markers. They 
found a significant association between n-3 fatty acid intake and levels of TNF receptors. 
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Blok et al. (Blok, Katan et al. 1996) have also investigated the effects of n-3 fatty acids on 
cytokines in animal studies and they reported 7 studies with an increase and 3 with a 
decrease in TNF-". Therefore, results regarding the effects of n-3 fatty acids on cytokines 
secretion are quite conflicting.  
 
When ApcMin/+ mice were analyzed by diets it was found that the animals fed corn oil 
had all the significant cytokines decreased (IL-2, IL-12p40, IL-12p60, IL-1# and VEGF) 
compared to the ApcMin/+ mice fed palm oil. However, animals fed fish oil had increased 
levels of many pro-inflammatory cytokines IFN!, IL-12p40, IP-10, MIP-1".  Analysing the 
cytokines in the ApcMin/+ mice by the different treatment diets, corn oil and fish oil had a 
different effect on inflammation compared to the ApcMin/+ mice fed the palm oil.  While 
corn oil significantly reduced the levels of cytokines considered to be pro-inflammatory 
(IL-2, IL-12p40, IL-12p60, IL-1# and VEGF), fish oil significantly increased the levels of 
IFN!, IL-12p40, IP-10, MIP-1" and only had a reduction of IL-5 and GMC-SF. 
 
Read et al. (Read, Beale et al. 2007) have performed a study in patients with advanced 
colorectal cancer to observe the effect of n-3 fatty acids (EPA) and energy dense oral 
nutrition supplement on cytokine profile in the plasma at baseline, and after 3 and 9 weeks. 
They found little change in cytokines between the three time points, and only 3 of the 16 
recorded cytokines changed significantly (Eotaxin, GM-CSF, RANTES). However they 
concluded that those cytokines changed are unlikely to be clinically relevant.  A more 
recent study by Pot et al. (Pot, Geelen et al. 2009) in patients with colorectal adenomas and 
nonactive ulcerative colitis receiving additional fish in their diets for  6 months reported no 
effect on local markers of inflammation in colon biopsies or faeces of a dose equivalent to 
1.2g/day of  EPA + DHA. 
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4.2.2.2. Colon 
 
The levels of pro-inflammatory cytokines in colon tissue of both strains (ApcMin/+ and 
wild-type combined) were analyzed by the treatment diets, and an increased level of IL-6, 
TNF" and MCP-1 was observed in animals fed the fish oil compared to animals fed palm 
oil. However, no significant differences were observed when the cytokines levels were 
analyzed by strain by each treatment diet. All wild-type and ApcMin/+ mice were also 
analyzed by diet, and the only significant difference was observed in the ApcMin/+ group 
in which fish oil has reduced the level of IL-6 compared to the ApcMin/+ fed palm oil. As 
previously mentioned, tumour development in the ApcMin/+ mice occurs predominantly in 
the small intestine. The observation that the cytokine prolife in the colon tissue did not 
differ much between wild-type and ApcMin/+ mice suggests that the changes may have 
been in response to the tumours rather than related to the underlying genetic defect.  This 
idea is supported by the fact that both normal and tumour tissue was included in the 
analysis of the small intestine as it was not practicable to separate the two but in the colon 
the few large tumours were removed before analysis. Analysis of this tumour tissue 
however did reveal much higher cytokine levels but there was insufficient data to include 
in the final analysis (data not included).  
 
4.2.2.3. Plasma 
 
The systemic cytokine profile was also analysed in the wild-type and ApcMin/+ mice in 
present study. When the strains were combined and analysed by treatment diet it was found 
that out of 20 only 4 cytokines appeared to be significantly changed, but many were at 
levels below detection limits. Corn oil decreased the level of IL-6, while fish oil increased 
the level of IL-5 and MCP-1, both compared to the palm oil group. None of the diets 
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dramatically changed the cytokine profile in the plasma. When data were analysed within 
each treatment diet by strain the following were observed. ApcMin/+ mice fed palm oil 
had decreased levels of IL-2 and MCP-1 compared to wild-type fed the same diet. While in 
the fish oil fed group IL-17 was lower in the ApcMin/+ mice compared to wild-type. Only 
ApcMin/+ mice fed corn oil had a pro-inflammation effect associated with the 
ApcMin/+phenotype in which IL-6 and KC were raised, even though MCP-1 and MIG 
were decreased.  Within the wild-type animals fish oil increased level of IL-4 and IL-17, 
whereas corn oil decreased level of IL-6 and KC. Fish oil also seemed to increase the 
cytokines level within the ApcMin/+ mice, as IL-5, IL-1# and MCP-1 were significantly 
changed compared to ApcMin+ mice fed palm oil. 
 
4.2.2.4. General conclusion 
 
In the present study, local and systemic cytokine profile seems to be differently affected by 
the different treatment diets. The small intestine had the greatest changes in the cytokines 
profile, which is possibly explained by the tumour development process happening in this 
region. According to Coussens and Werb (Coussens and Werb 2002)  tumour cells produce 
various cytokines and chemokines that attract leukocytes, and the inflammation component 
of a developing neoplasm may include a diverse leukocyte population (neutrophils, 
dendritic cells, macrophages, eosinophils, mast cells and lymphocytes). All these cells are 
capable of producing an assorted array of cytokines, cytotoxic mediators, interleukins, 
interferons, etc., which creates a tumour microenvironment that is indispensable participant 
in the neoplastic process. The different fatty acids tested in the present experiment had 
different effects on cytokines levels in the small intestine. Corn oil diet changed 28% of the 
cytokine levels, while fish oil diet changed 50%, and almost no effect of palm oil diet was 
observed on the level of cytokines between strains. Moreover, the fish oil diet seemed to 
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increase the pro-inflammatory cytokines both in the healthy animals, as in the disease 
model. Whereas, the corn oil diet had the opposite effect and reduced the levels of pro-
inflammatory cytokines, both in the healthy and disease model.  
 
In the colon tissue, not much effect was observed, apart from fish oil diet increasing the 
levels of TNF-" and MCP-1, when strain was combined. However, in the ApcMin/+ mice 
both corn oil and fish oil diet reduced the level the pro-inflammatory cytokine IL-6. In the 
plasma there was almost no effect on the levels of cytokines either. However among the 
significant changes, fish oil diet increased levels of pro-inflammatory cytokines both in the 
ApcMin/+ and wild-type animals.   
 
4.2.3. Tumour Development 
 
The present study demonstrates that a 10 weeks dietary treatment with fish oil, rich in EPA 
(average intake of 64 mg/mouse/day) and DHA (average intake of 82 mg/animal/day), 
suppressed the growth of tumours in the intestine of ApcMin/+ mice. Tumour size and 
tumour number was analysed in the small and large intestine of the animals. In the small 
intestine, tumour size analysis was done by measuring: the mean size of tumours for each 
treatment diet, mean size of tumours for each position of the small intestine (proximal, 
middle, distal), and the mean tumour size in each position of the small intestine by each 
treatment diet. Tumour size was also summarized across all the small intestinal positions 
and analysed by the treatment diet. Moreover, total tumour number was analysed by 
measuring the mean tumour number across all the small intestine, but it was also analysed 
in respect to each position of the small intestine for each treatment diet. The large intestine 
was not divided into different positions, so tumour number and tumour size was analysed 
in the colon as a whole tissue.  
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Tumour size in the small intestine varied according to the treatment diet. The mean of 
tumour size across all the small intestinal positions was significantly smaller for animals 
fed the fish oil diet compared to animals fed the corn oil or palm oil diet. However, when 
tumour size was summarized across all the small intestinal position and analysed by the 
treatment diets no significant effect of fish oil or corn oil was observed compared to the 
palm oil.  Although Paulsen et al. (Paulsen, Elvsaas et al. 1997) did not mentioned the 
effect of fish oil on total tumour burden in ApcMin/+ mice, they have mentioned that 
animals fed the K85 diet rich in fish oil had a shift in the cumulated frequency distribution 
curves to the left compared to the control curve, which illustrates inhibited tumour growth. 
Data supporting the positive effect of fish oil on tumour burden in humans is reported in 
the West et al. (West, Clark et al. 2010) study. They found that individuals with familial 
adenomatous polyposis (FAP) receiving EPA (2g/day) for 6 months had a modest 
significant improvement compared to the placebo group, which had an increased rectal 
polyp burden.   
 
It was very important in the present study to have analysed the tumour data by each 
position of the small intestine and the effect of the treatment diet, so significant effects 
could be observed. When the mean of tumour size was analysed by each position of the 
small intestine, it was found that the distal position had significantly larger tumours 
compared to the middle position. Taking the treatment diets into consideration for each 
position of the small intestine, the following results were found. In the proximal position 
animals fed the fish oil diet had smaller mean tumour size compared to animals fed the 
corn oil and the palm oil diet. In the middle position, animals fed the fish oil diet had 
smaller mean tumour size compared to animals fed the corn oil and palm oil diet. In the 
distal position, animals fed the fish oil diet also had significantly smaller tumours 
 137
compared to animals fed the corn oil or palm oil diet. Some significant results were 
observed when the tumour size was summarized by each position of the small intestine and 
analysed by the treatment diets. Animals fed the fish oil diet had a smaller summarized 
tumour size in the proximal, middle and distal position compared to the corn oil and palm 
oil group. 
 
Thus, it is clearly consistent in this experiment that animals fed the fish oil diet had 
reduced mean tumour size in all the positions of the small intestine. This result is in line 
with the study performed by Paulsen et al. (Paulsen, Elvsaas et al. 1997), where they also 
showed a decreased tumour size in ApcMin/+ mice treated with n-3 PUFA ethyl ester 
enriched fish oil K85 (54.4% of EPA and 30.3% of DHA). They reported that the 
suppressing effect of enriched fish oil K85 was even more pronounced when only medium 
size tumours (>1mm) were scored. Tumour size was also reduced in a study performed by 
Oshima et al. (Oshima, Takahashi et al. 1995), in which they fed Apc716 knockout mice, a 
different murine FAP model, with a DHA dietary treatment (3% DHA with an average 
intake of 78mg/mouse/day). The effect of DHA in that study was more significant in 
females than in males, which the proportion of larger polyps decreased.  
 
There is also a very recent study using ApcMin/+ mice, which has been performed by 
Bommreddy et al. (Bommareddy, Zhang et al. 2009). In their study they have used a diet 
rich in n-3 PUFA, but using flaxseed as the source of n-3 fatty acids. They found that 
dietary flaxseed (15% flaxseed meal or 15% flaxseed oil) suppressed intestinal polyp 
formation by about 45% compared with AIN and corn oil diet after 12 weeks treatment. 
Moreover, they also found that tumour area was significantly smaller (53%) compared to 
animals fed the AIN and corn oil diet.   
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Studies performed to analyse the effect of fish oil on the growth of human colon carcinoma 
xenograft in nude mice have also demonstrated a suppressive effect on tumour growth. 
Kato et al. (Kato, Hancock et al. 2002) injected nude mice with WiDr colon 
adenocarcinoma and treated them with a high fat fish oil diet (16% fish oil) for 53 days 
(7,5 weeks). They found the growth of the tumour significantly suppressed by the fish oil 
treatment compared with that of tumours in mice fed the corn oil diet. A most recent study 
from the same group (Kato, Kolenic et al. 2007) was performed using a different human 
colon carcinoma xenograft (COLO 205). They also found similar results, in which a high 
fat fish oil diet inhibited the tumour growth by 80%, while a high fat diet rich in DHA 
resulted in 93% growth inhibition. Bordreau et al. (Boudreau, Sohn et al. 2001) also 
performed a study treating nude mice with fish oil (18% w/w) for 2 weeks before the 
human colon cancer cell line (HCT-116) was injected into the mice. After injection the 
animals continued on the diet for three more weeks. They found that the growth of tumour 
cell xenografts was significant suppressed by the fish oil treatment compared to animals 
fed the safflower diet.    
 
Several studies done in chemically induced mice/rats have also demonstrated a positive 
effect of fish oil on preventing tumour development in the colon (Reddy and Sugie 1988; 
Latham, Lund et al. 1999; Latham, Lund et al. 2001; Rao, Hirose et al. 2001). One recent 
example is the study performed by van Beelen et al. (van Beelen, Spenkelink et al. 2009) 
in which AOM-induced rats were treated with 20% by weight of fish oil diet for 8 weeks. 
They found that animals given fish oil had only half the total number of aberrant crypt foci 
(ACF) compared to the animals given the corn oil diet, but also had a significantly lower 
number of large ACF. 
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ACF like those described after carcinogen treatment dot not occur spontaneously in the 
colon of ApcMin/+ mice, and therefore are not analyzed in ApcMin/+ mice (Paulsen, 
Namork et al. 2000). However Paulsen et al. (Paulsen, Elvsaas et al. 1997; Paulsen, 
Namork et al. 2000) discovered small flat dysplastic lesions, which they denoted ACFM in 
contrast to classical elevated ACF, These lesions were not elevated above the surrounding 
mucosa and their detection by surface examination in whole mount colon preparation was 
totally dependent on both methylene blue staining and transillumination. The ACFMin 
exhibited dysplastic crypts were similar to those found in adenomas, and like the 
adenomas, they responded to chemoprevention with dietary fish oil. In their experiment 
performed in 1997 (Paulsen, Elvsaas et al. 1997) showed in females that the mean number 
of ACFMin per animal was reduced by 73%, and the growth of ACFM in was reduced by 
60% with 2.5% of n-3 PUFA ethyl ester enriched fish oil K85.  
 
Overall, the results reported in the literature and those from my study with the ApcMin/+ 
mice, that fish oil reduces the size of the tumour in the small intestine are very consistent. 
However, regarding the number of tumours, in the present study there was no significant 
difference when number of tumours was analyzed across all the small intestine.  
 
Nevertheless, when tumours were categorized by size and position in the small intestine, it 
was possible to observe the differences in tumour number caused by the treatment diets. 
Tumours were categorized into 3 classes of size (small: <1mm2; medium: 1-5 mm2; large: 
>5mm2) for each position of the small intestine (proximal, middle, and distal). Animals fed 
the fish oil had a greater number of tumours in all the positions of the small intestine 
compared to animals fed the palm oil diet, which is in contrast with some studies where 
there was a reduction of the tumour number for animals fed a fish oil diet (Petrik, McEntee 
et al. 2000; Whelan and McEntee 2004). However, the majority of tumours found in the 
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animals fed the fish oil diet were small (< 1mm2). This result together with the fact that 
mean tumour size was consistently smaller in all the positions of the small intestine for the 
fish oil group, suggests that fish oil may be having an important effect on delaying or 
avoiding the promotion of the tumours. A similar pattern was observed by Paulsen et al. 
(Paulsen, Elvsaas et al. 1997) when they found a growth retarding effect of the tumours 
from animals treated with K85 rich fish oil diet. Oshima et al. (Oshima, Takahashi et al. 
1995) also found that Apc716 mice fed the diet rich in DHA also had the polyp size shifted 
toward the smaller side. So, it is convincing that fish oil does have an effect on suppressing 
the growth of intestinal polyps in ApcMin/+ mice. 
 
Paulsen et al. (Paulsen, Elvsaas et al. 1997) have performed a study giving fish oil to 
neonatal ApcMin/+ mice during the initiation of tumour development. They have 
demonstrated an effect of fish oil on suppressing the total number of monocryptal 
adenomas (<0.1mm in diameter) in the small intestine.  In the present experiment, animals 
received the treatment diet after weaning (3-4 weeks after birth), by which time tumours 
may already be present.  However, the timing mimics that of clinical intervention trials, 
when dietary interventions are often given to adults that already bear Min polyps. 
Nevertheless, treating animals at initiation or at post-initiation stage, fish oil in both cases 
seems to be beneficial against colorectal cancer. 
 
On the other hand, animals fed the corn oil diet did not differ from the palm oil group 
regarding the number of small tumours in the proximal and middle position of the small 
intestine. In the distal position the corn oil group had a significantly higher number of 
small tumours compared to the palm oil group, and this result was similar to the effect of 
the fish oil group. However no difference was found between corn oil and fish oil. Whelan 
et al. (Whelan and McEntee 2004) did not classify different size of tumours in their 
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experiment but they did find that the mean size of tumour was significantly bigger for 
ApcMin/+ mice fed the high omega-6 diet compared to fish oil diet. 
 
When the medium size of tumours from the small intestine were analysed, it was found 
that in the proximal position only the corn oil group had a significant effect on  reducing 
the number of medium size tumours by 27% compared to the palm oil group. In the middle 
position there was no difference, but in the distal position only animals fed the fish oil diet 
had fewer tumours (33% less) compared to palm oil group. The number of large tumours in 
the small intestine was the least frequently observed. However there was a significant 
effect in the proximal position, where the corn oil group had the number of large tumours 
reduced by 63% compared to the palm oil group, while fish oil led to a 77% reduction.  
 
Looking at the tumour number in the different positions of the small intestine, it was found 
that the distal position was the part of the tissue with the highest number of total tumours 
in the palm oil and corn oil group, and this fact was also observed by others authors 
(Paulsen, Elvsaas et al. 1997; Sang, Ju et al. 2006; van Beelen, Spenkelink et al. 2009). 
 
Furthermore, there was no significant difference in the average total number of tumours in 
the small intestine between diets. However, the results show an interesting pattern of 
effect. Fish oil seemed to increase the number of small tumours in the first 2/3 of the 
intestine by having increased the total number of tumours by 28% in the proximal, 40% in 
the middle, while only 4% increase was observed in the distal position of the small 
intestine. This observation may be related to its metabolism and its bioavailability, which 
could be an explanation for the consistent effects observed.  In the present study, fish oil 
consistently increased the total number of tumours in all the position of the small intestine. 
There was also a consistent effect of fish oil on being associated with smaller mean size of 
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tumours. Also, fish oil led to a consistently greater number of small tumours (<1mm2) in 
each of the position in the small intestine.  
 
Patten et al. (Patten, Augustin et al. 2009) performed a very extensive experiment on fish 
oil digestion and bioavailability in Sprague-Dawley rats, and they found significant levels 
of plasma EPA and DHA at 1.5h in rats gavaged with fish oil that was evident for up to 6h. 
The total n-3 PUFA plasma level was significantly higher at 2h and was maintained until 
6h. Moreover, significant amounts of EPA and DHA were recovered from fish oil fed 
animals up to 6h in the small intestine, while small amounts were recovered in the cecum. 
Their experiment was done in fasted rats, but they speculated that if rats were not in the 
fasted state during gavage, it was likely that fish oil would have been absorbed completely 
in the small intestine before reaching the cecum. 
 
Based on the findings described above, it could be speculated that fish oil diet given to 
ApcMin/+ mice has a quite fast metabolism and is well absorbed and bioavailable across 
all the small intestine, especially at the beginning of the small intestine. This fact could 
explain the higher activity of the fish oil in the first 2/3 of the intestine. And this 
availability of the fish oil in these animals could be having an effect on preventing 
promotion and/or progression of the tumours by a very specific mechanism.   
 
The ApcMin/+ mouse as a model of colorectal cancer is limited as although it has many 
tumours in the small intestine it only has a few tumours in the colon. By contrast, human 
tumours are rarely found in the small intestine but frequently in the colon. The reason for 
this discrepancy is unclear, but it may be related to differences in key enzymes between the 
small and large bowel of ApcMin/+ mice. Phospholipases A-2 and cyclooxygenase-2 are 
up regulated in colonic tumours of humans and rats, and in small intestinal tumour of 
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ApcMin/+ mice. The resulting increase in PGE2 level would promote cancer growth, and 
this up-regulation is not seen in the colon of ApcMin/+. These considerations would then 
suggest that the small intestine of ApcMin/+ mice is a reasonable model of human colon 
and better than the ApcMin/+ mouse colon. (Corpet and Pierre 2003). However, these 
authors ignore the role of intestinal bacteria which may play a key role in carcinogenesis 
and are several fold more numerous in the colon than in the small intestine. 
 
In the present study, the incidence of tumours in the colon was 98% less than the incidence 
of tumours observed in the small intestine. Because of the very low number of tumours 
present in the colon, statistical analysis on number of tumour by tumour size was not 
possible. However, it was possible to observe that fish oil increased the absolute number of 
all sizes of tumours compared to palm oil. In contrast, the total tumour size in the colon 
was significantly smaller in animals fed the fish oil compared to corn oil diet, but not to the 
palm oil group.  The same pattern was observed in the small intestine, where fish oil also 
increased the number of tumours, but reduced the tumour size. The effect of fish oil in the 
colon was not significant however it shows the effect on preventing promotion of the 
tumours in the large intestine. This is a similar effect of fish oil to that observed in the 
small intestine.  
 
Paulsen et al. (Paulsen, Elvsaas et al. 1997) were also unable to statistically prove the 
observed tendency in reduced incidence, formation and growth of tumours in the colon of 
ApcMin/+ mice fed dietary fish oil enriched in EPA and DHA. Despite the low number of 
tumours in the colon, Bommareddy et al, (Bommareddy, Zhang et al. 2009) were able to 
show a significantly reduced number and size of tumour in colon of ApcMin/+ mice fed 
flaxseed oil (rich in the n-3 PUFA ALA) compared to corn oil. However, Petrik et al. 
(Petrik, McEntee et al. 2000) tested different n-3 PUFA (ALA, SDA, EPA, DHA) in 
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ApcMin/+ mice, and they found that stearidonic acid (SDA) was the only n-3 PUFA 
associated with significantly fewer tumour in the colon, although EPA was effective in the 
small intestine. 
 
Animal models of colorectal cancer have provided convincing evidence that a western-
style diet high in saturated and animal fats and n-6 PUFAs promotes colorectal 
carcinogenesis, whereas diets rich in n-3 PUFAs would be preventive. Moreover, the 
present experiment also supports the benefits of the consumption of a diet rich in n-3 
PUFAs. Several studies performed in humans have also found positive effect of n-3 
PUFAs on preventing colorectal cancer (Anti, Marra et al. 1992; Tiemersma, Kampman et 
al. 2002; Busstra, Siezen et al. 2003; Norat, Bingham et al. 2005; Courtney, Matthews et 
al. 2007; Geelen, Schouten et al. 2007; Hall, Chavarro et al. 2008). However, studies with 
contradictory results also can be found (Kobayashi, Tsubono et al. 2004; Lin, Zhang et al. 
2004; Pot, Majsak-Newman et al. 2009). According to the present scenario, more research 
has to be carried out on the effect of fish oil and colorectal cancer and at what doses, as 
well as finding out the precise mechanism of its effect. 
 
4.2.4. General conclusion of the effects of fatty acids 
 
Increasing the consumption of fish or fish oil in the diet has been suggested to prevent 
colorectal cancer development. However, the evidences of its beneficial effects are still 
limited. The results of the present study did not show promising effects of fatty acids on 
colorectal cancer prevention either, especially regarding the n-3 polyunsaturated fatty acids 
from fish or fish oil. Increased cell proliferation has been considered an early step in 
colorectal cancer development and it was one of the end points analysed in this study. 
However, the fish oil diet did not show any beneficial effect in reducing cell proliferation 
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in the gut mucosa, either in the colorectal cancer disease animal model or in the wild-type 
animals, as was expected. Nevertheless, corn oil diet seemed to increase cell proliferation 
in the wild-type animals. The number of apoptotic cells was also measured in the present 
study because of its important role in the elimination of damaged cells. However, no effect 
of any fatty acids was found in the gut mucosa of the animals.    
 
Local and systemic cytokine profile was also performed in the experiment, as 
inflammation is regarded as an important factor in the development of cancer. Most 
changes in the cytokine profile were found in the small intestinal tissue, and the reason for 
that is believed to be in response to the presence of the intense tumour development in the 
tissue. In general, not only in the tissue of the small intestine from the disease animals, but 
also from the wild-type animals, the fish oil diet significantly increased mainly pro-
inflammatory cytokines. Whereas, animals fed the corn oil diet showed an opposite effect 
by decreasing the levels of pro-inflammatory cytokines, both in the ApcMin/+ mice and 
wild-type animals. In the colon tissue, there was no effect of fatty acids on the cytokine 
profile, apart from the unique reduction of IL-6 caused by the fish oil diet in the ApcMin/+ 
mice. In the plasma, the number of cytokines significantly changed was 45% less 
compared to the cytokine changes observed in the small intestine of the disease model. 
These changes were related to an increase in pro-inflammatory cytokines in the ApcMin/+ 
mice fed the fish oil diet. Overall, it seems that the fish oil diet in the present study 
promoted or allowed the increase of pro-inflammatory cytokines in both animal strains. 
 
The result regarding tumour development was the only endpoint analysed that fish oil diet 
seemed to have a slightly positive effect. In general, animals fed the fish oil diet had the 
mean size of tumour smaller in all the positions of the small intestine compared to the 
control diet. However, when the total tumour area was summarized across the small 
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intestine and analysed by the different treatment diets, no significant results were observed. 
Similar results were also previously found (Paulsen, Elvsaas et al. 1997). Regarding 
tumour number, none of the treatment diets reduced the total tumour number in the small 
intestine. On the contrary, fish oil diet consistently increased the number of small tumours 
in all the intestinal positions.  
 
All in all, the effects of fish oil in the present experiment were not promising in respect to 
any protective effects against the development of colorectal cancer in the ApcMin/+ mouse 
model.  
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5. PHYTOCHEMICAL STUDY 
 
The results and discussion of the animal intervention using ApcMin/+ mouse model to 
study the effects of phytochemicals on the prevention of colorectal cancer development are 
presented in this chapter. A high-fat diet (25% energy as fat) enriched with 10% of a 
phytochemical mix containing coffee, cocoa, turmeric, thyme, walnuts, and red berries was 
compared to high-fat palm oil diet (25% energy as fat) control diet.  Wild-type animals 
(n=16) and ApcMin/+ animals (n=16) were exposed to the treatment diet for 10 weeks. 
The endpoints evaluated were body and organ weights, mitosis and apoptosis, local and 
systemic inflammation, as well as tumour development.  
 
 
5.1. RESULTS 
 
5.1.1. Effects on body and organs weight 
 
The effect of sex, genotype and diet on age, body weight and organs are summarized in 
Table 5.1 and Table 5.2. Females had a smaller body weight when compared to the males 
(12.83 g ± 4.32 g vs. 15.95 ± 4.48 g, p=<0.05). However, they had a significantly greater 
stomach weight (6.42 ± 1.55 x10-3 g vs. 4.98 ± 0.95 x10-3 g, p=<0.05) and spleen (8.95 ± 
6.90 x10-3 g vs. 5.51 ± 3.37 x10-3 g). Genotype also had a significant effect on the 
animals, such that wild-type mice were bigger than the ApcMin/+ mice at the end of the 10 
weeks dietary treatment. However, ApcMin/+ had a significantly heavier liver, heart, and 
spleen. Data analysis revealed an apparent interaction between genotype and diet on age 
(p=0.01), that might also have contributed to effects on final body weight (p<0.01) and 
kidney weight (p=0.01) despite initial weights being similar. The dietary treatment was 
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also significant among genotypes. Mice fed the phytochemical diet were younger and 
larger than the animals fed the palm oil. Moreover, the phytochemical treatment apparently 
led to an increase in stomach, caecum, and liver size, while the heart was larger in the mice 
fed the control diet.  
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Variables Sex Genotype 
 Male Female ApcMin/+ Wild-type 
Age (days) 34.16 ± 6.24 a 32.15 ± 8,03 a 32.23 ± 5.84 a 33.97 ± 8.28 a 
Initial body weight (g) 15.95 ± 4.48 a 12.83 ± 4.32 b 13.84 ± 4.38 a 14.84 ± 4.88 a 
Final body weight (g) 26.72 ± 2.29 a 20.70 ± 2.45 b 22.56 ±3.50a 24.66 ± 3.92b 
Change in body weight  (g) 10.76 ± 4.50 a 7.86 ± 4.23 b 8.72 ± 4.43 a 9.81 ± 4.70 a 
Stomach (g) 4.98 ± 0.95 x10-3 a 6.42 ± 1.55 x10-3 b  5.84 ± 1.44 x10-3 a 5.60 ± 1.51 x10-3 a 
Caecum (g) 3.09 ± 1.10 x10-3 a 3.45 ± 1.19 x10-3 a 3.19 ± 0.91 x10-3 a  3.34 ± 1.35 x10-3 a 
Liver(g) 4.65 ± 0.61 x10-2 a 4.67 ± 0.58 x10-2 a 4.89 ± 0.54 x10-2 a  4.45 ± 0.57 x10-2 b 
Heart(g)  5.01± 0.68 x10-3 a 5.34 ± 1.04 x10-3 a 5,47 ± 0.99 x10-3 a 4.91 ± 0.71 x10-3 b 
Spleen(g) 5.51 ± 3.37 x10-3 a 8.95 ± 6.90 x10-3 b 9.54 ± 5.32 x10-3 a 5.18 ± 5.26 x10-3 b 
Kidney(g) 0.012 ± 0.001a 0.012 ± 0.0001a 0.012 ± 0.001 a 0.012 ± 0.0001a 
 
Table 5.1 Age, body and organ weight by sex and genotype. Values are mean ± SD. Values within a row were analysed separately by sex and genotype. Values having a different 
superscript are significantly different by one-way analysis of variance and are indicated using bold letters and different superscripts, p<0.05. Male n= 31, Female n=32, ApcMin/+ 
n= 30, Wild-type n=33. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.2 Differences in age, body and organ weight of mice on the phytochemical-rich and control diet.  Values are mean ± SD, Control n= 32; Phytochemical mix n=31.  
ApcMin/+ and wild-type mice combined. Significant effects of Genotype*Diet were identified by two-way analysis of variance p<0.05. ns=not significant
Variables Palm oil     Phytochemical Genotype*Diet 
Age (days) 35.38 ± 7.08 a 30.96 ± 6.77 b 0.01 
Initial body weight (g) 12.47 ± 4.46 a 16.32 ± 4.02 b ns 
Final body weight (g)  23.42 ± 3.94 a 23.91 ± 3.78 a 0.001 
Change in body weight (g) 10.95 ± 3.81 a 7.58 ± 4.71 b ns 
Stomach (g) 5.34 ± 1.29 x10-3 a 6.10 ± 1.56 x10-3 b ns 
Caecum (g) 2.50 ± 0.58 x10-3 a 4.07 ± 1.05 x10-3 b ns 
Liver (g) 4.37 ± 0,47 x10-2 a 4.96 ± 0.56 x10-2 b ns 
Heart (g) 5.45 ± 0.96 x10-3 a 4.89 ± 0.73 x10-3 b ns 
Spleen (g) 7.36 ± 5.92 x10-3 a 7.15 ± 5.52 x10-3 a ns 
Kidney (g) 0.012 ± 0.000 a 0.012 ± 0.001 a 0.01 
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5.1.2. Effects on mitosis, apoptosis and crypt length 
 
ApcMin/+ mice had higher cell proliferation in the distal small intestine compared to the 
wild-type in both treatment diets, (control diet: ApcMin/+ 2.99 ± 0.28 mitotic cell/crypt vs. 
wild-type 2.06 ± 0.17 mitotic cell/crypt, p=0.00; phytochemical diet: ApcMin/+ 2.72 ± 
0.24 mitotic cell/crypt vs. wild-type 2.10 ± 0.19 mitotic cell/crypt, p=0.05), Figure 5.1(a). 
ApcMin/+ also had a greater cell proliferation rate in the colon, as compared to the wild-
type, but this was only significant for the palm oil control diet (ApcMin/+ 1.58 ± 0.15 
mitotic cell/crypt vs. wild-type 0.98 ± 0.19 mitotic cell/crypt, p=0.01), Figure 5.1 (b). 
There was no significant difference in the colon tissue for the phytochemical group 
(ApcMin/+ 1.31 ± 0.20 mitotic cell/crypt vs. wild-type 1.00 ± 0.14 mitotic cell/crypt).  
 
The effect of apoptosis on wild-type and ApcMin/+ are summarized in Figure 5.2. There 
was no significant difference in apoptosis in the distal tissue of animals fed with palm oil 
(ApcMin/+ 0.12 ± 0.03 apoptotic cell/crypt vs. wild-type 0.03 ± 0.01 apoptotic cell/crypt). 
However, ApcMin/+ mice fed with the phytochemical-rich diet had a significantly higher 
rate of apoptosis compared to wild-type (2.72 ± 0.24 apoptotic cell/crypt vs. 2.10 ± 0.19 
apoptotic cell/crypt). No significant difference was observed in the colon between the 
treatment diets or genotypes. There was no significant effect on crypt length at the distal or 
colon tissue among diets or genotypes (Figure 5.3). 
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Figure 5.1 Effects of phytochemicals on cell proliferation in the distal (a), and in the colon (b) of wild-type 
and ApcMin/+ mice. The values represent the mean (n=32) and standard error of the mean. The values not 
sharing the same symbol are significantly different (p<0.05) by two-way ANOVA general linear model. Data 
analysed within the same diet by different genotype and is significantly different is indicated by *. No 
significant effect on same genotype by different diet. Ten crypts were analysed per animal. 
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Figure 5.2 Effects of phytochemicals on apoptosis in the distal small intestine (a), and in the colon (b) of 
wild-type and ApcMin/+ mice. The values represent the mean (n=32) and standard error of the mean. The 
values not sharing the same symbol are significantly different (p<0.05) by two-way ANOVA general linear 
model. Data analyzed within the same diet by different genotype (*).No significant effect on same genotype 
by different diet. Ten crypts were analysed per animal. 
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Figure 5.3 Effects of phytochemicals on crypt length in the distal small intestine (a), and in the colon (b) of 
wild-type and ApcMin/+ mice. The values represent the mean in mm on eyepiece scale (n=32) and standard 
error of the mean. Each unit equals 40"m. No significant effect was observed by two-way ANOVA general 
linear model. Ten crypts were analysed per animal. 
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5.1.3. Effects on local and systemic inflammation 
 
5.1.3.1. Distal small intestine tissue 
 
Of the total number of cytokines, 52% were significantly affected by diet, and the results 
are summarized in Table 5.3. The phytochemical diet increased the levels of seven 
cytokines (IFN-!, IL-1", IL-2, IL-12p40, IP-10, IL-1#, and MIP-1") compared to the 
control palm oil (p'0.05). Whereas, the control group had higher levels of IL-5, IL-10 and 
IL-1# compared to the phytochemical group.     
 
Table 5.4 summarizes the effects of palm oil and phytochemicals on the distal cytokine 
levels separated by strain. ApcMin/+ mice fed with the palm oil had higher levels of KC 
and IL-1" compared with palm oil wild-type animals. ApcMin/+ mice fed phytochemicals 
had not only higher levels of KC and IL-1", but also MCP1, IL-6 and IL-1" compared to 
wild-type mice on the same diet. For the palm oil group, wild-type animals had higher 
levels of IL-5, while for the phytochemicals group the wild-type animals had higher levels 
of INF-! and IL-2.   
 
Wild-type animals fed with the phytochemicals had significantly higher levels of IL-1", 
IL-2, and MIP-1", and lower levels of IL-5, IL-10, KC, and TNF-" compared to the 
control group (p'0.05). As with the wild-type mice fed phytochemicals the ApcMin/+ 
mice also had significantly higher levels of IL-1", and MIP-1".. Moreover, the levels of 
cytokines were also higher for IP-10 and MCP-1 within the ApcMin/+ fed phytochemicals. 
The anti-inflammatory cytokine IL-10 was significantly lower in mice fed with the 
phytochemicals (Table 5.5). 
 
 155
 
 
 
 
 
Table 5.3 Comparison of the levels of 20 different cytokines (pg/mg protein) n mice fed the control diet 
(n=28) vs. phytochemicals (n=29) in the distal small intestine tissue of mice after 10-week treatment. (A) 
Anti-inflammatory cytokine; (P) pro-inflammatory cytokine Values are presented as median and 95% 
confidence interval. ApcMin/+ and wild-type mice combined. Significant p-value was identified by Kruskal-
Wallis non-parametric at p<0.05. 
 
  
Cytokines 
Palm oil 
Median (95% CI) 
pg/mg protein 
Phytochemicals 
Median (95% CI) 
pg/mg protein 
  
p-value 
(A) IFN-! 0.08 (0.03-0.10) 0.16 (0.08-0.19) 0.03 
(P) IL-1" 0.46 (0.37-0.62)  0.95 (0.81-1.24) 0.001 
(P) IL-2 0.16 (0.11-0.19)  0.33 (0.19-0.44) 0.04 
(A) IL-4 0.03 (0.02-0.05)  0.02 (0.01-0.04) 0.29 
(P) IL-5 0.01 (0.004-0.13)  0.003 (0.003-0.004) 0.001 
(P) IL-6 0.26 (0.19-0.32)  0.18 (0.09-0.30) 0.54 
(A) IL-10 1.58 (0.60-2.17)  0.23 (0.14-0.35) 0.001 
(P) IL-12p40 0.77 (0.004-1.34)  1.23 (0.91-1.63) 0.03 
(P) IL-12p70 1.03 (0.78-1.16)  0.83 (0.64-1.14) 0.32 
(P) IL-15 0.48 (0.01-0.92) 0.26 (0.00-1.00) 0.20 
(P) IL-17 0.23 (0.16-0.38) 0.18 (0.10-0.28) 0.24 
(A) IP-10 1.59 (0.91-2.57) 2.69 (2.31-2.88) 0.001 
(P) KC 0.57 (0.44-0.85) 0.33 (0.23-1.29) 0.39 
(P) GMC-SF 0.0039 (0.0029-0.0038) 0.0029 (0.0026-0.032) 0.07 
(P) TNF-" 0.13 (0.12-0.20) 0.08 (0.04-0.13) 0.01 
(P) IL-1# 0.63 (0.44-0.99) 0.72 (0.31-0.81) 0.04 
(P) MCP1 0.63 (0.44-0.90) 0.62 (0.47-1.91) 0.28 
(A) MIG 26.38 (16.49-38.46) 28.74 (17.37-35.86) 0.77 
(P) MIP1" 0.22 (0.12-0.26) 0.40 (0.31-0.57) 0.001 
(P) VEGF 2.59 (2.29-3.67) 2.85 (2.47-3.30) 0.89 
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Cytokines 
Palm oil   Phytochemical   
Wild-type (n=14) 
Median (95% CI) 
pg/mg protein 
ApcMin/+ (n=14) 
Median (95% CI) 
pg/mg protein p-value 
Wild-type (n=15) 
Median (95% CI) 
pg/mg protein 
ApcMin/+ (n=15) 
Median (95% CI) 
pg/mg protein p-value 
(A) IFN-! 0.06  (0.004-0.35) 0.08  (0.003-0.10) 0.33 0.19 (0.13-0.22) 0.08 (0.003-0.18) 0.01 
(P) IL-1" 0.41  (0.25-0.59) 0.60  (0.31-1.13) 0.09 0.82 (0.56-1.24) 1.11 (0.82-2.05) 0.04 
(P) IL-2 0.15  (0.004-0.19) 0.16  (0.11-0.50) 0.09 0.39 (0.26-0.68) 0.25 (0.003-0.43) 0.04 
(A) IL-4 0.04  (0.01-0.07) 0.03  (0.01-0.06) 0.46 0.03 (0.01-0.05) 0.02 (0.01-0.04) 1.00 
(P) IL-5 0.09  (0.004-0.25) 0.003  (0.003-0.21) 0.001 0.0034 (0.0031-0.0045) 0.0036 (0.0031-0.0043) 0.97 
(P) IL-6 0.26  (0.08-0.42) 0.26  (0.16-0.47) 0.89 0.11 (0.08-0.28) 0.27 (0.10-0.79) 0.05 
(A) IL-10 1.97  (0.60-2.66) 0.89  (0.35-2.17) 0.60 0.17 (0.08-0.30) 0.23 (0.15-0.53) 0.14 
(P) IL-12p40 0.31  (0.003-4.44) 1.10  (0.003-1.43) 0.52 1.23 (0.73-1.66) 1.32 (0.77-1.79) 0.48 
(P) IL-12p70 1.01  (0.54-1.34) 1.11  (0.63-1.56) 0.52 0.78 (0.43-1.14) 0.90 (0.61-1.97) 0.29 
(P) IL-15 0.43  (0.004-1.28) 0.59  (0.003-1.06) 0.89 0.34 (0.002-1.11) 0.003 (0.002-1.40) 0.83 
(P) IL-17 0.21  (0.14-0.48) 0.25  (0.12-0.52) 0.67 0.18 (0.06-0.27) 0.21 (0.09-0.72) 0.32 
(A) IP-10 0.91  (0.57-2.89) 1.96  (1.02-2.81) 0.12 2.57 (1.88-2.86) 2.77 (2.29-3.25) 0.15 
(P) KC 0.47  (0.25-0.87) 0.71  (0.49-1.24) 0.03 0.23 (0.11-0.33) 1.46 (0.30-2.96) 0.001 
(P) GMC-SF 0.0035  (0.0029-0.0045) 0.0030  (0.0027-0.0038) 0.29 0.0030 (0.0026-0.0035) 0.0028 (0.0025-0.0034) 0.65 
(P) TNF-" 0.17  (0.11-0.26) 0.13  (0.09-0.24) 0.29 0.06 (0.01-0.10) 0.09 (0.04-0.29) 0.32 
(P) IL-1# 0.48  (0.25-0.80) 1.03  (0.44-1.27) 0.01 0.20 (0.02-0.54) 0.79 (0.72-1.39) 0.001 
(P) MCP1 0.50  (0.32-0.79) 0.79  (0.44-1.01) 0.15 0.49 (0.38-0.55) 2.02 (1.03-3.08) 0.001 
(A) MIG 20.17  (1.67-48.14) 33.03  (18.67-53.58) 0.21 28.74 (13.08-35.86) 28.47 (14.26-60.00) 0.60 
(P) MIP1" 0.21  (0.004-0.27) 0.22  (0.08-0.40) 0.43 0.33 (0.22-0.81) 0.54 (0.26-0.79) 0.28 
(P) VEGF 2.50  (1.31-3.99) 2.95 (2.29-6.16) 0.08 3.08 (2.46-3.46) 2.71 (1.57-3.37) 0.46 
 
Table 5.4 Effect of phytochemicals on cytokine level (pg/mg protein) in the distal small intestine tissue of wild-type and ApcMin/+ mice. (A) Anti-inflammatory cytokine; (P) 
pro-inflammatory cytokine Values are presented as median and 95% confidence interval. Significant p-Value (p<0.05) was identified by Kruskal-Wallis test.   
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Cytokines 
Wild-type 
 
 
 
ApcMin/+  
Palm oil  (n=14) 
Median (95% CI) 
pg/mg protein 
Phytochemical (n=15) 
Median (95% CI) 
pg/mg protein p-value 
 Palm oil  (n=14) 
Median (95% CI) 
pg/mg protein 
Phytochemical  (n=14) 
Median (95% CI) 
pg/mg protein p-value 
(A) IFN-! 0.06  (0.00-0.35) 0.19 (0.13-0.22) 0.12 0.08  (0.003-0.10)  0.08 (0.00-0.18) 0.41 
(P) IL-1" 0.41  (0.25-0.59) 0.82 (0.56-1.24) 0.01 0.60  (0.31-1.13)  1.11 (0.82-2.05) 0.001 
(P) IL-2 0.15  (0.00-0.19) 0.39 (0.26-0.68) 0.001 0.16  (0.11-0.50)  0.25 (0.00-0.43) 0.82 
(A) IL-4 0.04  (0.01-0.07) 0.03 (0.01-0.05) 0.48 0.03  (0.01-0.06) 0.02 (0.01-0.04) 0.25 
(P) IL-5 0.09  (0.00-0.25)  0.003 (0.003-0.004) 0.001 0.003  (0.003-0.21)  0.003 (0.003-0.004) 0.54 
(P) IL-6 0.26  (0.08-0.42) 0.11 (0.08-0.28) 0.22 0.26  (0.16-0.47) 0.27 (0.10-0.79) 0.52 
(A) IL-10 1.97  (0.60-2.66)  0.17 (0.08-0.30) 0.001 0.89  (0.35-2.17) 0.23 (0.15-0.53) 0.001 
(P) IL-12p40 0.31  (0.00-4.44)  1.23 (0.73-1.66) 0.11 1.10  (0.00-1.43)  1.32 (0.77-1.79) 0.15 
(P) IL-12p70 1.01  (0.54-1.34)  0.78 (0.43-1.14) 0.26 1.11  (0.63-1.56)  0.90 (0.61-1.97) 0.89 
(P) IL-15 0.43  (0.00-1.28)  0.34 (0.00-1.11) 0.51 0.59  (0.00-1.06)  0.003 (0.002-1.40) 0.33 
(P) IL-17 0.21  (0.14-0.48) 0.18 (0.06-0.27) 0.19 0.25  (0.12-0.52) 0.21 (0.09-0.72) 0.82 
(A) IP-10 0.91  (0.57-2.89)  2.57 (1.88-2.86) 0.07 1.96  (1.02-2.81)  2.77 (2.29-3.25) 0.02 
(P) KC 0.47  (0.25-0.87)  0.23 (0.11-0.33) 0.01 0.71  (0.49-1.24) 1.46 (0.30-2.96) 0.07 
(P) GMC-SF 0.003  (0.002-0.004) 0.003 (0.002-0.003) 0.18 0.003 (0.002-0.003)  0.002 (0.002-0.003) 0.26 
(P) TNF-" 0.17  (0.11-0.26)  0.06 (0.01-0.10) 0.01 0.13  (0.09-0.24) 0.09 (0.04-0.29) 0.46 
(P) IL-1# 0.48  (0.25-0.80) 0.20 (0.02-0.54) 0.11 1.03  (0.44-1.27)  0.79 (0.72-1.39) 0.96 
(P) MCP1 0.50  (0.32-0.79) 0.49 (0.38-0.55) 0.54 0.79  (0.44-1.01) 2.02 (1.03-3.08) 0.01 
(A) MIG 20.17  (1.67-48.14) 28.74 (13.08-35.86) 0.54 33.03  (18.67-53.58) 28.47 (14.26-60.00) 0.85 
(P) MIP1" 0.21  (0.00-0.27)  0.33 (0.22-0.81) 0.001 0.22  (0.08-0.40)  0.54 (0.26-0.79) 0.001 
(P) VEGF 2.50  (1.31-3.99)  3.08 (2.46-3.46) 0.29 2.95 (2.29-6.16)  2.71 (1.57-3.37) 0.20 
 
Table 5.5 Effect of strain on cytokine level (pg/mg protein) in the distal small intestine tissue of according to the diet treatment. (A) Anti-inflammatory cytokine; (P) pro-
inflammatory cytokine.  Values are presented as median and 95% confidence interval. *Significant p-Value (p<0.05) was identified by Kruskal-Wallis test. Values having 
different superscript are significantly different by post-hoc Mann-Whitney test p<0.05. 
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5.1.3.2. Colon – large intestine tissue 
 
There were no effects of diet on the cytokine levels in the large intestinal tissue (Table 
5.6). In addition, there were also no significant effects of diet when compared within strain 
(Table 5.7). The only significant effect observed in the colon is shown in the Table 5.8, in 
which the level of MCP-1 was 30% higher in ApcMin/+ fed phytochemicals when 
compared to the ApcMin/+ animals from the control diet (p=0.04). A trend of having a 
higher level of GMC-SF was also observed for the ApcMin/+ mice fed with 
phytochemicals (p=0.07).   
 
 
Cytokines 
Palm oil (n=16) 
Median (95% CI) 
pg/mg protein 
Phytochemical (n=18) 
Median (95% CI) 
pg/mg protein 
 
p-value 
(P) GMC-SF 0.02 (0.01-0.09) 0.07 (0.01-0.12) 0.17 
(P) IL-1# 0.02 (0.01-0.10) 0.03 (0.01-0.14) 0.21 
(P) IL-6 1.00 (0.17-6.13) 1.00 (0.61-5.77) 0.94 
(P) TNF-" 0.01 (0.00-0.98) 0.01 (0.00-0.13) 0.39 
(P) MCP-1 0.55 (0.43-0.62) 0.62 (0.50-0.90) 0.10 
 
Table 5.6 Comparison of the control palm oil diet (n=16) with a phytochemical enriched diet (n=18) on 
cytokines levels (pg/mg protein) in the colon in mice after a 10-week treatment. (P) Pro-inflammatory 
cytokine. Values are presented as median and 95% confidence interval. Male ApcMin/+ and wild-type mice 
combined. *P-value of Kruskal-Wallis test.   
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Cytokines 
Palm oil 
p-value 
Phytochemicals  
 
 
p-value 
Wild-type (n=8) 
Median (95% CI) 
pg/mg protein 
ApcMin/+ (n=8) 
Median (95% CI) 
pg/mg protein 
Wild-type(n=9) 
Median (95% CI) 
pg/mg protein 
ApcMin/+ (n=9) 
Median (95% CI) 
pg/mg protein 
(P) GMC-SF 0.02 (0.01-0.10) 0.02 (0.01-0.18) 0.75 0.05 (0.01-0.12) 0.08 (0.06-0.14) 0.12 
(P) IL-1# 0.02 (0.01-0.27) 0.02 (0.01-0.20) 0.75 0.01 (0.01-0.08) 0.07 (0.01-0.29) 0.15 
(P) IL-6 1.00 (0.03-8.63) 1.00 (0.09-11.46) 0.24 1.00 (0.79-5.77) 3.23 (0.21-11.36) 0.96 
(P) TNF-" 0.01 (0.00-7.95) 0.01 (0.00-1.18) 0.60 0.01 (0.00-0.10) 0.02 (0.00-1.53) 0.69 
(P) MCP-1 0.55 (0.29-1.17) 0.55 (0.39-0.60) 0.60 0.60 (0.35-0.78) 0.72 (0.50-1.18) 0.23 
 
Table 5.7 Effect of diet on cytokine level (pg/mg protein) in the colon tissue of the large intestine according to mouse strain. (P) Pro-inflammatory cytokine. Values are presented 
as median and 95% confidence interval (CI). Significant p-value (p<0.05) was identified by Kruskal-Wallis test.   
 
 
Cytokines 
Wild-type ApcMin/+ 
Palm oil (n=8) 
Median (95% 
CI) 
pg/mg protein 
Phytochemical (n=9) 
Median (95% CI) 
pg/mg protein p-value 
Palm oil (n=8) 
Median (95% CI) 
pg/mg protein 
Phytochemical (n=9) 
Median (95% CI) 
pg/mg protein p-value 
(P) GMC-SF 0.02 (0.01-0.10) 0.05 (0.01-0.12) 0.77 0.02 (0.01-0.18) 0.08 (0.06-0.14) 0.07 
(P) IL-1# 0.02 (0.01-0.27) 0.01 (0.01-0.08) 0.92 0.02 (0.01-0.20) 0.07 (0.01-0.29) 0.10 
(P) IL-6 1.00 (0.03-8.63) 1.00 (0.79-5.77) 0.63 1.00 (0.09-11.46) 3.23 (0.21-11.36) 0.85 
(P) TNF-" 0.01 (0.00-7.95) 0.01 (0.00-0.10) 0.92 0.01 (0.00-1.18) 0.02 (0.00-1.53) 0.21 
(P) MCP-1 0.55 (0.29-1.17) 0.60 (0.35-0.78) 0.85 0.55 (0.39-0.60) 0.72 (0.50-1.18) 0.04 
 
Table 5.8 Effect of strain on cytokine level (pg/mg protein) in the colon tissue of the large intestine according to the diet treatment. (P) Pro-inflammatory cytokine. Values are 
presented as median and 95% confidence interval. Significant p-Value (p<0.05) was identified by Kruskal-Wallis test. 
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5.1.3.3. Plasma 
 
Animals fed with phytochemicals had significantly lower levels of IL-6 and IL-2 compared 
to the control (Table 5.9). The ApcMin/+ fed palm oil had significantly lower (30%) level 
of IL-1" compared to the wild-type mice fed the same diet (p=0.02). However, the 
ApcMin/+ mice fed phytochemicals had a 3 times higher level of IL-6 than the wild-type 
(p=0.02), Table 5.10. Wild-type animals fed the phytochemical diet had significantly lower 
levels of IL-1" and IL-6 when compared to ApcMin/+ fed the palm oil diet, whereas 
ApcMin/+ mice fed the phytochemical diet has significantly higher level of the growth 
factor VEGF compared to the palm oil group. 
 
 
Cytokines 
 
Palm oil (n=29) 
Median (95% CI) 
pg/ml 
Phytochemicals (n=8) 
Median (95% CI) 
pg/ml 
 
 
p-value 
(A) IFN-! 3.20 (3.07-3.20) 3.20 (3.20-3.20) 0.97 
(P) IL-1" 45.96 (3.20-97.19) 3.20 (3.20-33.03) 0.60 
(P) IL-2 3.20 (3.20-15.85) 3.20 (3.20-20.77) 0.02 
(A) IL-4 3.20 (1.79-3.20) 3.20 (1.19-3.20) 1.00 
(P) IL-5 8.99 (4.58-13.24) 8.85 (5.72-16.23) 0.19 
(P) IL-6 9.89 (3.20-30.00) 3.20 (3.20-7.68) 0.04 
(A) IL-10 3.20 (3.20-10.73) 3.36 (3.20-15.00) 0.09 
(P) IL-12p40 58.74 (3.75-116.16) 65.96 (16.33-97.57) 0.47 
(P) IL-12p70 3.20 (3.20-478.92) 3.20 (3.20-529.82) 0.88 
(P) IL-15 57.81 (3.20-211.73) 25.42 (3.20-260.45) 0.13 
(P) IL-17 3.20 (3.20-53.09) 3.20 (3.20-54.16) 0.17 
(A) IP-10 200.30 (169.59-268.32) 243.27 (178.34-288.01) 0.45 
(P) KC 77.99 (3.20-127.49) 42.13 (3.20-77.18) 0.29 
(P) GMC-SF 3.20 (3.20-41.24) 3.20 (3.20-45.85) 0.29 
(P) TNF-" 3.20 (1.37-3.20) 3.20 (0.91-3.20) 0.71 
(P) IL-1# 3.20 (3.20-17.68) 10.61 (3.27-25.40) 0.09 
(P) MCP1 14.27 (5.22-41.78) 31.96 (27.92-42.90) 0.30 
(A) MIG 144.09 (120.62-311.93) 201.56 (167.16-274.27) 0.48 
(P) MIP1" 3.20 (3.20-24.42) 3.20 (3.20-16.29) 0.75 
(P) VEGF 3.20 (0.65-3.20) 3.20 (2.82-3.20) 0.06 
 
Table 5.9 Effect of phytochemicals on cytokines levels (pg/ml) in the plasma of mice after 10-week 
treatment. (A) Anti-inflammatory cytokine; (P) pro-inflammatory cytokine. Values are presented as median 
and 95% confidence interval. Male ApcMin/+ and wild-type mice combined.  Palm oil n=29 and 
phytochemicals n=28. *P-value of Kruskal-Wallis test significant at p<0.05. 
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Cytokines 
 
Palm oil  Phytochemical  
Wild-type (n=13) 
Median (95% CI) 
pg/ml 
ApcMin/+ (n=16) 
Median (95% CI) 
pg/ml p-value 
Wild-type (n=16) 
Median (95% CI) 
pg/ml 
ApcMin/+ (n=12) 
Median (95% CI) 
pg/ml 
 
 
p-value 
(A) IFN-! 3.20 (2.25-3.20) 3.20 (1.58-3.42) 0.82 3.20 (3.20-3.20) 3.20 (3.20-3.20) 0.92 
(P) IL-1" 50.64 (3.20-408.51) 35.49 (3.20-85.90) 0.02 3.20 (3.20-28.98) 18.11 (3.20-100.71) 0.36 
(P) IL-2 3.20 (3.20-21.21) 3.20 (1.79-15.85) 0.33 3.20 (3.20-22.25) 3.20 (3.20-24.06) 0.89 
(A) IL-4 3.20 (1.09-3.20) 3.20 (1.16-3.20) 0.27 3.20 (1.19-3.20) 3.20 (0.55-3.20) 0.39 
(P) IL-5 9.87 (5.48-15.64) 5.25 (3.42-15.26) 0.51 12.51 (3.20-17.26) 6.71 (4.42-22.45) 0.61 
(P) IL-6 28.64 (3.20-62.01) 7.10 (3.20-18.79) 0.29 3.20 (3.20-3.23) 8.42 (3.20-42.36) 0.02 
(A) IL-10 3.20 (3.20-12.99) 3.20 (3.20-12.20) 0.69 3.20 (3.20-30.17) 8.21 (3.20-21.64) 0.57 
(P) IL-12p40 58.74 (3.20-215.81) 66.74 (3.20-116.75) 0.44 70.02 (12.07-132.12) 65.22 (16.33-92.52) 0.44 
(P) IL-12p70 18.13 (3.20-534.56) 3.20 (3.20-494.83) 0.82 3.20 (3.20-555.38) 9.02 (3.20-530.53) 0.78 
(P) IL-15 64.75 (3.20-318.12) 41.31 (3.20-316.07) 0.56 11.65 (3.20-343.56) 119.78 (3.20-264.02) 0.74 
(P) IL-17 3.20 (1.08-53.37) 3.20 (3.20-53.48) 0.65 3.20 (3.20-54.48) 3.20 (0.78-54.51) 0.85 
(A) IP-10 200.83 (167.65-321.32) 192.41 (163.47-268.32) 0.33 262.39 (185.14-360.58) 195.15 (47.49-275.42) 0.09 
(P) KC 77.99 (3.20-143.42) 72.44 (3.20-155.49) 0.98 45.54 (3.20-113.79) 36.80 (3.20-100.30) 0.92 
(P) GMC-SF 3.20 (3.20-49.51) 3.20 (3.20-67.85) 0.89 3.20 (3.20-62.42) 3.20 (3.20-68.92) 0.91 
(P) TNF-" 3.20 (1.37-3.20) 3.20 (0.75-3.20) 0.69 3.20 (0.79-3.20) 3.20 (0.79-3.20) 0.94 
(P) IL-1# 4.27 (3.20-35.22) 3.20 (2.94-19.53) 0.22 15.76 (3.11-30.07) 4.94 (3.20-25.31) 0.11 
(P) MCP1 31.05 (3.20-49.19) 12.77 (3.20-41.78) 0.09 29.83 (9.67-51.98) 34.17 (6.99-42.90) 0.26 
(A) MIG 127.20 (105.75-688.79) 149.97 (110.56-360.71) 0.16 209.38 (185.04-319.62) 153.98 (100.00-267.75) 0.21 
(P) MIP1" 3.20 (3.20-28.11) 6.17 (3.20-35.67) 0.82 3.20 (3.20-22.02) 8.35 (3.20-23.18) 1.00 
(P) VEGF 3.20 (0.26-3.20) 3.20 (0.44-3.20) 0.91 3.20 (0.57-3.20) 3.20 (0.39-4.96) 0.11 
 
Table 5.10 Effect of dietary palm oil, or phytochemicals on cytokine level in the plasma of wild-type and ApcMin/+ mice. (A) Anti-inflammatory cytokine; (P) pro-inflammatory 
cytokine. Values are presented as median (pg/ml) and 95% confidence interval (CI). Significant p-value (p<0.05) was identified by Mann-Whitney test.   
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Cytokines 
 
Wild-type  ApcMin/+  
Palm oil (n=13) 
Median (95% CI) 
pg/ml 
Phytochemical (n=16) 
Median (95% CI) 
pg/ml p-value 
Palm oil (n=16) 
Median (95% CI) 
pg/ml 
Phytochemical (n=12) 
Median (95% CI) 
pg/ml p-value 
(A) IFN-! 3.20 (2.25-3.20) 3.20 (3.20-3.20) 0.87 3.20 (1.58-3.42) 3.20 (3.20-3.20) 0.90 
(P) IL-1" 50.64 (3.20-408.51) 3.20 (3.20-28.98) 0.02 35.49 (3.20-85.90) 18.11 (3.20-100.71) 0.24 
(P) IL-2 3.20 (3.20-21.21) 3.20 (3.20-22.25) 0.24 3.20 (1.79-15.85) 3.20 (3.20-24.06) 0.07 
(A) IL-4 3.20 (1.09-3.20) 3.20 (1.19-3.20) 0.85 3.20 (1.16-3.20) 3.20 (0.55-3.20) 0.83 
(P) IL-5 9.87 (5.48-15.64) 12.51 (3.20-17.26) 0.79 5.25 (3.42-15.26) 6.71 (4.42-22.45) 0.13 
(P) IL-6 28.64 (3.20-62.01) 3.20 (3.20-3.23) 0.001 7.10 (3.20-18.79) 8.42 (3.20-42.36) 0.64 
(A) IL-10 3.20 (3.20-12.99) 3.20 (3.20-30.17) 0.45 3.20 (3.20-12.20) 8.21 (3.20-21.64) 0.09 
(P) IL-12p40 58.74 (3.20-215.81) 70.02 (12.07-132.12) 0.58 66.74 (3.20-116.75) 65.22 (16.33-92.52) 0.56 
(P) IL-12p70 18.13 (3.20-534.56) 3.20 (3.20-555.38) 0.91 3.20 (3.20-494.83) 9.02 (3.20-530.53) 0.96 
(P) IL-15 64.75 (3.20-318.12) 11.65 (3.20-343.56) 0.39 41.31 (3.20-316.07) 119.78 (3.20-264.02) 0.22 
(P) IL-17 3.20 (1.08-53.37) 3.20 (3.20-54.48) 0.21 3.20 (3.20-53.48) 3.20 (0.78-54.51) 0.42 
(A) IP-10 200.83 (167.65-321.32) 262.39 (185.14-360.58) 0.33 192.41 (163.47-268.32) 195.15 (47.49-275.42) 0.58 
(P) KC 77.99 (3.20-143.42) 45.54 (3.20-113.79) 0.37 72.44 (3.20-155.49) 36.80 (3.20-100.30) 0.62 
(P) GMC-SF 3.20 (3.20-49.51) 3.20 (3.20-62.42) 0.37 3.20 (3.20-67.85) 3.20 (3.20-68.92) 0.51 
(P) TNF-" 3.20 (1.37-3.20) 3.20 (0.79-3.20) 0.91 3.20 (0.75-3.20) 3.20 (0.79-3.20) 0.60 
(P) IL-1# 4.27 (3.20-35.22) 15.76 (3.11-30.07) 0.25 3.20 (2.94-19.53) 4.94 (3.20-25.31) 0.32 
(P) MCP1 31.05 (3.20-49.19) 29.83 (9.67-51.98) 0.77 12.77 (3.20-41.78) 34.17 (6.99-42.90) 0.39 
(A) MIG 127.20 (105.75-688.79) 209.38 (185.04-319.62) 0.66 149.97 (110.56-360.71) 153.98 (100.00-267.75) 0.58 
(P) MIP1" 3.20 (3.20-28.11) 3.20 (3.20-22.02) 0.89 6.17 (3.20-35.67) 8.35 (3.20-23.18) 0.78 
(P) VEGF 3.20 (0.26-3.20) 3.20 (0.57-3.20) 0.49 3.20 (0.44-3.20) 3.20 (0.39-4.96) 0.03 
 
Table 5.11 Effect of genotype on cytokine level in the plasma of wild-type and ApcMin/+ mice. (A) Anti-inflammatory cytokine; (P) pro-inflammatory cytokine.Values are 
presented as median (pg/ml) and 95% confidence interval (CI). Significant p-value (p<0.05) was identified by Mann-Whitney test
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5.1.4. Effects on tumour development 
 
5.1.4.1. Effect of diet on tumour size 
 
In figure 5.4 it shows that mice fed with phytochemical diet (1.93 ± 0.90 mm2) had 
significantly larger tumours across the whole small intestine compared to the palm oil diet 
(1.54 ± 0.81 mm2), p<0.0001.  
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Figure 5.4 Effect of treatment diet on mean size of tumour (mm2) in the small intestine (SI) of the ApcMin/+ 
mice fed for 10 weeks. (n=16 mice/diet). Values having different superscript indicate statistically significant 
difference between groups by ANOVA at p<0.05. 
 
 
5.1.4.2. Effect of intestinal position on tumour size 
 
Figure 5.5 summarizes the effect of intestinal position on tumour size, which varied 
significantly. Larger tumours developed in the proximal (2.43 ± 1.10 mm2) small intestine 
compared to tumours sized in the middle(1.37 ± 0.61 mm2)  or distal (1.61 ± 0.71 mm2), 
(p<0.0001, p<0.002 respectively).  
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Figure 5.5 Mean tumour size (mm2 ± stdev) according to the intestinal position in the small intestine of 
ApcMin/+ mice (n=32). Values having different superscript indicate statistically significant difference 
between the intestinal positions by ANOVA at p<0.05. 
 
 
There was no significant effect of phytochemicals on tumour size in the proximal (PHY= 
2.76 ± 1.20 mm2 vs. PO= 2.10 ± 0.90 mm2) and in the middle intestine (PHY= 1.58 ± 0.69 
mm2 vs. PO= 1.20 ± 0.40 mm2) (Figure 5.6 and Figure 5.7). In the distal position of the 
small intestine (Figure 5.8) the phytochemical group (2.03 ± 0.54 mm2) had significant 
larger tumours compared to control palm oil (1.20 ± 0.60 mm2).  
 
a 
b
b 
 165
0
0,5
1
1,5
2
2,5
3
3,5
4
4,5
PO PHY
Diet
M
ea
n 
si
ze
 o
f t
um
ou
r i
n 
th
e 
pr
ox
im
a 
(m
m
2)
 
Figure 5.6 Effect of treatment diet on mean size of tumour (mm2 ± stdev) in the proximal part the small 
intestine of the ApcMin/+ mice (n=16 mice/diet). PO=palm oil; PHY=phytochemical. No statistically 
significant difference were found between the treatment groups by ANOVA at p<0.05.   
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Figure 5.7 Effect of treatment diet on mean size of tumour (mm2 ± stdev) in the middle part the small 
intestine of the ApcMin/+ mice (n=16 mice/diet). PO=palm oil; PHY=phytochemical. No statistically 
significant difference were found between the treatment groups by ANOVA at p<0.05.   
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Figure 5.8 Effect of treatment diet on mean size of tumour (mm2 ± stdev) in the distal part the small 
intestine of the ApcMin/+ mice (n=16 mice/diet). PO=palm oil; PHY=phytochemical. Values having 
different superscript indicate statistically significant difference between the treatment groups by ANOVA at 
p<0.05.   
 
 
5.1.4.3. Effect of diet on total tumour area 
 
Figure 5.9 summarises the total tumour area (mm2) across all the small intestine and the 
effect of the treatment diet. Total tumour size was significantly increased in animals fed 
with the phytochemical diet (2559.7 mm2) compared to the control diet (1355 mm2), 
p=0.003.   
*
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Figure 5.9 Effect of treatment diet on total tumour area (mm2) in the across all the small intestine of the 
ApcMin/+ mice (n=16 mice/diet). PO=palm oil; PHY=phytochemical. Values having different superscript 
indicate statistically significant difference between the treatment groups by ANOVA at p<0.05.   
 
 
5.1.4.4. Effect of diet on total tumour number 
 
There was no significant difference on total tumour number in the small intestine of mice 
fed the phytochemical diet (1321 tumours) compared to the palm oil control (1044 
tumours). However, when the number of tumours was compared separately in each region 
of the small intestine (proximal, middle, distal) by different sizes (<1mm2; 1-5mm2; 
>5mm2), many significant differences were observed (Table 5.12). In the proximal 
position animals fed the phytochemical diet had significantly fewer medium size tumours 
compared to palm oil (53 vs. 104 tumours, p=0.0001). However, in the middle position 
animals fed the phytochemical diet increased the number of large tumours by 300% 
compared to control (16 vs. 4 tumours, p=0.007). Moreover, in the distal position, animals 
fed the phytochemical diet had significantly increased numbers of tumours of all sizes 
*
 168
compared to control, (small: 275 vs. 207 tumours, p=0.002; medium: 404 vs. 212 tumours, 
p=0.0001; distal: 57 vs. 8 tumours, p=0.0001). 
 
 
 
Tumour region 
and size 
Palm oil Phytochemicals p-value 
Proximal 
< 1 mm2 
1-5 mm2 
> 5 mm2 
 
108 
104  
27  
 
89 
53 
30 
 
0.176 
0.0001 
0.691 
Middle 
< 1 mm2 
1-5 mm2 
> 5 mm2 
 
204  
170  
4 
 
214 
184 
16 
 
0.625 
0.457 
0.007 
Distal 
< 1 mm2 
1-5 mm2 
> 5 mm2 
 
207 
212 
8 
 
275 
404 
57 
 
0.002 
0.0001 
0.0001 
 
Table 5.12 Incidence of tumours in the small intestine of ApcMin/+ mice fed with palm oil and 
phytochemicals for 10 weeks.  Values are presented as numbers of tumours. Male and female ApcMin/+ 
mice combined (n=16 animals/diet). Values are significantly different by General Linear Model p<0.05. 
 
 
5.1.4.5. Effect of diet on tumour area and tumour number in the colon  
 
No significant difference was seen in the colon for tumour area, although the 
phytochemical group had a larger mean tumour area compared to the animals fed palm oil, 
(3.68 ± 2.98 mm2 vs. 0.84 ± 0.52 mm2). However, when tumour number was categorized 
by size (<1mm2; 1-5mm2; >5mm2), significant differences were seen (Table 5.13). 
Animals fed the phytochemicals had increased numbers of tumours of all sizes compared 
to control animals (small: 28 vs. 9 tumours, p=0.002; medium: 9 vs. 2 tumours, p=0.035; 
large: 9 vs. 0 tumours, p=0.012). 
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Colon  
Tumour region and size 
Palm oil Phytochemicals p-value 
< 1 mm2 
1-5 mm2 
> 5 mm2 
9 
2  
0 
28 
9 
9 
0.002 
0.035 
0.012 
 
Table 5.13 Incidence of tumours in the colon of ApcMin/+ mice fed with palm oil and phytochemicals for 10 
weeks.  Values are presented as numbers of tumours. Male and female ApcMin/+ mice combined (n=16 
animals/diet). Values are significantly different by General Linear Model p<0.05. 
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5.2. DISCUSSION  
 
5.2.1. General effects of the phytochemical mix 
 
5.2.1.1. Body and organs weight 
 
As expected, female mice were smaller compared to males. In relation to the organs 
weight, liver, heart, and spleen showed no difference between sex, however when 
compared between strains, ApcMin/+ mice had larger organs, and lower final body weight. 
Animals fed the phytochemical diet did not show difference in the final body weight. 
However they had larger organs (stomach, caecum, liver, and heart). 
 
5.2.1.2. Mitosis, apoptosis, and crypt length 
 
ApcMin/+ mice fed the phytochemical diet had increased the number of mitoses in the 
small intestine in ApcMin/+ mice compared to the wild-type fed the same diet, but not 
compared to ApcMin/+ mice fed the control diet. The same was observed in the control 
group, ApcMin/+ mice fed palm oil had higher number of mitosis compared to wild-type 
animals fed the same diet. In the colon tissue, animals fed the phytochemical had no effect 
regarding the number of mitoses. However, within the control group, the ApcMin/+ mice 
had higher numbers of mitoses compared to wild-type animals. 
 
On the other hand, ApcMin/+ mice fed the phytochemical diet had increased number of 
apoptosis in the small intestine by 4-fold increased compared to the wild-type animals fed 
the same diet. However, no difference was observed between strains in the control group. 
Animals fed the phytochemical did not change in the number of apoptosis in the colon. In 
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resume, the ApcMin/+ mice fed the phytochemical diet did not show a positive effect on 
reducing the proliferation of intestinal cells or increasing the cell death in the intestine 
tissues in the present experiment. All the significant changes were observed only when the 
strains were being fed the same diet. 
 
5.2.1.3. Inflammation 
 
Small intestine 
Distal tissue from animals (wild-type and ApcMin/+ combined) fed the palm oil and the 
phytochemical treatment diet were analyzed for 20 cytokines. Significant changes were 
observed in ten of the cytokines, which were mostly increased in the phytochemical group. 
IFN-!, IL-1", IL-2, IL-12p40, IP-10, IL-1#, and MIP-1" were all increased by the 
phytochemical diet while IL-5, IL-10, and TNF-" were reduced. When the cytokine profile 
was analyzed by strain the following was observed. ApcMin/+ mice fed the palm oil diet 
had KC, the mouse equivalent to IL8, and IL-1# increased, and IL-5 decreased compared 
to the wild-type. ApcMin/+ mice fed the phytochemical diet had KC, IL-1#, MCP-1, IL-6 
and IL-1" increased, whereas IFN-! and IL-2 were decreased. These results clearly show 
that the phytochemical diet has increased the inflammation in ApcMin/+ mice, which 
contradicts the hypothesis that phytochemicals can act as anti-inflammatory agents.  
 
Colon 
In the colon tissue the only significant change in the cytokine level was in the ApcMin/+ 
mice fed the phytochemical diet, which had the level of MCP-1 increased compared to the 
ApcMin/+ mice fed the control diet. In the ApcMin/+ mice the tumour development occurs 
mainly in the small intestine, as a result changes in the cytokine profile in the colon tissue 
might be less affected, when compared to the small intestine.  
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Plasma 
Minimal changes were observed in the plasma in response to the phytochemical diet. When 
both strains were combined, animals fed the phytochemical diet increased levels of IL-2 
and reduced levels of IL-6. When the strains were observed separately, the phytochemical 
diet only increased level of VEGF in the ApcMin/+ animals, while in the wild-type 
animals, the phytochemical diet decreased IL-1" and IL-6.  
 
5.2.1.4. Tumour development 
 
Phytochemicals have been associated with a decrease in colorectal cancer in several cell 
culture and animal cancer models by inhibiting carcinogenesis at different stages. 
However, in the present study the results seem to be contradictory when compared to 
several other studies. The phytochemical diet containing coffee, cocoa, turmeric, thyme, 
walnuts and berries, fed for 10 weeks did not inhibit carcinogenesis in ApcMin/+ mice. 
Furthermore, phytochemicals have increased the size of tumour throughout the small 
intestine. It was also observed that the phytochemical diet had a different effect on tumour 
size according to the position of tumours in the small intestine. For example, in the distal 
part of the small intestine the tumour size was larger in ApcMin/+ mice fed the 
phytochemical diet when compared to control. Moreover, when all the tumour size was 
summarized, animals fed the phytochemical diet also showed increased value.  
 
In respect to the total number of tumours in the small intestine, a 26% increase was 
observed in the group fed the phytochemical diet compared to the control diet, but it was 
not significant. However, when the region of the intestine was taken into consideration a 
tremendous increase was observed in the number of tumours in the distal part of animals 
fed the phytochemical diet by 72% compared to the control. The ApcMin/+ mouse is 
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regarded as a model of colorectal cancer. However it does not develop a significant 
carcinogenic process in the colon. Besides, phytochemical also increased the number of 
tumours in the colon tissue of animals by 4.1-fold compared to the control diet. 
 
5.2.2. Discussion of the effects by each  phytochemical 
 
The phytochemical diet was enriched with a mix of dietary foods such as coffee, cocoa, 
turmeric, thyme, walnuts, bilberries, and blackcurrant, rich in different phytochemicals. 
Because of that, it is difficult to attribute a specific effect to a particular food ingredient. 
However, when the animals consumed a mix of dietary foods within the diet, it mimics the 
manner of a real human consumption of phytochemicals. 
 
5.2.2.1. Coffee 
 
Coffee (Coffea robusta) is one of the major commodities worldwide, and also one of the 
most commonly consumed beverages. The main constituents of coffee include caffeine, 
diterpenes, phenolic acids, and melaniods and acrylamide produced during roasting of 
coffee beans.  
 
A meta-analysis of colorectal cancer and coffee consumption was completed and published 
in 2004 (Tavani and La Vecchia 2004). That work compiled 3 cohort and 15 case-control 
studies, together were experiences from over 8,713 cases among 147,227 subjects. The 3 
cohort studies showed no association, however in the case-control studies there was a 
potentially protective effect of coffee and colorectal cancer. Two other recent cohort 
studies from Japan have found 60% reductions in risk of colorectal cancer with coffee 
consumption among women only (Oba, Shimizu et al. 2006; Lee, Inoue et al. 2007). Due 
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to the heterogeneity of effect and the lack of dose-response effect, there is very weak 
evidence of a preventive effect (Arab 2010). 
 
Effect of coffee on mitosis and apoptosis 
 
Grubben et al. (Grubben, Van Den et al. 2000) have  performed a randomized trial in 
healthy subjects to study the effect of drinking coffee on cell proliferation as a biomarker 
of colorectal cancer.  They found that the consumption of 1 L of unfiltered coffee per day 
did not affect the colorectal cell proliferation. On the other hand, Wang et al. (Wang, 
Dashwood et al. 2008) performed a study using rats treated with 3 cycles of 2-amino-1-
methyl-6-phenylimidazol pyridine carcinogen to evaluate the effect of caffeine on 
tumorigenesis. They found that caffeine altered colonic crypt homeostasis by not only 
enhancing cell proliferation, but by inhibiting apoptosis. Both studies contradict the 
epidemiological evidence that coffee may be protective against colorectal cancer by 
inhibiting cell proliferation. However, they are consistent with the current study. 
 
There is limited literature available regarding the effect of coffee on apoptosis in cell lines 
or animal models of colorectal cancer. However, Oh et al. (Um, Oh et al. 2010) performed 
a study to evaluate the effect of kahweol (coffee-specific diterpene) on apoptosis in human 
renal carcinoma Caki cell line. They found that cell treating cells with kahweol had no 
effect on enhancing apoptosis, however when kahweol was combined with tumour necrosis 
factor-related apoptosis-inducing ligand, which is a potent anti-cancer drug, apoptosis was 
significantly increased.   
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Effect of coffee on inflammation 
 
Kempf et al. (Kempf, Herder et al. 2010) studied the effect of drinking coffee on human 
serum inflammatory markers. They found that the consumption of 8 cups of coffee/day 
decreased the levels of IL-18, but had no effect on IL-6 and C-reactive protein. However, 
there are a few studies that have shown contradictory results (Zampelas, Panagiotakos et 
al. 2004). The effect of kahweol, which is present in coffee beans, was studied by Kim et 
al. (Kim, Kim et al. 2006) to confirm the anti-inflammatory effects of kahweol by 
examining its effect on the inflammatory response induced in a rat using an acute air pouch 
inflammation model. They found that kahweol significantly reduced the levels of the 
inflammatory process as well as the levels of TNF-" and prostaglandin E2 (Kim, Kim et al. 
2006). 
 
Only a few papers can be found on coffee and its effect on cytokines prolife in animal 
models of colorectal cancer, however, it had been shown that coffee does affect key 
molecules such as NF-kB, which is directly related to the production of cytokines.  NF-kB 
is a transcription factor that plays a critical role in inflammatory responses, and its aberrant 
regulation had been noted in several human cancers and inflammatory bowel disease 
(Karin 2006; Karin 2008). Paur et al. (Paur, Balstad et al. 2010) have studied the effect of 
coffee on the activity of NF-kB in vitro (U937-3xkB-LUC cells) stimulated with LPS, 
treated with 30mg/mL of coffee) and in vivo (mice injected D-luciferin with PBS, treated 
with a single dose extract of 600mg coffee). They found coffee inhibited NF-kB activity by 
more than 80% in vitro, and by 63% in mice. 
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Effects of coffee on tumour development 
 
Park et al. (Park, Davis et al. 2010) have studied the effect of coffee compounds in the 
tumour development in the colon of AOM-induced mice. They fed the animals for 20 
weeks a 0.01% of chlorogenic acid, which is equivalent to ~0.5 servings of coffee 
consumed/day in humans, or 0.1% of chlorogenic acid, which is equivalent to ~5 servings. 
They found no effect of coffee on tumour number, but found an increase  in total number 
of ACF in animals fed the 0.01% chlorogenic acid compared to control. 
 
The effects of coffee have also been studied in the ApcMin/+ mouse model. Oikarinen et 
al. (Oikarinen, Erlund et al. 2007) fed the ApcMin/+ mice with filtered (low levels of 
kahweol/cafestol) and unfiltered coffee (high levels of kahweol/cafestol) for 9 weeks. That 
study was similar to the present study in that they also used a high-fat diet (40%), and 
because the coffee was served as a dietary ingredient and not as a drink. However, 
comparing the amount of coffee ingested per mice/day was very different between their 
and the present experiment. Their animal consumption was 2.4g/day, in which 0.24g was 
coffee, whereas in the present experiment animals were fed the equivalent of 0.09g of 
coffee per day. This means that in their experiment, the ApcMin/+ mice received 2.5 times 
more coffee than the animals in the present study.  However, they found no effects on total 
tumour number or size in the small intestine and in the colon of ApcMin/+ mice compared 
to control. Hong et al. (Ju, Hong et al. 2005) have also treated ApcMin/+ mice with an 
administration of caffeine at a dose of 0.044% in drinking fluid and they also found no 
effect on tumour formation. 
 
Mutations in the APC gene lead to the accumulation of hypo-phosphorylated #-catenin 
protein in the cytosol and later in the nucleus, which contributes to the activation of cyclin 
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D1 gene and is related to the progression of cancer (Korinek, Barker et al. 1997). 
Oikarinen et al. (Oikarinen, Erlund et al. 2007) tested if coffee could interfere in the levels 
of #-catenin and cyclin D1 in ApcMin/+ mice. Therefore, they concluded that coffee 
consumption does not affect cancer progression in the adenoma tissue in animals, as the 
level of #-ccatenin and cyclin D1 did not change with coffee, as well as the number of 
tumours which were not different from control diet. 
 
5.2.2.2. Walnuts 
 
Walnuts (Juglans regia) are rich source of both n-3 and n-6 polyunsaturated fatty acids 
with known anti-inflammatory properties, but also rich in phenolic acids.  Epidemiological 
studies have shown a positive association between regular consumption of nuts and the 
prevention of some types of cancer.  
 
Effects of walnuts on mitosis and apoptosis 
 
Carvalho et al. (Carvalho, Ferreira et al. 2010) have studied the anti-proliferative activities 
from walnuts (seed, green husk, and leaf) in colon cancer Caco-2 cell line. They found an 
inhibition of cell proliferation between 23-78% by the walnuts extracts. The level of cell 
growth inhibition observed with leaf extracts ranged from 13% to 78%, followed by 15-
41% with green husk extracts, and 0-23% with seed extracts. In the present study, the 
phytochemical mix used in the experiment contained 31g of walnuts/ kg of diet, and so 
animals may have ingested on average 0.09g of walnuts/ day.   
 
Yang et al. (Yang, Liu et al. 2009) have also studied the effect of different nuts on cell 
proliferation of Caco-2 cell line. They found that walnuts had the highest phenolics content 
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and was among the nuts that had the highest anti-proliferative effect on the Caco-2 
colorectal cancer cell line, and that effect was seen to be dose-dependent.  
 
Hardman and Ion. (Hardman and Ion 2008) performed a study by implanting MDA-MB 
231 human breast cancers into nude mice, which were fed an 18% (calorie) walnut diet for 
35 days. The quantity of the walnut in the animal diet was used to mimic two servings of 
walnuts per day in humans. In contrast to the present study they found significantly 
decreased cell proliferation in mice that consumed walnuts, however, no effect was found 
in number of apoptotic cells/crypt.  
 
Effects of walnuts on inflammation 
 
Not much is found in the literature about the effects of walnuts on inflammation in animal 
model of colorectal cancer. However, it has been reported in the literature that walnuts can 
reduce inflammation related to other chronic diseases such as cardiovascular (Cortés, 
Núñez et al. 2006). However, recent studies have demonstrated that walnuts inhibit NF-kB 
in vitro and in vivo (Paur, Austenaa et al. 2008; Paur, Balstad et al. 2010). NF-kB has 
recently been demonstrated as a pivotal factor connecting inflammation and cancer 
(Greten, Eckmann et al. 2004).    
 
Effects of walnuts on tumour development 
 
Hardman and Ion. (Hardman and Ion 2008) found a positive effect of walnuts in their in 
vivo study. Nude mice implanted with MDA-MB 231 human breast cancers had a 
decreased tumour growth rate after 10 days of intervention with 18% of the dietary calories 
from walnuts (11.3g of walnuts). Considering a mouse average intake of 2.8 g/day, that 
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would be equal to a consumption of 0.03g of walnuts/day. In the present experiment, the 
ApcMin/+ mice ingested the equivalent to 0.09g of walnuts/day. However, tumour number 
and tumour area were not reduced in the group treated with phytochemicals. That positive 
effect on preventing tumour development attributed in Hardman and Ion’s study, may be a 
result the alpha linolenic acid (ALA, C18:3), an n-3 fatty acids, present in walnuts. 
However, many of the mechanisms proposed for suppression of cancer growth by omega 3 
fatty acids required the presence of long chain (20 or 22C) omega 3 fatty acids (Hardman 
2002). In the study performed by Hardamn and Ion, EPA and DHA had no effect despite 
significantly higher levels of EPA and DHA being found in the liver of  mice fed the 
walnuts diet compared to control. Because the only source  of the omega 3 bond was the 
ALA of the walnuts, the increased EPA and DHA indicates that the ALA of the walnut 
was probably being effectively elongated and desaturated to EPA and DHA in the liver. As 
a consequence, it is likely that the arachidonic acid was significantly decreased, reducing 
the amount of substrate available for synthesis of inflammatory prostaglandin E2 (PGE2) 
in the tumour. PGE2 has been found to be promotional to tumour cell proliferation 
(Amano, Hayashi et al. 2003).  
 
The beneficial effects of ALA from walnuts on tumour suppression has also been shown in 
ApcMin/+ mice, however using a different dietary source of ALA. Bommareddy et al. 
(Bommareddy, Zhang et al. 2009) fed ApcMin/+ mice for 12 weeks with a diet with 15% 
of the dietary calorie from flaxseed meal or flaxseed oil, which is also rich in ALA. They 
found that flaxseed meal and oil not only significantly suppressed intestinal polyp 
formation by about 45%, but also lowered tumour multiplicity and tumour size compared 
to control diet. They also found lower levels of AA, COX-1 and COX-2 expression in the 
animal group fed the flaxseed oil and meal compared to control. As a result, they 
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speculated that the conversion of AA to prostaglandins (tumour promoters) mediated by 
COX might have also been decreased.    
 
5.2.2.3. Cocoa 
 
Although numerous polyphenolic compounds are present in the (Theobroma cacao L.), 
cocoa powder is particularly rich in a subclass of polyphenolics known as flavonoids 
(catechin, epicatechin, procyanidins), which can be also found in tea. There is limited 
epidemiological data that shows interesting effects of cocoa in relation to cancer 
(Maskarinec 2009). On the other hand, several experiments have demonstrated a variety of 
anti-cancer effects of phytochemicals present in the cocoa (Ramljak, Romanczyk et al. 
2005; Gu, House et al. 2006; Aron and Kennedy 2008). 
 
Effects of cocoa on mitosis and apoptosis 
 
Flavonols and procyanidins from cocoa have shown to have positive effects against colonic 
cancer in cell line. Carnesecchi et al. (Carnésecchi, Schneider et al. 2002) have treated 
Caco-2 cells with 50ug/ml of cocoa powder (CC), crude procyanidin (CP) and 
procyanidin-enriched extracts (PE). They found 25% inhibition of cell proliferation by CP, 
whereas PE extracts inhibited 75% of cell growth. CC which had the lowest content had no 
effect on mitosis. No effect on apoptosis, measured by DNA fragmentation was observed 
in the cells treated with PE extracts. However, cocoa flavonols and procyanidins caused 
Caco-2 cell death by a non-apoptotic process, which as measured by the lactate 
dehydrogenase release into the culture medium. Procyanidin from cocoa have also 
demonstrated its anti-proliferative effect in human breast cancer cells (Ramljak, 
Romanczyk et al. 2005). 
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An animal study with ApcMin/+ mouse has also shown a positive effect of a catechin on 
cell proliferation inhibition. Bose et al. (Bose, Hao et al. 2007) have fed the ApcMin/+ 
mice with a high fat (20% (w/w) diet added 0.16% of (-)-epigallocatechin-3-gallate 
(EGCG) or high fat fish oil diet in combination of EGCG for 9 weeks. They found that 
EGCG decreased the proliferation index by 53%, and the combination of EGCG with fish 
oil reduced by 25% compared to its control. The apoptotic index was also significantly 
higher in the tumours of all treatment groups.   
 
Effects of cocoa on inflammation 
 
In that same study performed by Bose et al. (Bose, Hao et al. 2007), they have tested the 
effect of EGCG on PGE2 level on the small intestine, and a significant decrease was 
observed. They found that the dietary EGCG combined with fish oil reduced PGE2 levels 
by 81%. However, in the present study PGE2 levels were not measured.  PGE2 mediates 
the inflammation process, and is also involved in the production of cytokines (Dooper, 
Wassink et al. 2002).  
 
ECGC has also been shown to decrease NF-kB levels and activity in a dose dependent 
manner in cancer and normal human epidermal keratinocytes (Ahmad and Mukhtar 1999). 
In accordance with that result, other studies have reported the inhibitory effect of ECGC on 
NF-kB activation, which is also directely connected with cytokines production (Ahmad 
and Mukhtar 1999; Wenzel, Kuntz et al. 2000; Nishikawa, Nakajima et al. 2006). 
 
While NF-kB can be modulated by phytochemicals, and consequently may be affecting 
cytokines production (Paur, Austenaa et al. 2008; Paur, Balstad et al. 2010; Paur, Balstad 
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et al. 2010), Crouvezier et al. (Crouvezier, Powell et al. 2001) has shown that phenolic 
components of tea may modulate pro- and anti-inflammatory cytokine production. They 
studied the effect of 4 different catechins (epicatechin EC; epicatechin gallate ECG; 
epigallocatechin EGC; and EGCG) and tea extract (TE) on cytokines production by human 
leukocytes in vitro. Their results in whole blood cultures showed that EC or ECG had no 
effect on the production of IL-1#, IL-6 or TNF-". However EGC and EGCG inhibited IL-
1#. The TE thus produced a small, but inconsistent, inhibition of IL-1#. Moreover, the 
combination of all 4 catechins had no effect on any of the pro-inflammatory cytokines.  
They speculated that tea-derived catechin may not affect inflammation through mechanism 
involving the NF-kB, as the most of the pro-inflammatory cytokines were not affected in 
their study. 
 
Effects of cocoa on tumour development 
 
The effect of EGCG on tumorigenesis in ApcMin/+ mice has been reported in the study 
performed by Bose et al. (Bose, Hao et al. 2007). They fed the mice an EGCG plus fish oil 
diet for 9 weeks and found that 0.16% of EGCG combined with fish oil reduced 
multiplicity of tumours by 53%, while EGCG alone reduced by 19%, and fish oil alone had 
no effect. They found the distal part of the small intestine was most affected by the EGCG 
+ fish oil diet, and tumours were reduced by 58% compared to control. In the present 
study, the distal part was also the most affected by the phytochemical diet; however, the 
result went in the opposite direction and the phytochemical diet increased the multiplicity 
by 72% compared to control.  
 
There is another study in which the effect of white and green tea on tumorigenesis in 
ApcMin/+ was also studied. Orner et al. (Orner, Dashwood et al. 2003) have given a 
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standard diet plus 1.5% of white and green tea as drinking water for 12 weeks. They found 
that both teas reduced the number of tumours. In the distal part of the small intestine, they 
found that white tea was more effective than green tea in reducing tumour number. 
Interestingly, they reported that when both teas were combined with the chemopreventive 
pharmaceutical sulindac (a non-steirodal anti-inflammatory drug, NSAIDs) the 
chemopreventive effect of the diet was 70% more effective in reducing the number of 
tumours in the ApcMin/+ mice.  
 
In contrast with the results found by Oikarinen et al. (Oikarinen, Erlund et al. 2007),  in 
which coffee had no effect on levels of #-catenin in tumours of ApcMin/+ mice, Bose et al. 
showed that catechins from tea significantly reduced the level of #-catenin translocation 
from the cell membrane to the nucleus in the group fed not only the EGCG diet, but also in 
the group fed the EGCG plus fish oil. In accordance to that result, Orner et al (Orner, 
Dashwood et al. 2003) have also found reduced level of #-catenin when tea was combined 
with sulindac. 
 
5.2.2.4. Turmeric and Thyme 
 
Turmeric (Curcuma longa) is a dietary plant rich in phenolic acids, especially curcumin, 
which is a yellow pigment, also found in mustard, and is widely used for flavouring and 
colouring in foods. Thyme (Thymus spp.) is an herbal plant used for flavouring and it is 
also rich in phenolic acid, such as rosmarinic acid.  
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Effects of turmeric and thyme on mitosis and apoptosis 
 
Mahmoud et al. (Mahmoud, Carothers et al. 2000) performed a study with ApcMin/+ mice 
for 15 weeks to in order to observe the effect of plant derived-phenolics on cell 
proliferation and cell death. They have analysed the enterocyte proliferation and found that 
treatment with curcumin increased enterocyte proliferation in the intestinal tissue of 
ApcMin/+ mice, resulting in a normalisation of enterocyte proliferation. It has been 
previously demonstrated in the literature that a normal migration of enterocytes from the 
crypts to the villus tips is inhibited in the ApcMin+ mice, and consequently, the mucosal 
enterocytes of these animals have a reduced turnover rate (Mahmoud, Bilinski et al. 1999). 
So in that study, curcumin restored the enterocyte migration rate to the level of wild-type 
animals.  
 
The same study also showed that 1.5% of curcumin in the diet led to a 10-fold increase in 
the number of apoptotic cells in ApcMin/+ mice when compared to the untreated 
ApcMin/+ mice. However no difference was found when compared to wild-type animals. 
Their result is in contradiction to the result found in the present experiment, in which the 
phytochemical mix did not show any difference between treated and untreated ApcMin/+ 
mice.  
 
Effects of turmeric and thyme on inflammation 
 
Lim and Kwon (Lim and Kwon 2010) showed that curcumin induced a down regulation of 
MCP-1 expression in human monocytic cell lines from lymphoma (U937). In animal 
model that develop colitis, Nones et al. (Nones, Knoch et al. 2009) have shown that adding 
curcumin to the diet significantly reduced intestinal inflammation. Moreover, curcumin has 
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been demonstrated to inhibit NF-kB (Gong, Li et al. 2003; Shishodia, Amin et al. 2005; 
Paur, Austenaa et al. 2008). Thyme has also been reported to inhibit NF-kB (Paur, Balstad 
et al. 2010). 
 
Effects of turmeric and thyme on tumour development 
 
A very recent study performed by Mudduluru et al. (Mudduluru, George-William et al. 
2010) has shown the anti-carcinogenic effects of curcumin in colonic epithelial cell line 
(HCT116). The cancer cells treated with curcumin reduced the expression of miR-21, 
which is normally over expressed in tumours, inhibited tumour growth and invasion. 
Nautiyal et al. (Nautiyal, Banerjee et al. 2010) have also found similar results using the 
same cell HCT116 cell line. 
 
There are only two studies performed in the ApcMin/+ mouse to study the 
chemopreventive effect of curcumin (Mahmoud, Carothers et al. 2000)(Perkins, 
Verschoyle et al. 2002). In the first study 0.15% curcumin in the diet reduced intestinal 
tumour formation by 64% after 10 weeks. In the second study various concentrations of 
curcumin in the diet were tested (0.1, 0.2, or 0.5%) for a period of 15 weeks and they 
found that although the concentration of 0.1% curcumin had no effect on tumour burden 
diets containing 0.2 and 0.5% curcumin significantly reduced tumour burden by 40% and 
tumour number by 30% but not significantly. They also found differences in the effect of 
curcumin on tumour size according to the dose and region of the intestine.  
 
Similarly, Perkins et al. (Perkins, Verschoyle et al. 2002) have found that curcumin have to 
be administered in a certain amount in the diet to be able to affect tumorigenesis, at least in 
ApcMin/+ mouse. They found no effect of curcumin in the diet with 150 mg/kg body 
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weight/day, whereas at ~300 mg/kg/day curcumin prevented, or retarded, adenoma 
formation. A further increase to ~750 mg/kg/day failed to yield any additional gain in 
efficacy. In the present study the dietary turmeric was present at 3.1 g/kg (0.3%) of diet, 
and the daily consumption was ~9mg per day/mouse (450 mg/kg body weight/ day). 
However they have used pure curcumin. It is suggested that in 100g of turmeric there is 3-
5g of curcumin. Based on that, the amount of curcumin in the present diet was at least 
0.09g/kg. The amount of curcumin ingested by the animals in the present study was well 
below the lowest dose used by Perkins et al. (Perkins, Verschoyle et al. 2002) 
(~0.42mg/animal/day), in which they found no effect. The positive effect of curcumin in 
ApcMin/+ mouse was found when animals ingested at least 0.84mg of curcumin in the diet  
(Perkins, Verschoyle et al. 2002). Based on that, the amount of curcumin present in the 
present study would have no effect on adenoma formation.  
 
5.2.2.5. Berries 
 
Berries present in the phytochemical mix used in this study were bilberries (Vaccinium 
myrtillus L) and blackcurrant (Ribes Nigrum). Both berries are among the fruits with  the 
highest content of phytochemicals, such as anthocyanins, but also contain flavonols 
(quercetin, kaempferol), and isoflavonoids. 
 
Effects of berries on mitosis and apoptosis 
 
Musk et al. (Musk, Stephenson et al. 1995) have studied the effect of quercetin on cell 
proliferation of human colorectal adenocarcinomas cell line HT29, and found a significant 
inhibition by the treatment with quercetin. Quercitin not only inhibited mitosis but also 
induced apoptosis. 
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Gee et al. (Gee, Hara et al. 2002) tested the effect of quercetin in tissue of rats treated with 
quercetin in the diet for 7 days. They found that quercetin significantly reduced the 
frequency of crypt cell mitosis in the proximal, mid, and distal small intestine, and the 
distal colon. However, a trend for quercetin to induce mitosis in the caecum was also 
observed. Regarding the apoptosis levels, that study showed no effect of quercetin either in 
the small or large intestine. In the present study cell proliferation was not measured in the 
proximal and mid small intestine, but only in the distal small intestine and in the colon. 
The reason for choosing only the distal part for the cytokinetics measurements was because 
the tumour load in the distal part was the highest compared to the other regions of the 
small intestine. In that same experiment, Gee et al. injected rats with DMH and rats fed 
1g/kg quercetin had reduced cell proliferation after 30h of exposure. At 6 weeks after a 
second exposure of DMH, lower levels of cell proliferation were still evident. However, 
the frequencies of apoptosis in DMH-induced rats were not affected by quercetin.  
 
Blueberry extract has also been shown to reduce cell proliferation in endothelial cell 
neoplasms by oral treatment of mice with hemaangioendothelioma (Gordillo, Fang et al. 
2009). In that same study, Gordillo et al. reported that blueberry extract inhibited the NF-
kB signalling pathway. Berries have also been reported to inhibit cell proliferation in cell 
lines of colorectal cancer. Blackberry juice and blackberry extract inhibited HT29 colon 
cancer cell proliferation (Kang, Seeram et al. 2003). Proliferation of breast cancer line 
MCF-7 and the colon cancer cell line HT29 was reduced by up to 74% following exposure 
to extracts of several fruits and berries including blueberries, blackcurrant, black 
chokeberries and raspberries at concentrations ranging from 0.025 to 0.5% (Olsson, 
Gustavsson et al. 2004).   
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Effects of berries on inflammation 
 
Camuesco et al. (Camuesco, Comalada et al. 2006) performed a study in rats with 
intestinal inflammatory disorder (DSS-induced colitis) to evaluate the effect of the 
bioflavonoid quercetin combined with fish oil on the concentration of colonic pro-
inflammatory mediators. They found a significant reduction in TNF-" and IL-1#, and that 
effect was greater when compared with rats receiving a fish oil diet without the flavonoid. 
That study brings attention to the fact that synergism may occur between phytochemicals 
and the type of fatty acids consumed in the diet.    
 
Ziegler et al. (Ziegler, Rainwater et al. 2004) have performed a study in ApcMin/+ mice in 
which they analysed the levels of COX-2 and PGE2 in tumours from mice treated with 
dietary resveratrol, which is a phytochemical present in grapes, berries and red wines. They 
found that animals treated with resveratrol for 7 weeks had decreased levels of PGE2 in 
tumour tissue by 42%, but no effect was observed in COX-2 protein expression. 
Prostaglandins and COX-2 are key mediators in inflammation and inflammation-associated 
tumours (Schetter, Heegaard et al. 2010). 
 
Effects of berries on tumour development 
 
The chemopreventive effect of quercetin on the number of ACF in the colon was analysed 
by Gee et al. (Gee, Hara et al. 2002). They fed DMH-induced rat with quercetin in the diet 
and found that after 42 days the numbers of single aberrant crypts in the distal part of the 
colon, the total area of aberrant crypt foci, and the numbers of larger ACF were 
significantly lower in animals fed quercetin than in control animals. A study performed by 
Bobe et al. (Bobe, Wang et al. 2006) was done with a slightly different approach from the 
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previous study. They combined a dietary phytochemical therapy with an anticarcinogenic 
pharmaceutical at a suboptimal dosage to minimize any potential adverse side effects, to 
study the chemopreventive effect on tumorigenesis. ApcMin/+ mice were fed various 
dosages of anthocyanin-rich tart cherry extract with 0.01% sulindac for 19 weeks. The 
small intestine of ApcMin/+ mice fed the anthocyanin-rich tart cherry with sulindac had a 
20% reduced total tumour area compared to animals fed sulindac alone. Tumour number 
was also reduced by 22% in the intestine of animals treated with the phytochemical and 
sulindac. Similarly to my own observation, they also found decreased tumorigenesis in the 
proximal and in the mid small intestine, while increased tumour number and tumour area 
was found in the distal SI. There was no effect between different dosages (0, 375, 750, 
1500, 3000mg of the anthocyanin-rich tart cherry extract on tumour number or area in any 
of the three intestinal sections.        
 
In the present experiment the phytochemical mix had a huge effect on increasing 
tumorigenesis in the colon of ApcMin/+ mice, as mentioned before. The present result is in 
accordance with that found by Bobe et al. when no sulindac was added to the diet (Bobe, 
Wang et al. 2006). They found that the prevalence of papillary tumours in the large 
intestine were similar between the treated and untreated group. However, when different 
doses of anthocyanin-rich tart cherry extract was considered, they found animals receiving 
the highest dose, 1500mg of anthocyanin-rich extract/kg of diet had or tended to have a 
greater prevalence and number of papillary tumours when compared to the group receiving 
the lowest dose of anthocyanin-rich extract. These results show that the amount of 
phytochemicals used in the diet might have a great influence on tumorigenesis in the colon 
of ApcMin/+ mouse.  
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Another study performed by Cooke et al. (Cooke, Steward et al. 2005) has also used the 
ApcMin/+ mouse model but showed a positive effect of an anthocyanin-rich diet on 
preventing tumorigenesis. Furthermore, anthocyanin has also been shown to decrease 
colonic ACF formation, which is a biological markers for tumorigenesis in carcinogen-
induced rat models (Hagiwara, Miyashita et al. 2001; Harris, Gupta et al. 2001; Hagiwara, 
Yoshino et al. 2002) 
 
Misikangas et al. (Misikangas, Pajari et al. 2007) have also shown a positive 
chemopreventive effect of 3 different berries on colorectal cancer in ApcMin/+ mice. They 
have fed ApcMin/+ mice for 10 weeks with a high fat diet with added bilberry (10%), 
lingonberry or cloudberry. They found that all the berries significantly inhibited the 
formation of intestinal adenomas by 15-30%. However, only lingonberry and cloudberry 
inhibited adenoma growth by over 60% in the distal small intestine. In the present study, 
the phytochemical mix had 0.16% of bilberries and blackcurrant in the phytochemical diet, 
and maybe this amount was not enough to have an effect however synergisms can occur 
between the phytochemicals and produce an unpredictable effect. Although no tests were 
performed in the present experiment to study the synergism between the phytochemical 
compounds used in the experimental diet. 
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5.2.3. General conclusion on the effects of phytochemicals 
 
Despite the positive effects of several phytochemicals shown in the literature by different 
studies including epidemiological, in cell lines and in animals, the real effects of 
phytochemicals are still unclear, especially in human studies. Another point that should be 
considered is that in many studies only 1 or 2 phytochemicals are tested. But, in real life 
people eat daily a combination of phytochemicals of which little is known of their effects 
in combination or on bioavailability and dose.  
 
In the present experiment, the mix of phytochemicals used in the phytochemical treatment 
diet significantly increased inflammation, not only in the small intestine, where all the 
tumour development process was taking place in the animal model used, but also in the 
colon, and in the plasma. However, in the wild-type mice the phytochemical diet actually 
had a positive anti-inflammatory effect. Based on these results, it could be speculated that 
these phytochemicals might be acting in a more specific way. For example their 
antioxidant effect may adversely modify the carcinogenesis process happening in the 
ApcMin/+ mice, which might also have a direct effect on the inflammatory markers. The 
mechanisms of action of phytochemicals in inflammation and carcinogenesis are still 
unclear, but it has been shown that these chemical compounds present in several foods and 
plants are considered to have an effect on inhibition of signalling through NF-kB, which its 
activation plays a central role in inflammation, which consequently affects carcinogenesis. 
The expression of NF-kB proteins can provide site and event-specificity in response to a 
particular stimulus, such as activation of pro-inflammatory genes, production of TNF-", 
IL-1#, IL-6 and IL-8, and also expression of COX-2  (Tak and Firestein 2001). NF-kB has 
also been implicated in the induction of pro-inflammatory cytokines in animal models of 
inflammation, however it is not certain whether its activation in colonic epithelium and 
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increases in pro-inflammatory cytokine production are the cause or result of NF-kB 
binding (Tak and Firestein 2001). Overall, more studies on the preventive effects of 
phytochemicals against the development of colorectal cancer are necessary to be 
performed in order to clarify by which mechanisms phytochemicals could affect 
carcinogenesis.   
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6. CONCLUSION 
 
The present thesis tested in vivo the chemopreventive effects of dietary foods such as fatty 
acids and phytochemicals on colorectal cancer.  The animal model chosen to perform the 
experiment was the ApcMin/+ mouse because of its similarities to the development of 
adenomatous polyposis in humans. Thus, the present work contributes to the understanding 
of how fatty acids and phytochemicals can affect the tumour development of colorectal 
cancer. 
 
The fatty acids experiment has demonstrated contradictory results. It has been widely 
published and accepted in several previous studies that n-3 PUFAs may module cytokinetic 
activities by reducing cell proliferation and increasing apoptosis in models of colorectal 
cancer. However, in the present study n-3 PUFAs did not have a positive effect in 
ApcMin/+ mice regarding these endpoints. Besides, contradicting the several studies in the 
literature, n-6 PUFAs did not look to be pro-carcinogenic by up regulating the cell 
proliferation activities and inhibiting apoptosis in the animal model used in the present 
work. The results on inflammation was also contradictory, because n-3 PUFAs increased 
local inflammation, acting as a pro-inflammatory agent while n-6 PUFAs reduced local 
inflammation in ApcMin/+ mice. Despite these unexpected results relating to cytokinetics 
and inflammation, the n-3 PUFAs did inhibit tumour promotion in ApcMin/+ mice by 
reducing the size of tumours, but not the numbers of tumours. In order to really elucidate 
the effects of fatty acids on colorectal cancer prevention, more studies are needed as 
outlined below.  
 
As regards the effects the phytochemicals, the results were not promising either. While 
there were no effects of the phytochemical mix used in the diet on the cytokinetic activities 
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in the small or large intestine, phytochemicals did increase the local and systemic 
inflammation in the disease model. Moreover, phytochemicals also promoted tumour 
development in ApcMin/+ mice by increasing the number and size of tumours, both in the 
small and large intestine. Despite all the anti-proliferative, anti-inflammatory and anti-
carcinogenic effects that have been attributed to coffee, walnuts, cocoa, turmeric, thyme, 
and berries in the literature, the present study showed that this specific dietary 
phytochemical mix did not prevent the promotion of colorectal cancer in ApcMin/+ mice, 
but instead promoted tumour development. Using dietary foods as source of 
phytochemicals, the information on individual components and their potential effect are 
lost, however the relevance to nutrition is increased, as it mimics the human food 
consumption. 
 
In conclusion, more studies are needed to really understand the effects and the mechanisms 
by which fatty acids and phytochemicals may or may not be preventive against colorectal 
cancer prevention.   
 
 
6.1. LIMITATION OF THE STUDY 
 
The present study has certain limitations that need to be taken into account when 
considering the study and its contributions. The first limitation to be considered is in 
regards the animal breeding. Breeding ApcMin/+ mice can be quite challenging, which in 
the present study this process took a very long time until the total amount of animals were 
obtained for each treatment group. Moreover, mice at weaning age (3 weeks) were not 
always ready to go on a treatment diet, as they were too small. So a longer time had to be 
waited until they could have gone on the treatment diet. Regarding the experimental 
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design, the dietary treatment diets had to be limited to only a high fat composition diet at 
25%kcal fat. However it would have been interesting to also have a normal fat diet (7-9% 
kcal fat) to be used in the experiment. However it would have doubled the size and the cost 
of the experiment. Regarding the cytokinetics analysis, cell proliferation and apoptosis 
were measured at the normal looking gut tissue. However, if the measurements had also 
been done in the adenoma tissue maybe different effect would have being observed. 
Moreover, those measurements were done only in the distal part of the small intestine, but 
having the measurements done in all the parts of the intestine could have shown a better 
picture of what was happening regarding cell proliferation and apoptosis. The 
measurement of the cytokines present was also a limitation in the present study. The 
profile of cytokines was only measured after the dietary treatment at week 10, but not at 
baseline. Besides, an accurate effect of the dietary treatments could not be verified.  
 
 
6.2. FUTURE WORK 
 
Following the investigations described in the thesis, a number of further analyses could be 
carried out. Regarding the fatty acids experiment, a gene expression study could be done to 
find out how different fatty acids could affect the expression of genes related to cell 
proliferation, apoptosis, inflammation, and tumorigenesis. Regarding the phytochemical 
study, separate animal experiments could be done to test the effect of individual dietary 
foods on tumour development in ApcMin/+ mouse, as well as different mixes of those 
dietary compounds.    
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